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By
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DeAnna L. Adkins, PhD
Colleen A. Hanlon, PhD

The corticospinal drive to the paretic soleus (SOL) and tibialis anterior (TA) is degraded,
but whether it changes and is task-dependent remains unclear. We examined the
relationships between corticospinal drive and muscle-specific neuromechanics. We
collected eight measures of corticospinal drive to SOL and TA in healthy and stroke
participants, and muscle-specific neuromechanics during walking and isolated task in
stroke participants. We examined the reliability, and the inter-group differences in
variance and mean for each corticospinal measure, and the correlations between
corticospinal drive and neuromechanics of each muscle in both tasks. Only certain
corticospinal measures were simultaneously reliable and had inter-group differences in
variance and mean. SOL resting latency was not associated with any neuromechanical
measure in either task, whereas TA resting and active latencies were associated with only
the ankle angular velocity during walking. In conclusion, TA latencies may strongly
indicate an impaired mechanical pattern in the ankle during walking.
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CHAPTER ONE
INTRODUCTION
1.1

Background and Need
The motoneurons of plantarflexors (PF) and dorsiflexors (DF) have connections

with their respective areas in the primary motor cortex (MC). Early work using
transcranial magnetic stimulation (TMS) suggested that corticomotoneuronal (CM)
connections (i.e., fast corticospinal projections that are monosynapticaly connected with
spinal motoneurons) to tibialis anterior (TA), which is the primary DF, are numerous and
strong whereas the CM connections to PF, gastrocnemius (GAS) and soleus (SOL), are
few and weak (Brouwer & Ashby, 1992; Brouwer & Qiao, 1995). Contradicting the
assumption that PF had fewer CM connections than DF, subsequent evidence showed
that PF, in particular SOL, had as many CM connections as TA, yet the strength of the
input-output relations was found to be weaker in SOL than in TA (Bawa, Chalmers,
Stewart, & Eisen, 2002). The weaker CM connections to the PF (SOL) led to the
suggestion that other descending pathways than corticospinal might contribute to the
control of these muscles (J. Nielsen & Petersen, 1995). This discrepancy in the strength
of CM connections might be due to the different functional role that each muscle group
plays. The PF, as high force generating muscles (e.g., active during the stabilization and
push off periods during the stance phase of walking), may have strong reliance on

subcortical pathways (i.e., corticoreticulospinal, corticorubrospinal) (J. Nielsen &
Petersen, 1995). In contrast, the DF, as fine motor skill muscles (e.g., foot clearance
during the swing phase of walking), may rely more on cortical control.
Regardless of the neurophysiological and functional differences between PF and
DF, the motor corticospinal excitability (MCE) of both muscle groups can be quantified
by using TMS (Ackermann, Scholz, Koehler, & Dichgans, 1991). Typically in those
without neurologic impairment, the resting motor threshold (rMT) is higher for PF than
DF, the motor evoked potential (MEP) amplitude is smaller in PF than in DF, and the
MEP latency is similar between PF and DF (Rossini et al., 1999). Furthermore, the MCE
of PF and DF may be task dependent. The PF (SOL) stimulus response curve was less
during the stance phase of walking than in maximum voluntary isometric contraction
(MVIC), whereas the DF MCE was high and similar in the swing phase of walking and
MVIC in early studies with healthy controls (Capaday, Lavoie, Barbeau, Schneider, &
Bonnard, 1999). Therefore, MC via the CM connections may strongly contribute to the
control of DF during the swing phase but not during the stance phase for PF control.
During MVIC, however, control of both PF and DF may rely heavily on motor cortical
input.
Though some evidence of the motor cortical control of PF and DF in healthy
adults does exist, only a few studies have examined the PF and DF MCE after stroke. In
order to detect real changes in MCE after stroke, the measure used to quantify MCE
should meet certain psychometric prerequisites such as reliability and validity. These
studies, one for each muscle group, reported good reliability for certain PF (SOL) and DF
MCE measures (Cacchio et al., 2011; Lewis, Signal, & Taylor, 2014). In addition to the

reliability studies, few studies tested the changes in PF and DF MCE after stroke using
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several MCE measures. The focus in those studies was on the paretic side in which the
greatest changes in PF and DF MCE occur. Compared to healthy controls, the active MT
(aMT) of PF (SOL) increases (i.e., greater stimulus intensity is required to elicit MEP)
(Lewis et al., 2014) while the MEP latency and amplitude of DF increase and decrease,
respectively (Beaulieu, Masse-Alarie, Brouwer, & Schneider, 2014). Nevertheless, a few
gaps still exist in the current knowledge regarding the measurement of PF and DF MCE
after stroke. No study has investigated systematically the reliability of the most
commonly used PF and DF MCE measures in either healthy controls or stroke
participants. In addition, little is known about which PF and DF MCE measures detect the
differences in central nervous system (CNS) function between individuals with stroke
and healthy controls.
After stroke, the PF and DF function during motor tasks is degraded like their
motor cortical control is degraded. However, it is not well understood whether the control
of each muscle group is task-specific and whether these alterations are similar between
PF and DF. An approach to elucidate these gaps is to investigate the associations between
the PF or DF MCE and specific measures of PF or DF neuromechanical function (i.e.,
muscle activity, joint kinetics and kinematics) during a functional task (e.g., walking) and
voluntary motor task (e.g., MVIC). In people with chronic stroke, a positive relationship
was reported between the amplitude of DF MEP and DF range of motion (ROM) and
strength during MVIC (Beaulieu et al., 2014). In addition, strong relationships were
found between the amplitude and latency of DF MEP and forefoot elevation (kinematic
measure that quantifies indirectly the function of TA during swing) during walking in

people with spinal cord injury (SCI) (Barthelemy et al., 2013; Barthelemy, Willerslev-
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Olsen, Lundell, Biering-Sørensen, & Nielsen, 2015; Barthelemy et al., 2010). Such
evidence strengthens the notion that investigating the associations between MCE and
neuromechanics of PF and DF may contribute to a better understanding of the motor
cortical control of PF and DF during different tasks in people post-stroke.

1.2

Problem Statement
Among the measures used in these associations, the PF and DF MCE measures

are the least well understood, especially in people post-stroke. Therefore, it is crucial to
use an MCE measure that has low methodological error (i.e. reliable) and detects the
differences in both central tendency (i.e., mean) and dispersion measures (i.e., variance)
between an intact and lesioned CNS (i.e., stroke). Though a few studies reported good
reliability of certain PF and DF MCE measures in people post-stroke (Cacchio et al.,
2011; Lewis et al., 2014), there is no clear understanding as to which measure clearly
elucidates changes in PF and DF MCE that result from damage to the nervous system.
This understanding is essential prior to conducting any sort of correlational analysis to
determine the relationships between the MCE and the neuromechanics of PF and DF.
Investigating the associations between MCE and neuromechanics of PF and DF
during functional and isolated tasks in people post-stroke may reveal the underlying
motor cortical control, which, as implied in the early control studies, may not be the same
for each muscle group. This evidence may provide vital information on how PF and DF
are controlled after a brain lesion and influence rehabilitation practices to help people
post-stroke optimally gain functional recovery. Unfortunately, such potential associations

have not been well investigated in stroke. Limited evidence exists during walking for PF
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and DF; the only existing evidence is for DF during MVIC (Beaulieu et al., 2014).

1.3

Specific Aims and Hypotheses

Specific aims for this dissertation were as follows:
Aims 1 and 2:
The overall goal of Aims 1 and 2 was to quantify eight MCE measures of SOL and TA in
people post-stroke and in healthy controls. For thorough explanation on the justification
for Aims 1 and 2 and their hypotheses, see section 3.1.
Specific Aim 1: To determine which of the eight SOL MCE measures was
reliable both in healthy controls and in people post-stroke yet differed in both variance
and mean between groups.
When SOL was at resting state:
Hypothesis 1.1.a: SOL rMT, latency, and normalized latency of SOL would be
the most reliable in both groups
Hypothesis 1.1.b: SOL rMT would be significantly higher and more variable in
people post-stroke than in healthy controls.
Hypothesis 1.1.c: SOL latency would be significantly longer and more variable in
people post-stroke than in healthy controls.
Hypothesis 1.1.d: SOL normalized latency would be significantly longer and
more variable in people post-stroke than in healthy controls.
When SOL was at active state:
Hypothesis 1.2.a: SOL latency, normalized latency, and contralateral silent period

(cSP) would be the most reliable in both groups.
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Hypothesis 1.2.b: SOL latency would be significantly longer and more variable in
people post-stroke than in healthy controls.
Hypothesis 1.2.c: SOL normalized latency would be significantly longer and more
variable in people post-stroke than in healthy controls.
Hypothesis 1.2.d: SOL cSP would be significantly longer and more variable in
people post-stroke than in healthy controls.
Specific Aim 2: To determine which of the eight TA MCE measures were
reliable both in healthy controls and in people post-stroke yet differed in both variance
and mean between groups.
When TA was at resting state:
Hypothesis 2.1.a: TA rMT, latency, and normalized latency of SOL would be the
most reliable in both groups.
Hypothesis 2.1.b: TA rMT would be significantly higher and more variable in
people post-stroke than in healthy controls.
Hypothesis 2.1.c: TA latency would be significantly longer and more variable in
people post-stroke than in healthy controls.
Hypothesis 2.1.d: TA normalized latency would be significantly longer and more
variable in people post-stroke than in healthy controls.
When TA was at active state:
Hypothesis 2.2.a: TA latency, normalized latency, and cSP would be the most
reliable in both groups.
Hypothesis 2.2.b: TA latency would be significantly longer and more variable in

people post-stroke than in healthy controls.
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Hypothesis 2.2.c: TA normalized latency would be significantly longer and more
variable in people post-stroke than in healthy controls.
Hypothesis 2.2.d: TA cSP would be significantly longer and more variable in
people post-stroke than in healthy controls.
Aims 3 and 4:
The overall goal of Aims 3 and 4 was to investigate the associations between the
descending drive, quantified by MCE measures determined in the two previous aims, and
the specific ankle neuromechanics of the paretic SOL and TA during walking and MVIC
in people post-stroke. For thorough explanation on the justification for Aims 1 and 2 and
their hypotheses, see section 3.1.
Specific Aim 3: To investigate the associations between the MCE measures
determined in Aim 1 and the neuromechanics of the paretic SOL during walking and
MVIC in people post-stroke.
For the functional task (i.e., walking):
Hypothesis 3.1.a: SOL MCE would not be significantly associated with SOL
electromyography (EMG) in stance phase.
Hypothesis 3.1.b: SOL MCE would not be significantly associated with
propulsive impulse (PI).
For the isolated voluntary task (i.e., MVIC):
Hypothesis 3.2.a: SOL MCE would be significantly and negatively associated
with SOL EMG.
Hypothesis 3.2.b: SOL MCE would be significantly and negatively associated

with SOL isometric torque.
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Specific Aim 4: To investigate the associations between the MCE measure(s), as
determined in Aim 2, and the neuromechanics of TA during walking and MVIC in people
post-stroke.
For the functional task (i.e., walking):
Hypothesis 4.1.a: TA MCE would be significantly and negatively associated
with TA EMG in the first half of swing phase.
Hypothesis 4.1.b: TA MCE would be significantly and negatively associated
with ankle angular velocity (AAV).
For the isolated voluntary task (i.e., MVIC):
Hypothesis 4.2.a: TA MCE would be significantly and negatively associated with
TA EMG.
Hypothesis 4.2.b: TA MCE would be significantly and negatively associated with
TA isometric torque.

CHAPTER TWO
REVIEW OF THE LITERATURE
2.1

Introduction
After a stroke, two muscle groups in the lower limb that are impaired significantly

are PF and DF. Since PF and DF play a significant role in various motor tasks, especially
in upright activities (e.g., walking), their impairments due to stroke detrimentally
influence the motor performance in these tasks. Though several rehabilitation strategies
exist, none can fully restore either PF or DF function or the performance of the specific
task. A possible reason might be the insufficient understanding of the underlying
neurophysiological mechanisms of the motor control of these two muscle groups. The
motor cortical input, which is one of the neural inputs to alpha motoneurons of the target
muscle during a task, can be quantified using TMS in both healthy adults and individuals
with neurological injury.
A potential approach is the investigation of the association between the motor
cortical control and specific neuromechanics of PF and DF. The motor cortical control of
PF and DF can be quantified using measures of MCE, while the task neuromechanics
quantify indirectly the contributions of each muscle group during a specific task. To
determine whether there are true associations between brain (i.e., MC) and motor
behavior, the measures used in these associations must truly identify the construct of
interest.
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This chapter reviews the main characteristics of PF, in particular SOL, and DF, in
particular TA, in terms of motor behavior, the basic principles and main measures of
TMS related to SOL and TA, the primary effects of stroke on SOL and TA function, the
principal measures that quantify indirectly the SOL and TA neuromechanics during
walking and MVIC, and the importance of using MCE-neuromechanics associations for
understanding the contributions of motor cortical output to SOL and TA during walking
and MVIC. Lastly, certain existing gaps in the current literature are identified.

2.2

Plantarflexors and Dorsiflexors
2.2.1

Anatomical and Physiological Characteristics

The PF and DF are muscles located at the posterior and anterior compartment of
the lower leg, respectively (Figure 2.1). The main function of the posterior muscles is to

Figure 2.1: Anatomical location of the plantarflexors and dorsiflexors

plantarflex the talocrural joint, whereas the main function of anterior muscle is to
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dorsiflex the talocrural joint (Schünke, Schulte, Ross, Schumacher, & Lamperti, 2006).
The primary PF are GAS that has two heads, medial gastrocnemius (MG) and lateral
gastrocnemius (LG), and SOL. The primary muscle of DF is TA.
MG and LG have an origin at the medial and lateral epicondyle of the femur,
respectively, while both heads are inserted at the calcaneal tuberosity via the Achilles
tendon (Schünke et al., 2006). Due to its origin and insertion characteristics, GAS is a
biarticular muscle (i.e., crossing two joints: knee and talocrural at the ankle). On the other
hand, SOL is a uniarticular muscle, it has an origin at the posterior surface of the head
and neck of the fibula, it is attached to the soleal line of the tibia via the tendinous arch,
and its insertion is the same as GAS (Schünke et al., 2006). The architectural properties
differ for GAS and SOL. GAS, in particular the MG, is composed mainly of fast and
relatively short fibers, whereas the SOL is composed only of slow and short fibers (R. L.
Lieber & Friden, 2000). On the other hand, the physiological cross sectional area (PCSA)
of the SOL is higher than MG (R. L. Lieber & Friden, 2000). PCSA and fiber length are
proportional to maximum muscle force and excursion, respectively. Regardless of the
few anatomical and physiological differences within PF, both GAS and SOL are
antigravity muscles designed to generate high force with small excursion of the muscle,
and they are innervated by the tibial nerve, which is derived from nerve roots of S1 and
S2.
Like the SOL, TA is also a uniarticular muscle. TA originates from the two upper
thirds of the lateral surface of the tibia, the crural interosseous membrane, and the highest
part of the superficial crural fascia. It is inserted at the medial and plantar surfaces of the

medial cuneiform and the medial base of the first metatarsal (Schünke et al., 2006).
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Compared to MG and SOL, TA weighs less, has larger fibers, is composed primarily by
slow twitch fibers, and has smaller PCSA (R.L. Lieber, 2010). A general conclusion is
that TA is more functional for long muscle excursions and less important for force
production (R. L. Lieber & Friden, 2000). It is innervated by the deep fibular nerve,
which is derived from the nerve roots of L4 and L5 (Schünke et al., 2006).
2.2.2

Muscle Activity during Walking

In intact human walking, PF and DF are active at different phases of the gait cycle
(GC) (Figure 2.2 A), and thus they have different functional roles. PF are mainly active
during the stance phase of gait (Figure 2.2 B), while DF are mainly active during early
stance and throughout swing (Figure 2.2 C).

Figure 2.2: Phase descriptions of the gait cycle, and muscle activity of Soleus and Tibialis Anterior
during gait cycle. (A) Depiction of a typical right gait cycle, and muscle activity of (B) Soleus and (C)
Tibialis Anterior during gait cycle. (A) Modified by Bowden et al. (2010).

Just prior to heel strike, at the onset of the GC, only the GAS is activated (among PF

13

muscles). As the leg rotates forward (5-40% of GC) PF contract mostly in isometric
mode (mainly the muscle fascicle) (Cronin, Avela, Finni, & Peltonen, 2013; Panizzolo,
Green, Lloyd, Maiorana, & Rubenson, 2013), while during the push-off phase (40-60%
of GC), PF shorten to plantarflex the foot and produce a high impulse of energy. After toe
off, GAS is slightly active due to its function as knee flexor, whereas SOL is silent. On
the other hand, DF has a big burst of muscle activity at early stance to produce forces that
isometrically (Chleboun, Busic, Graham, & Stuckey, 2007) control the lowering of the
foot to the ground. After the forefoot touches the ground, DF is less active and has a
minor role in pulling the leg forward over the foot. After the heel is off the ground, the
muscle activity of DF begins to rise again due to DF lengthening, whereas after toe off,
DF shorten and still increase muscle activity (Chleboun et al., 2007) to dorsiflex the foot
in order to clear it during mid-swing (Winter, 1987).
2.2.3

Corticomotoneuronal Connections
The motoneurons of PF and DF have connections with their respective areas in

the MC. Early work using TMS postulated that DF was more cortically controlled than
PF for three reasons. First, it was suggested that DF had more CM connections than any
other leg muscle (Brouwer & Ashby, 1992). Second, DF responses were less variable
than SOL and MG responses (Brouwer & Qiao, 1995). Third, PF responses were weak,
and other pathways (e.g., corticorubrospinal, corticoreticulospinal) might contribute to
their control (J. Nielsen & Petersen, 1995). Contradicting the assumption that PF had
fewer CM connections than DF, subsequent evidence showed that SOL has as many CM
connections as TA, yet the strength of the connections is weaker in SOL than in TA
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(Bawa et al., 2002). This discrepancy in the strength of CM connections might be due to
the different functional role that each muscle group plays. The PF, as high force
generating muscles (e.g., active during the stabilization and push off periods during the
stance phase of walking), may have strong reliance on subcortical mechanisms, whereas
the DF, as fine motor skill task muscles (e.g., foot clearance during the swing phase of

walking), may rely more on cortical control. Regardless of these neurophysiological and
functional differences between PF and DF, the MCE of SOL and TA, PF and DF muscles
that we investigated in this project can be quantified using TMS (Figure 2.3). In this
project, MCE is an umbrella term that reflects the excitatory and inhibitory characteristics
of the neuromotor axis (motor cortical areas, crossed descending motor pathways, alpha
motoneurons, and their corresponding muscles) when a stimulus via TMS is applied over
the MC.

Figure 2.3: Depiction of Soleus and Tibialis Anterior MCE assessment using TMS. Modified by
Geertsen et al. (2010)

2.3

Transcranial Magnetic Stimulation
2.3.1

15

Technical Principles

TMS is a non-invasive brain stimulation technique that can quantify the
corticospinal connectivity to muscles, as well as the intracortical and intercortical
excitability. Briefly, TMS was the successor of transcranial electric stimulation (TES),
which was developed in the early 1980’s (Merton & Morton, 1980). A few years later,
Antony Barker et al. successfully elicited an MEP in healthy adults by using a magnetic
stimulator and a coil that was placed on the person’s contralateral MC (Barker, Jalinous,
& Freeston, 1985). In contrast to TES, which can be uncomfortable and painful to the
participant due to the high intensity required, TMS can elicit an MEP to a target muscle
by applying a magnetic stimulation over the motor representation of that muscle. The
main fundamental principle of TMS is the use of electromagnetic conduction. Simply,
when an electric current passes through a metal (e.g., a stimulation coil) a magnetic field
is produced, and subsequently this changing magnetic field elicits a flow of an electric
current in the nearby environment (e.g., brain tissue) (Wasserman, Epstein, & Ziemann,
2008). When a stimulating coil is applied over the MC, the pulse generated from that coil
stimulates intracortical neurons that propagate a neural impulse from the MC to the target
muscle on the contralateral side through the crossed corticospinal tract (CST)
2.3.2

Stimulating PF and DF Motor Cortical Areas

TMS testing of the PF and DF MCE involves a few minor limitations associated
with the anatomical properties of the PF and DF motor cortical areas. First, the motor
areas of PF and DF are located adjacent to the interhemispheric fissure at approximately
3-4 cm below the scalp surface (Alkadhi et al., 2002; Conti et al., 2014; Terao & Ugawa,

2002) (Figure 2.4), while the axons of the corticospinal neurons are oriented
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perpendicular to the medial cortical surface. Second, the size of these areas is relatively
small, in particular when they are compared with hand and facial muscles (Conti et al.,
2014) (Figure 2.4). Third, these areas are not clearly segregated (Saisanen et al., 2010)
(Figure 2.5); therefore, accurate stimulation of the target motor cortical areas requires
cautious selection of certain stimulation parameters (i.e., coil type, current direction, and
optimal stimulation site).
2.3.3

Stimulation Parameters

Use of the correct coil type for stimulating the PF and DF motor cortical areas is
very important because different types of coil are capable of inducing different electric
fields in the brain. Historically, the circular/round coil was the first to be used for testing
PF and DF MCE. This type of coil has a diameter of 80-150 mm and 5-20 turns of wire
(Wasserman et al., 2008) and is typically placed usually a few centimeters (e.g., 4 cm)
anterior and lateral to vertex, the virtual intersection of the inter-aural and nasion-inion
lines (Meyer, Britton, Kloten, Steinmetz, & Benecke, 1991). Subsequently, two types of
figure-of-eight coil (i.e., two round coils together) were developed, flat and double cone,
which typically are positioned either over the vertex or over 1-2 cm posterior. Terao et al.
(1994) compared the effect of three coil types, large figure-of-eight with various angles,
small figure-of-eight, and round coil, on the TA MCE. The large figure-of-eight coil with
posterior current and round coil with lateral current induced the largest TA MEPs and
used the lowest MT. A large figure-of-eight coil was more efficient than the round coil
when TA was relaxed, whereas both coils elicited TA MEPs from all subjects when TA

was active (Terao et al., 1994).
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Figure 2.4: Neuronavigated TMS-based DTI tractography of leg, arm, and face muscle CST. Adapted
from Conti et al. (2014)

Figure 2.5: Neuronavigated TMS mapping of leg muscles. Mapping of right leg muscles was carried out
on a patient with cortical dysplasia. EDB: extensor digitorum brevis (blue); QF: quadriceps femoris
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(orange); GC: gastrocnemius (pink); TA: tibialis anterior (yellow); SOL: soleus (light yellow); TFL: tensor
fasciae latae (green). Adapted from Saisanen et al. (2010)

Other differences between the round and figure-of-eight coils are the location, the
area, and the amplitude of the electric field produced by the magnetic stimulation. In
round coils, the maximum induced electric field is below the outer edge of the coil, and
its area is diffuse (Cohen et al., 1990). In contrast, the maximum electric field induced by
figure-of-eight coils is exactly below the junction of the two round coils, and its area is
focal (Cohen et al., 1990; Toleikis, Sloan, & Ronai, 1991). These two characteristics of
the figure-of-eight coils increase the user’s ability to identify the stimulated site by
placing the center of the coil (intersection of the two round coils) over that site. Another
advantage of this type of coil is that only the center of the coil is close to the stimulated
site because the outer parts of the coil (flat) are farther from the brain tissue (Cohen et al.,
1990). Due to these characteristics, figure-of-eight coils are widely preferred and used for
testing the MCE of the lower extremities.
Several differences exist between the flat and double cone figure-of-eight coils.
The main difference is that the flat coil has no angle between the two round coils,
whereas the double cone coil has an angle (e.g., 100°). The outer diameter of the former
is usually smaller (e.g., 70 mm) than that the latter (e.g., 120 mm). The flat figure-ofeight coil can be pitched, yawed, and rolled, and the current can be manipulated in
numerous directions; the maximal magnetic field strength is usually around 2 Tesla (T).
On the other hand, a double cone coil can be pitched and rolled only because its
angulation does not allow yaw, the current can be manipulated only in two directions, and
the maximal magnetic field strength is usually less than 2 T. Both coils can induce mainly
indirect waves (I1-wave: the shortest in latency among the three I-waves that occur
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because of the indirect excitation of the CST via intracortical neurons (Maeda & Pascual-

Leone, 2003), resulting from transynaptic activation of the neurons in the leg motor areas.
Yet only the double cone coil can induce direct waves (D-waves) that result from direct
activation of the CST neurons at high stimulus intensity (Terao et al., 2000). Despite
these differences, the double cone coil is preferable to stimulate the leg motor area
because it fits more securely on the head, and it has deeper stimulation strength than the
flat figure-of-eight coil (Deng, Lisanby, & Peterchev, 2013, 2014; Lontis, Voigt, &
Struijk, 2006; Terao et al., 1994).
The type of coil used dictates the optimal stimulation site of the PF and DF motor
cortical areas that are typically located around the vertex. The optimal stimulation site is
the coil location that elicits the largest response at the contralateral target muscle with the
lowest intensity. When a round coil is used, the optimal site is usually a few centimeters
lateral (contralateral to the target muscle) and anterior to vertex (Meyer et al., 1991).
When figure-of-eight coils are used, the optimal site is usually closer to the vertex (e.g.,
1-2 cm lateral and posterior to vertex). Because of the close proximity between the PF
and DF cortical areas, a common procedure is to determine the site that elicits the largest
response in DF and then to use that site to test the MCE of both muscle groups. Although
this procedure is often used and might be valid, two alternative approaches may
determine more accurately the optimal sites of PF and DF.
One approach to distinguish PF and DF MC is to examine the MCE (e.g.,
amplitude of MEP) of each muscle group on separate days (Geertsen, Zuur, & Nielsen,
2010; Obata, Sekiguchi, Nakazawa, & Ohtsuki, 2009). The advantage of this approach is
that the number of stimulations applied in a single day on two proximal cortical areas is
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reduced; the disadvantage is that the participants must visit the lab twice. Furthermore, a
common characteristic of the two approaches is that they rely on locating vertex (i.e.,
virtual intersection of the inter-aural and nasion-inion lines). Although these approaches
are relatively simple, they do not consider the differences among individuals in the size,
anatomy, and morphology of the brain, or the thickness of the skull (Wasserman et al.,
2008).

The second approach to differentiate PF and DF MC is to use the neuronavigation
system with TMS (nTMS), which may solve the aforementioned issues. The nTMS is an
image-guided TMS; either structural or functional MRI images can be used (Krings et al.,
2001; Ruohonen & Karhu, 2010; Sparing, Hesse, & Fink, 2010). The basic function of
nTMS is to act as a positioning system to locate different anatomical landmarks in the
brain. An optical camera, which acts as a position sensor, detects signals that are
transmitted by reflective spheres placed on a stimulation coil, a pointer, and the
stimulated head. A registration matrix obtained by identifying homologous anatomical
landmarks on both images, which can be either the subject’s images or a representative
set of images, is utilized to find the location of the coil from the real world to the image
space. Then the coil can be displayed on the screen, and the target areas can be accurately
stimulated. The main advantage of using nTMS is that it assures constant stimulation
parameters within individuals across trials (Krings et al., 2001; Ruohonen & Karhu,
2010; Sparing et al., 2010), and the primary disadvantage is its high cost (~$50,000250,000). In relation to testing the PF and DF MCE, nTMS might be a useful tool to
eliminate the limitations of stimulating these areas. Several studies have used nTMS
(Eximia, Nexstim Ltd.; Helsinki, Finland) to test the MCE of PF (Saisanen et al., 2010)

and DF (Forster, Limbart, Seifert, & Senft, 2014; Niskanen et al., 2010; Saisanen,
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Julkunen, et al., 2008; Saisanen et al., 2010; Thordstein, Saar, Pegenius, & Elam, 2013;
Vaalto et al., 2013); those studies have found that nTMS has good reliability (TA only).

2.4

PF and DF MCE
2.4.1

Measures

The motor cortical control of the PF and DF can been quantified by several
measures, and each reflects a different physiological property of the MCE. MT reflects
the membrane-related neuronal excitability while MEP derived measures (i.e., the
electrical potential recorded by a surface EMG (sEMG) placed over the belly of the target
muscle in response to TMS stimulation of the MC) reflect the integrity and excitability of
the whole CST (George & Belmaker, 2007). Center of gravity and map size, measures of
cortical mapping, reflect the cortical representation of the target muscle. Recruitment
curve (RC) derived measures likely represent the strength of the corticospinal projections
(e.g., steeper curve requires low MT) (Chen, 2000). Another MCE measure is the silent
period (SP), which can be measured on either the contralateral (cSP) or the ipsilateral
target muscle (iSP). The cSP reflects the long-lasting motor cortical inhibition, which
might be mediated via GABAb receptors, whereas the iSP reflects the functional integrity
between the homologous motor areas (George & Belmaker, 2007). Lastly, measures of
intracortical activity represent either corticocortical inhibitory mechanisms that are
mediated by GABA receptors or corticocortical excitatory mechanisms that are mediated
by glutamate receptors (Rossini & Rossi, 2007). For both muscle groups, MT, MEP, and
RC derived measures are more commonly reported than others are.
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MT can be determined either during muscle relaxation (i.e., rMT) or during slight tonic
contraction of the target muscle (aMT). The MT of a muscle is defined as the lowest
stimulation intensity required for inducing a distinguishable MEP on the target muscle
(Groppa et al., 2012). Compared to the MT of distal hand muscles, the MT of distal leg

muscles is greater (Forster et al., 2014; Lotze et al., 2003; Rossini et al., 2015; Saisanen,
Julkunen, et al., 2008). In healthy adults, the PF MT (SOL) is usually higher than the DF
MT, meaning that the current required to stimulate the PF cortical area is greater than DF
(Needle, Palmer, Kesar, Binder-Macleod, & Swanik, 2013; Rossini et al., 1999; Rossini
et al., 2015). This difference in MT between PF and DF may be caused by several
potential factors. One factor is that the PF CM connections might be weaker than DF CM
connections (i.e., similar number of peak responses but lower responses to different
stimulus intensities) (Figure 2.6) (Bawa et al., 2002; Brouwer & Ashby, 1992). Other
factor might be that the PF cortical areas may be smaller than DF (Figure 2.5) (Saisanen
et al., 2010).

Figure 2.6. Comparisons of mean muscle activity responses of TA and SOL and responses of three
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concomitantly firing single motor units from TA and SOL. A and C: Thin lines with different symbols
represent the EMG responses to different TMS stimulus intensities for each participant. Thick lines with
large circles show the group means. The slope of the stimulus-response curve is higher for the TA (A) than
for SOL (C). The same can be osberved in the mean stimulus-response curve. B and D: The top figure in
each panel illutsrates the shapes of three concurrently recorded single motor units from TA (B) and SOL
(D) while at the bottom of each panel the peristimulus time histograms, which show the discharge of each
single motor unit of TA (B) and SOL (D), are illustrated. Modified from Bawa et al (2002)

MEP size parameters and latency are the other commonly used MCE measures.
The assumption is that the MEP size parameters (amplitude: peak-to-peak; area: the
integral of the rectified EMG between MEP onset and offset; duration: the time between
MEP onset and offset) may reflect the number of the activated motoneurons (Wasserman
et al., 2008). Among the three size parameters, amplitude is reported the most. The
latency is defined as the time from the stimulus onset to the MEP onset and reflects the
conduction time from MC to the target muscle. Latency may depend on two factors, the
location of the muscle and the presence of a lesion in the neuromotor axis (i.e., MC, CST,
alpha motoneuron pools, final common pathway, and muscle). Latency increases from
proximal (quadriceps and hamstrings) to distal (PF and DF) muscles (Dimitrijevic et al.,
1992), while the PF and DF latency are similar since both muscle groups are located at
the same body segment (Wochnik-Dyjas, Glazowski, & Niewiadomska, 1998). For this
reason, MEP latency is usually normalized by the person’s height. After a stroke, the
latency of the paretic DF increases, whereas the latency of the non-paretic DF is similar
compared to healthy controls (Beaulieu et al., 2014; Cacchio et al., 2011). Conversely,
the changes in the PF latency are unclear after stroke. A few studies have also
investigated the PF and DF MEP area. A study (Soto, Valls-Sole, Shanahan, & Rothwell,

2006) reported a task (rest vs. voluntary contraction vs. standing) effect on the MEP
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amplitude, latency, and area for TA and SOL in healthy adults. During rest, the amplitude
and area of both muscles were smaller than active tasks (Soto et al., 2006). Compared to
TA amplitude and area, SOL amplitude and area were smaller during rest yet larger
during voluntary and standing tasks (Soto et al., 2006). This evidence indicates that
comparisons between PF and DF MCE, in particular MEP derived measures, should
occur within the same task.
Cortical mapping of the area for each target muscle is often used as a measure of
MCE since each muscle has a unique representation within the cortex. The motor cortical
representation (i.e., cortical mapping) is the number of motor cortical sites that elicit
MEPs to a target muscle, and either the optimal stimulation site (i.e., hot spot or center of
gravity) or its extent (i.e., map size) can characterize it. Only a few studies have mapped
the motor cortical areas of PF (Saisanen et al., 2010) and DF and reported good test-retest
reliability (Forster et al., 2014) and low variation when nTMS is used (Niskanen et al.,
2010). Furthermore, TMS and functional MRI (fMRI) can complement each other , and
be equally reliable for mapping DF (Lotze et al., 2003). Since the stimulation site is vital
for reliable TMS application, findings from these studies provide normative information
about the exact location of both PF and DF.
RC (input-output or stimulus-response curve) has been commonly used to
quantify the change in MEP size as a function of the stimulus intensity during resting
(Devanne, Lavoie, & Capaday, 1997) and active tasks, such as voluntary contraction
(Sandbrink, Syed, Fujii, Dalakas, & Floeter, 2000), standing (Obata et al., 2009), and
walking (Capaday et al., 1999). The stimulus intensity (percentage of maximal stimulator
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output; % MSO) ranges from sub- to supra-threshold MT values with increments of 5%,
while the defined number of stimulations (e.g., 5) is applied at each intensity. The

common shape of the RC is sigmoidal, which is a result of the Boltzman equation (Press,
Flannery, Teukolsky, & Vetterling, 1986). The threshold (i.e., the x-intercept of the
regression line flitted to the rising section of the RC), slope, and plateau level (MEPmax)
(Devanne et al., 1997) are derived from RC and characterize the stimulus-response
parameters of the CST as a whole. Obata et al. (Obata et al., 2009) investigated the inputoutput relation of both PF (SOL) and DF (TA) during sitting and standing in 14 healthy
adults. Despite similar background EMG, slope and plateau level were significantly
greater during standing versus sitting, whereas threshold was similar between conditions
for both muscles (Obata et al., 2009). During standing, the plateau value and threshold of
SOL and TA were similar, while the TA maximum slope was greater than SOL (Obata et
al., 2009). These findings demonstrate that use of RC derived measures also can decouple
the motor cortical control between PF and DF during different tasks.
In contrast to the aforementioned MCE measures that characterize primarily
excitatory mechanisms, certain measures of MCE also can quantify inhibitory
mechanisms. One example is the SP, which is defined as the suppression of the EMG
following MEP during tonic voluntary contraction. This phenomenon of EMG
interruption can be observed when either the contralateral MC (cSP) or the ipsilateral MC
(iSP) is stimulated. Nearly all studies that have investigated the SP of PF and DF have
reported cSP. The first report on cSP was by Inghilleri et al. (1993). These authors argued
that cortical inhibitory mechanisms might contribute to the latter part of hand muscle
cSP. In the same year, Ziemann et al. (1993) investigated the SOL cSP and concluded

that cortical inputs might also contribute to the latter part of the SOL cSP. The TA cSP
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has been examined as well, mainly in studies that investigated the reliability and
variability of TA MCE measures (Cacchio, Cimini, Alosi, Santilli, & Marrelli, 2009;
Tallent et al., 2012; van Hedel, Murer, Dietz, & Curt, 2007). TA cSP is a reliable
measure with low variability (Cacchio et al., 2009; Tallent et al., 2012). Though these
studies provided normative data of TA cSP, it is not clear what the cSP implies in terms
of function. In addition, it is not well understood whether there are differences between
the cSP mechanisms of PF and DF or whether PF cSP is also a reliable measure with low
variability.
It is important to distinguish iSP from the measures of inter-hemispheric
inhibition. Though both measures reflect inhibitory effects, it has been suggested that
they are mediated via different mechanisms (Chen, Yung, & Li, 2003). No study has
investigated PF and DF iSP, yet one study recorded the iSP of a toe flexor muscle,
abductor hallucis (AH) (Lo & Fook-Chong, 2004). Use of posterior-anterior and lateromedial current directions induced by a figure-of-eight coil (70 mm diameter; 2.2 T)
elicited the most AH iSPs, while age and leg side did not have any effect on iSP (Lo &
Fook-Chong, 2004). iSP was recorded from the majority of the participants who all were
neurologically healthy adults (age range: 20-80), 100% of the MSO was required (Lo &
Fook-Chong, 2004). However, that high level of intensity might not be tolerable by every
participant; therefore, the use of this measure may have some limitations. Thus, future
studies should investigate whether iSP can be measured in PF and DF. If iSP of either PF
or DF can be quantified, this metric might be used to determine the contribution of the
ipsilateral MC to the target muscle, a phenomenon that is present in people post-stroke.
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Both the inhibitory and excitatory intracortical neuronal circuits that converge on

the CST can influence MEP. Using a paired pulse TMS (ppTMS), subthreshold condition
stimulus following by suprathreshold test stimulus with an inter-stimulus interval (ISI)
less than 6 ms, Kujirai et al. reported a suppression in hand muscle MEP (1993). They
suggested that this suppression might have cortical origin. A few years later, Stokic and
colleagues utilized a similar approach to characterize the intracortical inhibition in DF
motor areas (Stokic, McKay, Scott, Sherwood, & Dimitrijevic, 1997). They tested a wide
range of ISIs (1-15 ms). The MEP of the relaxed TA was suppressed when ISI was less
than 5 ms, whereas facilitated MEP was observed when the ISI was between 9-10 ms.
This study was the first to show that both inhibitory and excitatory intracortical circuits in
the leg motor areas can modulate the responses of the leg muscles. Since then, numerous
studies have examined both intracortical inhibition, either short interval (SICI) or long
interval, and facilitation (SICF) during different tasks (e.g., voluntary contraction,
cycling) and postures (e.g., seated, standing) in various populations (healthy young and
old adults, SCI, stroke, Parkinson disease) (Beaulieu et al., 2014; Mileva, Bowtell, &
Kossev, 2009; Oliveri et al., 2012; Roy, Zewdie, & Gorassini, 2011; Soto et al., 2006;
Stokic et al., 1997; Yamaguchi, Fujiwara, Liu, & Liu, 2012; Yang et al., 2013). The
cumulative evidence from these studies indicates that using ppTMS over the leg motor
area can elucidate the characteristics of the intracortical mechanisms during control of PF
and DF in various tasks and populations.
2.4.2

Effect of Posture during Testing

The motor cortical control of PF and DF MCE is posture-dependent. In most
studies, PF and DF MCE were tested while the subject was sitting on a chair and the foot

fixed in a footrest with either relaxed or slightly contracted muscle. MEP is facilitated
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when the target muscle is voluntarily contracted, even slightly. However, only a few
studies have examined the effect of posture (seated vs. lying vs. standing) on the SOL
and TA MCE, and their results were inconclusive. This inconsistency might be due to
several methodological differences among the studies. Ackermann et al. (1991) found
that the PF (SOL) and DF (TA) MEP size was larger in standing than in sitting or lying
supine. Similarly, Obata et al. (2009) found that maximum slope and plateau value of
both SOL and TA RC were significantly larger during standing than in sitting. Despite
similar findings, a main difference between the two studies was that the background
EMG was not matched among tasks in the former study, whereas it was matched in the
latter study. Conversely, two studies (Lavoie, Cody, & Capaday, 1995; Soto et al., 2006)
showed no difference in SOL MEP size between standing and sitting. The main reason
for this discrepancy was stimulus intensity, which was lower in Lavoie et al. (1995)
(125% MT) and Soto et al. (2006) (120% MT) than the intensity used in Obata et al.
(2009) (40-90% MSO). Additionally, SOL and TA responses were elicited from the same
stimulus site in the former studies (Lavoie et al., 1995; Soto et al., 2006), whereas the
optimal site of SOL was determined separately from TA in the study by Obata et al.
(2009). Another study examined the effects of voluntary contractions (rest, dorsiflexion,
and plantarflexion in lying supine) and postural tasks (standing on the soles, standing on
the heels, and standing on the toes) on the SOL and TA MCE while using 100% MSO
(Valls-Sole, Alvarez, & Tolosa, 1994). SOL MEPs were elicited 100% of the time during
the active conditions but were elicited only 61% of the time during rest. SOL MEP
latency was shorter during dorsiflexion and plantarflexion and during standing on the

heels and toes. On the other hand, TA MEP latency was shorter only during voluntary
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dorsiflexion and standing on the heels. Both SOL and TA MEP amplitudes were larger in
all voluntary and standing conditions compared to rest (Valls-Sole et al., 1994). The
findings from these studies indicate that posture may have an important effect on both PF
and TA MCE; therefore, the task used during MCE testing should be thoughtfully
selected. Among the different postures, sitting on a chair with fixed positions of the hip,
knee, and ankle joints while the target muscle is slightly contracted might be the most
feasible and reliable posture to use for testing PF and DF MCE across populations.
2.4.3

During Walking

Walking is a complex behavior resulting from integration of multiple structures
and functions of the musculoskeletal and nervous systems. In humans, walking is
controlled by three different subsystems of the nervous system (i.e., sensory receptors in
the skin, muscles, and joints; the spinal cord; and the brain). The integration of these
systems is responsible for the activation and modulation of motoneuron pools that
innervate the active muscles during walking (J. B. Nielsen, 2003). All three subsystems
are important during the GC, and the difference among them is their specific function
during walking. For instance, the input from the supraspinal areas (e.g., MC, brain stem,
cerebellum, visual cortex, etc.) (Figure 2.7) contribute to walking in several ways:
triggering walking-related spinal systems, regulating walking speed, fine-tuning motor
patterns in response to feedback from the moving limbs, and steering limb actions in
response to visual input (Armstrong, 1988; Kandel, Schwartz, & Jessell, 2000). One of
these supraspinal areas is the MC, the major motor cortical area responsible for the motor
output to the periphery. Initially, much of what we knew about the role of MC in walking

was derived from experiments in quadrupedal mammals (Drew, 1988, 1991; Drew,
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Andujar, Lajoie, & Yakovenko, 2008). These studies demonstrated that MC contributes
significantly to gait modifications, especially when precise end-point control is required
(e.g., paw placement and trajectory during stepping over obstacles) (Drew, 1988, 1991;
Drew et al., 2008; Drew & Marigold, 2015).

Figure 2.7. Schematic of the signal flows within and from supraspinal substrates. Adapted from
Takakusaki (2013)

In humans, it has been postulated that the MC is a prerequisite for normal walking
(J. B. Nielsen, 2003), yet the role of MC and CST during walking is not fully elucidated
(Barthelemy, Grey, Nielsen, & Bouyer, 2011). The existing evidence has been derived
from studies that used non-invasive techniques including TMS (Capaday et al., 1999;
Schubert, Curt, Colombo, Berger, & Dietz, 1999; Schubert, Curt, Jensen, & Dietz, 1997),
fMRI (Dobkin, Firestine, West, Saremi, & Woods, 2004), diffusion tensor imaging (Seo
et al., 2014), single photon emission tomography (Fukuyama et al., 1997),

31

encephalography (Gwin, Gramann, Makeig, & Ferris, 2011; T. H. Petersen, WillerslevOlsen, Conway, & Nielsen, 2012), and near-infrared spectroscopy (Miyai et al., 2001).
Among these techniques, the most evidence comes from studies that applied TMS over

the PF and DF cortical areas during walking on a treadmill. Those TMS studies tested the
effect of TMS on PF and DF muscle activity and reflexes during walking in healthy
adults.
An obvious limitation of using TMS during dynamic actions, such as walking on
a treadmill, is to keep the position of the TMS coil constant and, thus, maintain the
stimulation site in spite of rhythmic body actions. All studies that have applied TMS
during walking on a treadmill used the following methods to solve this issue. The coil
was mounted to a helmet by using Velcro® tapes that fix the inside of the coil to the
outer surface of a linen cap. The helmet was attached to a halo vest system. The coil
cable was held by an elastic restraint that could be fixed either to the ceiling or to a body
weight support system (Figure 2.8). This technique allowed the participant to walk in

Figure 2.8. Schematic depiction of the experimental set-up of TMS application during treadmill
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walking. Adapted from Knikou et al. (2013)

natural cadence and freely move the head without affecting the coil’s location.
The first study that stimulated the leg motor cortical areas in humans during
walking was by Schubert et al. (1997), who examined the effect of cortical input by using
TMS on PF (MG) and DF EMG during treadmill walking. Thirteen young healthy adults
walked on the treadmill with an average walking speed of 4.27 km/h (1.19 m/s). The
TMS coil was fixed with the approach described in the previous paragraph. Because the
results showed constant MEPs across strides that indicated stable stimulation, subsequent
studies adopted those techniques. TMS stimuli were applied at different moments during
GC, which was divided into 16 periods. The main finding was that there was a
modulation (i.e., changes relative to muscle activity during tonic voluntary muscle
contraction) of TA and MG MEP amplitudes during walking. This modulation was
predominant for TA MEP during pre-swing and swing phases in which TA is typically
active, whereas the modulation was minor for MG MEP during mid-stance in which MG
is mainly active. Between muscles, the response to TMS was greater in TA than MG.
This was the first study to suggest a potential difference in the motor cortical control
between PF (MG) and DF during walking in humans (Schubert et al., 1997). The same
authors also found an effect of visual input on the motor cortical control of PF (MG) and
DF during walking in humans (Schubert et al., 1999). Eleven healthy adults walked on
the treadmill in two conditions: normal (walking without visual feedback of foot
placement) and precision stepping (hit a colored spot on the treadmill). The main finding
was that visual feedback of foot placement facilitated MG MEP and inhibited TA MEP
during swing phase, whereas it facilitated only TA MEP during stance (i.e., pre-swing).
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The results from both studies indicate that the motor cortical control of PF and DF differ
during walking and can be modulated by visual feedback.
In addition to muscle responses, stimulation of the cortex can modulate the PF
and DF reflexes during walking. In one study, 17 healthy adults walked on a treadmill
while subthreshold TMS stimuli were applied over the leg motor area at different
instances during the stance phase (N. Petersen, Christensen, & Nielsen, 1998).
Recordings of the SOL H-reflex during stance showed a large short-latency facilitation

due to TMS. Based on these results, the authors argued that SOL CM neurons are highly
excitable during walking. In addition, they found no difference in the excitability of SOL
CM cells between the stance phase of walking, tonic, and dynamic plantarflexion (N.
Petersen et al., 1998). A subsequent study from the same lab examined the effect of TMS
during stretch of the DF during walking (Christensen, Andersen, Sinkjaer, & Nielsen,
2001). Seventeen healthy adults walked on a treadmill while DF was stretched by
imposing a quick plantarflexion and suprathreshold TMS was applied. The researchers
found that the combined response to stretch and TMS increased as the interval between
the two stimuli increased (Christensen et al., 2001). This finding provided further
evidence on the cortical control of DF during walking. Though the findings from both
studies are crucial for understanding the neural control of PF and DF during walking,
their results do not determine the actual activation of corticospinal cells of these two
muscle groups during walking (J.B. Nielsen, 2002).
To clarify this issue, the same group conducted a study in which subthreshold
TMS was applied during walking in 19 healthy adults while PF (SOL) and DF EMG
were recorded (N. T. Petersen et al., 2001). A suppression of SOL EMG (300 ms after
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heel contact) and DF EMG (700 ms after heel contact) was found, yet neither muscle was
suppressed when TESn was applied. The authors suggested that this TMS-specific
suppression of PF (SOL) and DF EMG was probably restricted to the cortical level. This
study was one of the first to indicate that PF (SOL) and DF muscles receive cortical
contributions during walking.
Around the same time, another seminal study examined the extent to which CSTs
are associated with PF (SOL) and DF spinal circuits during walking and tonic voluntary
tasks (Capaday et al., 1999). The methodology of TMS application during walking was

similar to the aforementioned studies. One of the main differences between this study and
the others was the use of RC instead of reflexes or just MEPs. Utilization of the RC
allowed the quantification of MEPs across several stimulation intensities, whereas the
other studies used a single stimulation intensity. To compare the SOL and TA MCE
between tasks, the prescribed level of SOL and TA EMG activities during the voluntary
task were matched with their equivalent level of EMG activities during walking (e.g.,
SOL: early part of stance; TA: early part of swing). Twenty healthy adults participated in
the study. The results showed that SOL MCE was less during walking (stance phase) than
in MVIC, whereas the DF MCE was high and similar during walking (swing phase) and
MVIC (Capaday et al., 1999). In addition to these findings, the results showed something
that was not anticipated; TA MCE during the stance phase of walking was similar to SOL
MCE during MVIC (Capaday et al., 1999). The authors suggested that during walking,
the MC via the CM connections may strongly contribute to the control of TA during the
swing phase and to a lesser extent during the stance phase, yet it has weak control over
the SOL during the stance phase. During MVIC, however, motor cortical input is heavily
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required for the control of both PF and DF. Similar to other studies, this study pointed out
the extent to which SOL and TA are cortically controlled, and how this control differs for
each muscle group between tasks (Figure 2.9).

Figure 2.9. Schematic depiction of the strength of the linkage between the motor cortical areas and
the muscle activities of SOL and TA during walking and MVIC. Modified from Capaday et al (1999).

2.4.4

Reliability of PF and DF MCE Measures

Consistent measurement of MCE requires the minimization of error (e.g., noise)
to demonstrate that these metrics (e.g., MEP amplitude) reflect the actual MCE property
(e.g., the number of the activated corticospinal motoneurons) measured. Though there is
enough evidence to verify the investigation of PF and DF MCE using different MCE
measures during multiple tasks, only a few studies have investigated the reliability for PF
(SOL; one study) and for DF (three studies).
The intra- and inter-session reliability of three SOL MCE measures were tested in
13 neurologically healthy participants who were seated on a chair with the test leg in a

fixed position (Lewis et al., 2014). During TMS stimulation, which was applied via
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double cone coil at 120% of aMT, participants contracted their SOL (electrode was
placed at the medial site) at 10% of maximal voluntary contraction (MVC: voluntary
contraction in which the maximal force of a muscle group is tested (Winter, 1991)). The
MCE measures tested were the amplitude and area of the MEP and aMT, and reliability
was quantified using the intraclass correlation coefficient (ICC). The results showed that
amplitude and area had good (ICC>0.75) intra- and inter-session reliability when using as
few as six MEP responses. In addition, aMT had high inter-session reliability. This is the
only study that has examined the reliability of SOL MCE measures. Further studies
should investigate the reliability of the other PF (i.e., LG and MG) MCE measures during
resting and active conditions of the target muscle.
The reliability of several TA MCE measures was also found to be very good to
excellent. Van Hedel et al. (2007) investigated the test-retest reliability (14.0 ± 11.4 days)
of DF MCE measures (amplitude and latency of the MEP, and cSP) during static and
dynamic tasks at different levels of MVC (10, 20, 40, and 60%). Twenty healthy adults
lay in a supine position while biphasic TMS stimuli were applied via a figure-of-eight
coil at 120% of aMT. Findings showed that the amplitude was the most reliable (ICC:
0.77) during static condition at 40% MVC, the latency was reliable during static and
dynamic conditions at both 40% and 60% MVC (0.74 < ICC < 0.81), and cSP was not
reliable (van Hedel et al., 2007). Cacchio et al. (2009) investigated the intra- and interinvestigator, and test-retest reliability (within-session with a 1.5-h interval; betweensession with a 4-week interval) of TA MCE measures (rMT, three RC measures, latency,
and cSP) in 50 healthy adults. TMS was applied via circular coil while participants were
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seated on a chair. For all three types of reliability the ICC of rMT, latency, and cSP was
higher than 0.75; among the three measures, rMT always had the highest ICC. On the
other hand, the RC measures had only moderate to good reliability; therefore, these

measures should be used for quantifying the DF MCE with caution. Tallent et al. (2012)
investigated the repeatability of TA MCE measures (rMT, amplitude of MEP, and cSP)
during shortening and lengthening of TA at different levels of MVC (15, 25, 50, and
80%) on three consecutive days. Experiments took place at the same time of the day.
Twenty healthy adults were seated on a dynamometer while stimulations were applied via
double cone coil. The ICC of rMT, amplitudes during shortening at 25% MVC, and cSP
during shortening and lengthening were very good to excellent across 3 days. The
cumulative evidence from these three studies indicates that a few TA MCE measures are
very reliable especially during muscle contraction. None of these studies used nTMS,
which may increase reliability, or investigated the reliability of SICI or SICF.
In healthy adults, PF and DF are cortically controlled, and this control depends on
several factors. Use of TMS can reliably measure the MCE of these muscle groups. After
a stroke, however, these two muscle groups are impaired while there is a lesion in the
brain. Therefore, stroke can alter the motor cortical control to PF and DF, but its
ramifications during a motor task are not well understood.

2.5

Stroke
2.5.1

Categories

Stroke is a sudden neurologic deficit, either focal or global, due to occlusion
(ischemic stroke) or rupture (hemorrhagic stroke) of blood vessels that supply the brain
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blood circulation (Corbyn, 2014; Cuccurullo, 2004). To be classified as stroke, symptoms
and signs of this deficit must last more than 24 hours; otherwise it is classified as a
transient ischemic attack (TIA) or mini stroke (Aminoff, Greenberg, Simon, &
Greenberg, 2005). Ischemic stroke accounts for 85% of all strokes, and it is classified
either as thrombotic (~35%), embolic (~30%), or lacunar (~20%) (Cuccurullo, 2004).
Hemorrhagic stroke is less prevalent, accounts only for 15% of all strokes, and can be
caused by either intracerebral (hypertensive; ~10%) or subarachnoid (ruptured
aneurysms; ~5%) hemorrhage (Cuccurullo, 2004).
2.5.2

Epidemiology of Stroke

In the U.S. in 2010, an estimated 6.8 million people, older than 20 years of age,
had experienced a stroke. The prevalence rate of stroke is 2.8 %. Stroke is less prevalent
in men than women, and it is most prevalent in African Americans, for both genders.
Each year, nearly 795,000 people have a stroke, either new (610,000) or recurrent
(185,000). The incidence is lower in men than women, and it is higher in whites than in
African Americans. Stroke is the fourth leading cause of death, and a person dies from
stroke every four minutes. The stroke death rate is the highest in the Southeastern states.
Furthermore, stroke is a leading cause of chronic disability, and the combined direct and
indirect costs of stroke in 2010 were $36.5 billion (Mozaffarian et al., 2015). The most
common impairments after stroke are motor-related and include detrimental alterations in
muscle strength, tone, and activation. One of the most common limitations is impaired
walking.
2.5.3

PF and DF Impairments

Typically, the main walking impairments after stroke are limited joint motion,
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altered muscle activity, and impaired force production, which contribute to the reduction
of walking speed and the alteration of spatiotemporal measures (Olney & Richards,
1996). These impairments are observed in all three lower extremity joints causing
different gait patterns to emerge (Mulroy, Gronley, Weiss, Newsam, & Perry, 2003). The
ROM, torque, and power of the ankle joint in the sagittal plane as well as PF and DF
activity are smaller in the paretic side than in the non-paretic (Kim & Eng, 2004). The
main impairment in the ankle sagittal motion is the reduced dorsiflexion motion during
the swing phase, in particular during the mid-swing in which the foot clearance is a
crucial gait event to advance the swing limb (Winter, 1992). The PF EMG is reduced
during stance, while DF EMG is reduced during swing (Lamontagne, Malouin, Richards,
& Dumas, 2002). The ankle plantarflexion torque is reduced during the push off phase;
also decreased are the ankle power absorption during the first half of stance and the
power generation during push off. Certain aforementioned ankle neuromechanics (muscle
activity, joint kinematics, and kinetics) are positively correlated with gait speed. On the
paretic side, only ankle power absorption and generation are associated with gait speed,
whereas non-paretic ankle ROM, plantarflexion torque, and power absorption and
generation are associated with gait speed (Kim & Eng, 2004). This evidence indicates
that gait speed improvement is multifactorial, and it may have different contributions for
each side’s neuromechanics.
These impairments have an effect on the overall function of people post-stroke.
Six months after stroke onset, 1 of 4 people require assistance with activities of daily
living and one of three is unable to ambulate independently (Mozaffarian et al., 2015).

Two-thirds of people after stroke may experience critical limitations in functional
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walking and may be at risk for additional declines in physical mobility and independent
walking (Jorgensen, Nakayama, Raaschou, & Olsen, 1995; Pouwels et al., 2009;
Weerdesteyn, de Niet, van Duijnhoven, & Geurts, 2008). Impaired locomotion restricts a
person after stroke from both performing mobility activities (e.g., walking) and
participating in vocational and avocational activities.
2.5.4

PF and DF Rehabilitation

Improving walking is one of the main goals in stroke rehabilitation (Bohannon,
Andrews, & Smith, 1988) while numerous rehabilitation strategies have been developed
to improve the functionality of walking and to promote participation in social activities in
people post-stroke (Bowden, Embry, Perry, & Duncan, 2012).
Among all the rehabilitation strategies, impairment-based and task-specific
approaches are the two most common. The main principle of the impairment-based
approach is that the focus of the rehabilitation should be on a specific impairment. For
example, DF are weak after a stroke; therefore, rehabilitation should focus on
strengthening this muscle group. On the other hand, a task-specific approach is used to
improve a certain activity. Since walking after stroke is limited, people post-stroke should
be trained during walking activities. Strength/power training is an example of an
impairment-based rehabilitation approach, whereas treadmill training, either with or
without a body weight support system, is an example of a task-specific approach. Yet,
neither approach has been found to be capable of fully restoring walking after stroke
(Dickstein, 2008), and neither has demonstrated superiority over other interventions.
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Research in this area is limited for many reasons, two of which we will highlight
here. First, there is insufficient understanding of the underlying neurophysiological
mechanisms of the motor control of walking and how to apply specific rehabilitation
techniques to engage these mechanisms. Second, it is not well understood what the
relationships are between the neural control (e.g., motor cortical control) and

neuromechanics (muscle activation, joint kinematics, and kinetics) of walking. Therefore,
a potential area of study to understand the recovery mechanisms of walking after a stroke
is to focus on a specific neural mechanism (i.e., motor cortical input) of the motor control
of walking and then to examine the association between that mechanism and the
neuromechanics of walking. Such a research focus is warranted for both PF and DF, since
those two muscle groups play a significant role during walking.
2.5.5

PF and DF MCE after Stroke

Since stroke affects brain areas and potentially the descending pathways, TMS
can be generally used to test the integrity of connectivity between MC and the target
muscle after a stroke. One of the uses of TMS after stroke is to predict recovery. Several
studies have showed that testing the DF MCE after stroke could predict recovery of
mobility as measured by clinical evaluation tests (Arac, Sagduyu, Binai, & Ertekin, 1994;
Hendricks, Pasman, van Limbeek, & Zwarts, 2003; Piron, Piccione, Tonin, & Dam,
2005). Yet no study has examined whether PF MCE can be a strong predictor of mobility
recovery after a stroke. Another use of TMS after stroke is to assess the effect of a
rehabilitation strategy on the MCE of a certain muscle. For example, 4 weeks of treadmill
training enhanced certain DF MCE measures in people with chronic stroke, whereas
general physical therapy of the same duration did not have the same effects on DF MCE
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(Yen, Wang, Liao, Huang, & Yang, 2008). Furthermore, TMS can be used as a research
tool to elucidate the residual motor cortical control (i.e., functional integrity of CST) of
the target muscle.

Compared to the existing evidence on the motor cortical control of PF and DF in
healthy adults, only a few studies have examined the PF and DF MCE after stroke, and in
those studies, the greatest changes in PF and DF MCE occurred on the paretic side.
Compared to DF MCE, there is minimal evidence regarding PF MCE. To elicit an MEP
in PF (SOL), relatively greater stimulus intensity is required as compared to that in
healthy controls (i.e., an increase in aMT) (Lewis et al., 2014). For DF, latency increases
and the amplitude and SICF decrease compared to healthy controls (Beaulieu et al.,
2014). Although these studies provided some evidence on changes in PF and DF MCE,
further research should be conducted to elucidate clearly the changes in PF and DF MCE.
2.5.6

Reliability of PF and DF MCE Measures after Stroke

The reliability of measuring the PF and DF MCE has been minimally investigated
in stroke. There is one study for each muscle group. Lewis et al. (2014) investigated the
intra- and inter-session (7 days apart) reliability of PF (SOL) MCE measures (area and
amplitude of MEP, and aMT) in 13 people with chronic stroke. TMS stimuli (120% of
aMT) were applied via double cone coil while participants were seated on a chair with
the test leg in a fixed position, and they contracted their SOL at 10% of MVC; only the
paretic side was assessed. The intra-session reliability was excellent for the area and
amplitude. This reliability increased as the MEP responses increased (from 4 to 10) and
was similar for both methods used for calculating the MEP measures (average trace vs.
single traces). Conversely, the inter-session reliability of both MEP measures was poor,

but the inter-session reliability of aMT was good (ICC: 0.82). This evidence indicates
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that certain PF MCE measures are very reliable within a single session, but for assessing
PF MCE between sessions, only aMT is highly reliable. However, not all PF MCE
measures were tested, and testing occurred only during tonic contraction. Therefore,
further studies should examine the reliability of other PF (MG) and MCE measures (e.g.,
latency, MEP duration, cSP, RC derived measures, SICI, SICF) during both resting and
active muscle contraction in people post-stroke.
The test-retest reliability (4 weeks apart) of DF MCE measures (rMT, amplitude,
and latency) was tested in 16 people post-stroke (Cacchio et al., 2011). Both paretic and
non-paretic legs were assessed. TMS stimuli were applied via circular coil while
participants were seated on a chair. For the paretic leg, the inter-session reliability was
excellent for rMT (ICC: 0.90) and latency (ICC: 0.85), yet poor for the amplitude (ICC:
0.38). In contrast, all measures on the non-paretic leg had excellent inter-session
reliability. It is unclear whether these results would be different if figure-of-eight coils,
either flat or double cone, were used in combination with nTMS. Similar to these
findings, the inter-session reliability (7-10 days apart) of MCE measures of the
quadriceps (vastus medialis and lateralis) was high on the paretic leg (rMT) and nonparetic leg (rMT and amplitude) in 23 people with chronic stroke (Wheaton, Villagra,
Hanley, Macko, & Forrester, 2009).
Based on the existing evidence, MT, either resting or active, might be the most
reliable measure for quantifying both PF and DF MCE measures on the paretic side in
people post-stroke, while latency might be also a reliable MCE measure for the paretic
DF only.

2.6

PF and DF Neuromechanics
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Due to their respective locations in the lower leg and to their muscle properties,
PF and DF have different functions during walking. One may argue that the use of
clinical tests may not elucidate specifically and precisely the PF and DF contributions
during a task. On the other hand, the function of PF and DF can be quantified using
neuromechanical measures, either muscle activity, which is quantified using EMG, or
body segment motions, which can be quantified by either kinematics or kinetics.
2.6.1

Electromyography

EMG characterizes the amplitude and the temporal characteristics of the electric
signal associated with the muscle contraction during a motor task (Winter, 2009). EMG is
quantified using either sEMG electrodes or fine wire electrodes. The former electrodes
are easy to place and handle, but they measure the activity of surface muscles only. The
latter type of electrodes is used when the electrical activity of deep and small muscles
must be measured. The main limitation of fine wire electrodes is that they are invasively
applied; this application is not simple and easy to handle, and it may cause discomfort to
the participants. Since both PF and DF are relatively superficial muscles, their activity
can be accurately quantified using sEMG electrodes.
Using EMG has a few strengths and drawbacks. The main strength of EMG is that
it records the electrical activity from individual muscles; therefore, comparisons in
muscle activity can be done between unilateral muscles and bilateral muscles. Another
advantage is that EMG provides information about the timing and coordination of the
muscle activity during a task (e.g., during intact gait the TA EMG profiles has two
prominent bursts, early stance, and swing). One clinical application of EMG is in people

with hemiparesis whose bilateral EMG recordings elucidate the integrity of muscle

45

activity in both paretic and non-paretic muscles. However, EMG has a few inherent
weaknesses. EMG can be influenced by multiple factors (Farina, Merletti, & Enoka,
2004). Physiological cross talk (i.e., sEMG detection from neighboring muscles) and
external noise (e.g., power line noise) are a few of those factors, which can be eliminated
by using the right methodology. Similarly, EMG can have high variability due to factors
such as adipose tissue, oily skin, electrode placement, and artificial movement of the
electrode during the task. Of course, the experimenter can control nearly all these
preceding factors. Furthermore, EMG does not provide direct information about the type
of muscle contraction (e.g., eccentric vs. concentric). For example, TA is active during
early stance and swing phase of GC, yet the type of contraction of the TA is not the same
during these phases (Chleboun et al., 2007). By combining EMG with ultrasound and
kinematic recordings, muscle contraction can be determined during specific subtasks of a
motor task (e.g., walking). Lastly, EMG is not a direct measure of motion, which can be
fully characterized using both kinematics and kinetics.
2.6.2

Kinematics

Kinematics describe bodies in motion using the linear and angular positions and
their temporal derivatives (i.e., velocity and acceleration), without regard to the motion’s
cause (forces at work) (Robertson, 2004). The kinematics of dynamic tasks can be
quantified either in two dimensions (planar) or in three dimensions (spatial). Via modern
motion capture systems, three dimensional body kinematics can be characterized from the
data collected from spatial kinematics (position) of reflective markers (passive markers),
or light-emitting diodes (LEDs; active markers) positioned on specific body landmarks of

46

the participant. Then the three dimensional joint angles (sagittal, frontal, transverse) can

be calculated offline using several methods, most commonly the Cardan/Euler approach;
and subsequently, both joint linear and angular velocities and accelerations are quantified
(Robertson, 2004). During walking, joint ROM and joint angular velocities are usually
used to quantify joint kinematics, especially in the sagittal plane, which characterize joint
flexion and extension. At the case of the ankle joint, which consists of two joints
(talocrural and subtalar), the sagittal ankle kinematics reported in gait studies quantify the
motion at the talocrural joint, which GAS/SOL plantarflexes and TA dorsiflexes. In
addition to motion capture systems, simple goniometers can be used to measure the active
joint moved voluntarily by the participant or passive joint moved by the examiner
without assistance from the participant in order to determine joint ROM (i.e., the arc of
joint motion) in static conditions (Norkin & White, 2003).
Although the kinematic analyses of certain joints during specific tasks can answer
questions related to the speed of motion and the ROM, kinematics do not describe
directly the forces that cause the motion; however, kinetics do. Nevertheless, kinematics
can be used as one of the inputs in inverse dynamics modeling to estimate the joint
torques and powers of a linked system.
2.6.3

Kinetics

Kinetics describe the forces that cause a motion in a rigid body and their resultant
energetics. The three laws of motion can explain the relationship between the forces and
the motion (1st: Law of inertia; 2nd: Law of acceleration; 3rd: Law of action-reaction). The
motion of the rigid body can be either linear (caused by force) or angular (caused by
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torque); the motion is caused either by intrinsic musculoskeletal forces or forces present
in the interaction with the surroundings (e.g., ground reaction forces; GRFs).
Intrinsic musculoskeletal forces include the joint reaction forces and muscle
forces (Enoka, 2008). Muscle forces can be measured in vivo using buckle transducers
that are implanted invasively. Although few studies have measured these forces (e.g.,

force exerted at Achilles’ tendon) in humans (Komi, Fukashiro, & Jarvinen, 1992), direct
force measurement is limited due to the invasiveness of the technique. However, the net
force, the sum of all these forces, can be indirectly calculated with the inverse dynamics
approach. Three sets of data are used as inputs in the inverse dynamics: body segment
kinematics (position, velocity, acceleration), anthropometric measures (mass and mass
distribution of body segments), and external forces (e.g., GRFs) (Winter, 2009). Two of
the main outputs of this modeling are joint torques and powers. Joint torque is the net
result of all forces (e.g., from muscles and ligaments.) acting internally upon that joint,
while joint power is the product of joint torque and angular velocity and quantifies the
rate of energy change (Winter, 1991). To calculate joint torques and powers during
walking, kinematics collected via motion capture system, anthropometric measures, and
GRFs measured by force plates are required. During an isolated task, joint torques and
powers, if the task is isokinetic or isotonic, are calculated using just a dynamometer.
Lastly, both joint torques and powers can be used when the level of interest is at the joint.
In addition to intrinsic musculoskeletal forces, external forces can cause a motion.
Such external forces are the GRFs, which are examples of the 3rd law of motion that
states that “when one object (e.g., human body) applies a force to another object (e.g.,
surface of the earth), the latter exerts an equal and opposite reaction force on the former”

(Robertson, 2004). GRFs have three components to the force vector, vertical (GRFV),
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anterior-posterior (GRFAP), and medio-lateral (GRFML). Each component (i.e., the
algebraic summation of the mass-acceleration products of all body segments during foot
contact (Winter, 1991)) represents the reaction of the support surface on which the task is
performed (e.g., treadmill’s surface) to body motions (e.g., walking) that exert forces
through the feet to the ground (Enoka, 2008). GRFs are present only during the stance
phase of GC in which the foot is in contact with the ground; therefore, GRFs can be used
to quantify kinetics only in stance. All three components of GRFs during walking can be
measured by force plates that are located underneath the walking surface. Modern
instrumented treadmills (e.g., split-belt) can measure the GRFs exerted on each leg.
Among the three GRF components, the GRFV and GRFAP are the largest and most
commonly used during walking. During stance, the GRFV has a typical bimodal profile
(two modes representing peak vertical forces at heel strike/weight acceptance and toe
off/late stance), whereas the GRFAP has negative and positive phases. In GRFAP, the
negative phase in the first half of stance demonstrates a net braking of the whole body,
while the positive phase in the second half of the stance demonstrates the forward
acceleration of the body, which is the force that moves the body anteriorly over the
ground. Although GRFs are limited to stance phase only, they provide great information
about the whole body’s kinetics during stance and can be used to calculate the joint
torques with inverse dynamic calculations.
Both kinematic and kinetic data during a task should be acquired because they
provide a comprehensive description of the motion during that task. Otherwise,
description of the motion will be incomplete. A perfect example is walking. Using just

kinematics to describe the motion of the leg joints during walking omits the significant
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contributions of GRF during the stance, yet this kinematic analysis occurs throughout the
GC. Conversely, capturing only kinetic data during gait can quantify causes of motion
mainly during stance because joint torques and powers during swing are low (especially
at the ankle joint) compared to stance. Therefore, if the goal is to capture fully the motion
of certain joints during a task, both kinematic and kinetic data should be collected. A
limitation of this approach is the high cost of acquiring the tools that collect this data;
however, currently nearly all motion analysis laboratories obtain all the required tools for
collecting both kinematic and kinetic data.
2.6.4

Quantification of PF and DF Function

All aforementioned neuromechanical measures indirectly describe the body
motion during a task. However, not all measures represent the specific contribution of a
certain muscle during a motor task. In both walking and isolated tasks, certain
neuromechanical measures can be used to quantify indirectly the function of a specific
muscle.
Plantarflexors: During walking, PF have three functions. First, PF stabilize and
control the ankle joint as the lower leg rotates forward during the early part of single leg
stance (Winter, 1991) while they contract isometrically (Cronin et al., 2013; Panizzolo et
al., 2013). Second, PF move the body’s center of mass (COM) forward by major energy
generation during the single leg stance (push-off phase; ~40-60% of GC in healthy
controls) (Neptune, Kautz, & Zajac, 2001; Winter, 1983) while contracting
concentrically. Third, PF contribute to swing initiation during the pre-swing phase of GC
(second double limb support) (Neptune et al., 2001). SOL and GAS are synergists, yet
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their contributions in these three functions differ. SOL may contribute more than GAS to

ankle stabilization throughout single leg stance (Neptune et al., 2001), whereas GAS (i.e.,
MG) may be the strongest contributor during push-off (Gottschall & Kram, 2003;
Neptune et al., 2001) and pre-swing (Neptune et al., 2001). Among all three functions of
PF, the second function might be the most crucial. Therefore, EMG and GRFs can
quantify this function of PF because during the push-off phase in stance, PF, both SOL
and GAS, are concentrically active, and the positive phase of GRFAP occurs.
Since in push-off, PF shorten and contribute to a PI (the time integral of the
positive GRFAP), any impairment to PF will have an impact on both muscle activity and
PI. After stroke, the push-off phase of stance is limited due to impairments in PF whose
muscle activity decreases compared to healthy controls (Knutsson & Richards, 1979; Peat
et al., 1976). The PI reflects the forward acceleration of the body. In an intact system, PI
results from a large ankle power burst, which occurs while PF are active during the push
off phase of stance, and from the angle of the trail leg (i.e., the angle between a line from
the pelvis COM to the foot COM and vertical) during the second half of the single leg
stance and the second double limb support (Peterson, Cheng, Kautz, & Neptune, 2010).
After stroke, in which one side is more affected than the other, the PI generated from
each leg has been found to be asymmetrical (Bowden, Balasubramanian, Neptune, &
Kautz, 2006; Sousa, Silva, Santos, Sousa, & Tavares, 2013), and it can be influenced by
joint torques other than ankle joint torque (Peterson et al., 2010). One of the advantages
of using PI is that only force plates are required to calculate directly PI, whereas ankle
joint torques and powers can be calculated only using inverse dynamics, which require

multiple sets of different data. Therefore, PI may provide a quantitative measure of the
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coordinated output from PF either in healthy controls or people post-stroke.
Dorsiflexors: During walking, DF have two distinct functions. First, just prior to
and just after heel contact, DF are isometrically active (largest DF burst during GC)
(Chleboun et al., 2007) in order to lower the foot to the ground and to avoid slapping the
foot. Second, DF is concentrically active immediately after toe off to clear the foot
sufficiently during mid-swing. Between the two functions, the second holds more
significance, especially in people post-stroke. The main goal in swing is to move the
unloaded limb from behind the body to the front of the body with minimum foot lift and
to optimize energetic efficiency. In normal walking, the minimum toe clearance has been
reported to be less than 20 mm with low variability (Moosabhoy & Gard, 2006; Winter,
1992), and it occurs typically at about mid-swing (Moosabhoy & Gard, 2006), which is
preceded by DF EMG burst at the time point when the ankle joint is dorsiflexing with
peak AAV (Winter, 1991).
Toe clearance in swing is partly controlled by DF. This function of DF is
considered to be cortically driven because of the strong CM connections. In addition, in
contrast to stance in which the leg is in contact with the ground, the swing limb is not
affected by the environmental surroundings. Therefore, this precise motor task (clear the
foot with minimum lift) may rely on input from supraspinal centers (e.g., MC) (Capaday
et al., 1999; Schubert et al., 1997). This cortical reliance of the DF during swing may
explain the decreased dorsiflexion ROM (drop foot) during swing in people post-stroke.
Further evidence for the cortical control of DF is that the PF and DF isometric strength
both decrease in people with incomplete SCI and stroke. However, unlike in people with

incomplete SCI, ankle motor skill quantified by the root mean square error during a
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visuomotor ankle torque-tracking task is deteriorated in people post-stroke (van Hedel,
Wirth, & Curt, 2010). Since toe clearance is a type of fine motor skill, this evidence may
explain why people post-stroke are usually unable to clear the foot during swing without
using compensatory patterns generated in other joints.
Toe clearance is an important kinematic measure that describes quantitatively the
ability of the swing limb to be advanced and positioned forward by clearing the floor. In
two studies, toe clearance (toe elevation) was employed to quantify foot drop in people
with incomplete SCI; the authors suggested that toe elevation during swing is more valid
and reliable than angular changes (Barthelemy et al., 2013; Barthelemy et al., 2010).
Nevertheless, toe clearance may not fully quantify the function of DF during swing. A
reason may be that the angular changes in other joints, both ipsilateral and contralateral,
can contribute to toe clearance as well (Winter, 1992). For example, activating DF
immediately after toe off achieves toe clearance in healthy adults, yet in people poststroke, whose DF are impaired, toe clearance can be accomplished by either increasing
the knee and hip flexion during swing or through circumduction ( greater than normal
frontal thigh ROM during mid-swing (Kerrigan, Frates, Rogan, & Riley, 2000)).
Therefore, improving toe clearance after stroke does not necessarily imply improvement
in DF function.
Other measures than toe clearance should be used to quantify the contribution of
DF during swing. Reliance on DF EMG has the same limitations that have been
discussed in a previous section. In contrast to stance phase, in which the foot is in contact
with the ground and GRFs contribute to joint torques and powers, ankle torque, and ankle

power in swing are minimum. Thus, the ankle motion during swing is primarily
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quantified by the ankle kinematics, joint ankle angle and angular velocity. Between the
two, ankle joint angular velocity might be the most appropriate to characterize the
contributions of DF during swing (the peak AAV when the ankle joint is dorsiflexing
during the first half of swing); because the ankle joint torque is so low in swing, the AAV
during swing can be used as a surrogate of mechanical power, which is the product of
joint torque and joint angular velocity. Therefore, ankle joint power during swing
primarily represents the AAV.
Compared to research on ankle joint angle, few studies have used ankle joint
angular velocity to quantify local kinematics at the ankle during walking. Granata et al.
(2000) investigated whether joint angular velocities were influenced by muscle-tendon
lengthening in children with spastic diplegia (cerebral palsy). They reported that joint
angular velocity was a better discriminator than joint angle for gait patterns between
clinical and normal populations (Granata et al., 2000). Similarly, another study showed
no differences in ankle excursions (i.e., the difference between the maximum dorsiflexion
and plantarflexion during gait) between healthy individuals and people with incomplete
SCI whereas ankle joint angular velocity during the second double limb support differed
between groups (Krawetz & Nance, 1996). Findings from these studies indicated that
using joint angular velocities might help to discriminate gait changes between healthy
people and neurologically impaired people more accurately than the typically reported
joint angles. Granata et al. (2000) proposed two potential reasons for the superiority of
joint angular velocity to discriminate gait patterns. First, joint angular velocities may
have less variability between individuals than joint angles. Second, compared to joint

angles, which are prone to bias errors (e.g., incorrect marker placement and calibration
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procedures), joint angular velocities are not influenced by those bias errors because they
characterize the relative change in joint angles.
Regardless of the measure used to quantify PF or DF during walking, we should
bear in mind that joint kinematics and kinetics can be influenced by other factors (e.g.,
walking speed). Conversely, during MVIC, which is a closed chain task, PF and DF
neuromechanics may be less influenced by external factors. Therefore, measuring both
muscle activity and torques during MVIC may accurately quantify the contributions of
each muscle group.

2.7

Associations between PF and DF MCE and Motor Behavior
Associations between the motor cortical input to a leg muscle and motor behavior

of that muscle during a motor task have been found in both healthy controls and
neurologically disabled individuals. In nine people with chronic stroke, Jayaram et al.
(2012) investigated the relationship between an MCE measure of the vastus lateralis
(knee extensor) and two commonly used clinical measures, Fugl-Meyer lower extremity
(FM-LE) score and walking speed. The authors used the functional connectivity ratio to
assess the corticospinal connectivity from each MC to both the paretic and non-paretic
vastus lateralis muscles. This functional connectivity measure represented the ratio
between the slope of ipsilateral and contralateral RC. Values of the functional
connectivity ratio less than 1 indicated predominant contralateral connectivity (normal
state). Results showed negative relationships between the functional connectivity ratio
and both FM-LE score and walking speed. These findings demonstrated that greater

reliance from the ipsilateral MC was associated with lower FM-LE score and slower
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walking speed. This study was the first to show that the functional integrity of the
bilateral CST that innervates a leg muscle was associated with clinical measures in
people post-stroke. Despite the clinical importance of this study, its results should be
interpreted with caution. Walking speed is a global measure that can be influenced by
multiple factors. Therefore, the significant relationship between the cortical control of the
vastus lateralis and walking speed does not explicitly explain the contributions of the
motor cortical input to vastus lateralis during walking after stroke. In addition, a recent
study that applied TMS during treadmill walking in 13 healthy adults showed that the
vastus lateralis was less cortically driven than ankle muscles, suggesting weak motor
cortical contributions to the vastus lateralis during walking (Iglesias, Lourenco, &
Marchand-Pauvert, 2012).
For a better understanding of how a certain muscle is cortically controlled during
a task, the association should be between the MCE of that muscle and a specific
neuromechanical measure that quantifies its function during a specific task. Few studies
utilized that approach. Barthelemy et al. (2010) tested whether there was a relationship
between the TA MCE and foot drop in people with chronic SCI. As a measure of foot
drop and function of TA, Barthelemy and colleagues used toe elevation; the largest
distance between the marker placed on the 5th metatarsophalangeal joint and the ground
during swing. Their results showed a negative relationship between MEP latency and toe
elevation and a positive relationship between MEP amplitude and toe elevation. The
findings suggested that adequate toe elevation during the swing phase requires sound TA
MCE in people with SCI. Barthelemy et al. (2013) also investigated whether TA MCE
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measures (amplitude and latency of MEP) were associated with clinical measures such as
walking speed, the 6 minute walking test (6MWT), and Timed Up and Go (TUG). The

results demonstrated no relationship between any TA MCE measure and clinical tests, yet
toe elevation was strongly associated with all clinical tests. In contrast to Jayaram et al.
(2012), the two studies by Barthelemy et al. (2013; 2010) showed that both amplitude and
latency of TA MEP were associated with the toe elevation, a kinematic measure that
indirectly quantifies the function of TA during swing, but not with any clinical tests.
Therefore, this evidence strengthens the argument that to investigate the motor cortical
control of a muscle during a task, a neuromechanical measure that quantifies the function
of that muscle should be used in the association instead of a clinical measure.
The existence of this type of association between MCE of either PF or DF and a
neuromechanical measure in people post-stroke is limited. A recent study (Beaulieu et al.,
2014) examined whether the impairment of voluntary dorsiflexion motion was associated
with the functional integrity of CST in 18 people with chronic stroke. The DF MCE
measures used were the aMT, latency, amplitude, cSP, SICI, and SICF. Ankle
dorsiflexion was quantified using the neuromechanical measures of active dorsiflexion
ROM, MVICn, and TA EMG in both tasks (i.e., ROM and isometric muscle strength).
The rresults demonstrated only two significant relationships among all the relationships
examined between the DF MCE measures and the neuromechanical measures (six TMS
measures x four clinical measures: 24). The amplitude of DF MEP was positively
associated with DF ROM and strength during MVIC.
The cumulative evidence from these studies supports the notion that investigating
the association between MCE and neuromechanics of DF can contribute to a better

understanding of the motor cortical control of DF during different tasks in people post-
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stroke. Such potential associations have not been widely investigated in stroke or for PF.
The only existing evidence is for DF during MVIC, whereas none exists during walking.

2.8

Remaining Gaps
The measures used in these associations must be fully understood for the

associations to be scientifically and clinically important. Among the measures used in
these associations, the PF and DF MCE measures are the least well understood,
especially in people post-stroke. First, the reliability of the PF and DF MCE measures has
not been adequately investigated either in neurologically intact adults or in people poststroke. Within the last decade, only a few studies have tested the reliability of certain
MCE measures in healthy controls. These studies focused primarily on TA (Cacchio et
al., 2009; Tallent et al., 2012; van Hedel et al., 2007); only one study investigated a few
MCE measures of SOL (Lewis et al., 2014). In people post-stroke, only two studies have
reported good reliability of certain PF (only for SOL) (Lewis et al., 2014) and DF
(Cacchio et al., 2011) MCE measures, even though all possible MCE measures have been
used in stroke studies that have investigated the motor cortical control of PF and DF.
Although the findings from these studies are important, several gaps in knowledge
regarding reliability still exist. First, both physiological (state of muscle contraction
during stimulation) and methodological (type of coil, use of nTMS) factors that may
influence the reliability of PF and DF MCE measures have not been thoroughly
investigated. Secondly, the reliability has not been established for all potential measures
that quantify the MCE of SOL and TA. In addition to lack of certain knowledge about
reliability, no consensus exists regarding which MCE measure of PF and DF should be
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used to examine comparisons across persons. The MCE measure used in the brain and leg
motor behavior associations in people post-stroke must detect the differences between an
intact and lesioned CNS (i.e., stroke). In addition, it may be inaccurate to assume that the
measure used to characterize the best PF MCE is the same for DF MCE. These brain and
leg motor behavior associations in people post-stroke can be useful only after the
characterization of MCE measures for each muscle.
Investigating the associations between MCE and the neuromechanics of PF and
DF during functional and isolated tasks in stroke has the potential to elucidate the extent
to which deficits in post-stroke motor cortical contributions to PF and DF are related with
muscle-specific neuromechanics and whether these relationships are task-specific. This
evidence may provide vital information about how PF and DF are cortically controlled
after a brain lesion. Moreover, this evidence may influence rehabilitation strategies to
help people post-stroke optimally gain full functional recovery. In healthy adults, MC
may contribute less to the control of PF than DF, but MC’s input is still necessary and
depends on the nature of the task. For example, PF and DF MCE are task-specific in
healthy people and similar during MVIC but different during walking (Capaday et al.,
1999). Following a stroke, the motor cortical input to PF and DF changes, yet how this
motor cortical control changes remains unclear. Moreover, studies have yet to examine
whether motor cortical control differs between PF and DF depending on the mechanical
demands of the task (e.g., a walking vs. an isolated task). Unfortunately, such potential
associations have not been well investigated in people post-stroke. No study has
investigated the associations between PF MCE measures and PF neuromechanics in
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people post-stroke, either during walking or during MVIC. The only existing evidence is
for DF during MVIC (Beaulieu et al., 2014), whereas none exists during walking.

CHAPTER THREE
RESEARCH DESIGN AND METHODS
3.1

Specific Aims and Hypotheses
The overall objectives of this project were to investigate the extent to which 1) the

SOL and TA were cortically driven in people post-stroke (paretic leg) and in healthy
controls (dominant leg) and 2) deficits in post stroke motor cortical control were
associated with the neuromechanics of the paretic SOL and TA during walking (i.e., a
functional task) and MVIC (i.e., voluntary isolated task) (Figure 3.1). Prior to any
correlational analysis, we systematically investigated which MCE measure, among 8, for
each muscle was the most reliable and detected the differences in variances and means
between an intact CNS (healthy controls) and lesioned CNS (people post-stroke) (Aims 1
and 2 in Figure 3.1). Then we investigated the associations between the MCE and ankle
neuromechanics (i.e., muscle activation, joint kinematics, and kinetics) for the paretic
SOL and TA during walking and MVIC tasks in people post-stroke (Aims 3 and 4 in
Figure 3.1). Eight MCE measures were quantified while the target muscle was relaxed,
either SOL (Figure 3.1 A) or TA (Figure 3.1 B), on the paretic side in people post-stroke
and the dominant side in healthy controls during the resting condition (rMT, MEP
amplitude, MEP latency, and normalized MEP latency) and slightly contracted during the
active condition (MEP amplitude, MEP latency, normalized MEP latency, and cSP).

The neuromechanical measures of the paretic SOL were the EMG and PI in single leg
stance (SLS1 & SLS2) and second double limb support (DLS2) during walking as well as
EMG and torque during MVIC (Figure 3.1 C). The neuromechanical measures of the
paretic TA were the EMG and AAV during the first half of the swing (50% Swing1)
during walking and EMG and torque during MVIC (Figure 3.1 D).
Specific aims for this dissertation were as follows:
Aims 1 and 2:
The overall goal of Aims 1 and 2 was to quantify eight MCE measures of SOL
and TA in people post-stroke and in healthy controls. The quantification of each measure
occurred in three steps. The first step was to investigate the intra-rater test-retest
reliability in both groups. Only measures that were reliable in both groups were used in
the next step. The second step was to examine the inter-group difference in variance for
the measures that passed the first step. The third step was to examine the inter-group
difference in mean for the measures that passed the second step. We employed those
three steps for the following reasons. A main goal was to avoid running multiple
correlations using SOL and TA MCE measures that had not been quantified to the
populations of interest in our study. Furthermore, instead of examining only the reliability
of each measure, we sought to identify the measure that could best distinguish damage to
CNS. To determine this distinction, we investigated the inter-group differences for both
variance and means. We expected low between-subject variance within a group with
healthy CNS, as the integrity of the neuromotor axis is the same among the healthy
participants. Conversely, within a group with damaged CNS, due to the different level of
impairment of the neuromotor axis, we expected high between-subject variance because

the integrity of the neuromotor axis is not the same among stroke participants.
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Furthermore, the group mean of a MCE measure in healthy adults should differ from the
group mean of the same measure in stroke participants. Consequently, significant intergroup differences in both variance and mean would indicate the distinction between
damaged and healthy CNS. In Aims 3 and 4, therefore, we used only the MCE measures
of SOL and TA that were reliable in both groups and that differed in variance and mean
between groups.
The evidence for the quantification of the SOL and TA MCE is limited for both
groups, especially for SOL. Although SOL MCE may differ from TA MCE, we expected
that the measurement characteristics of SOL MCE would be similar to TA MCE.
Therefore, the hypotheses of these two aims were based mainly on the TA MCE studies,
which demonstrated good reliability for rMT, latencies, and cSP (Cacchio et al., 2009;
Cacchio et al., 2011; Forster et al., 2014; Meaney, Collett, Dawes, Howells, & Izadi,
2015; Tallent et al., 2012; van Hedel et al., 2007). Furthermore, these three particular
measures typically increase after a stroke (Kobayashi & Pascual-Leone, 2003).
Specific Aim 1: To determine which of the eight SOL MCE measures was
reliable both in healthy controls and in people post-stroke yet differed in both variance
and mean between groups (Figure 3.1 A).
When SOL was at resting state (Figure 3.2 A-I):
Hypothesis 1.1.a: SOL rMT, latency, and normalized latency of SOL would be
the most reliable in both groups
Hypothesis 1.1.b: SOL rMT would be significantly higher and more variable in
people post-stroke than in healthy controls.
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Hypothesis 1.1.c: SOL latency would be significantly longer and more variable in
people post-stroke than in healthy controls.
Hypothesis 1.1.d: SOL normalized latency would be significantly longer and
more variable in people post-stroke than in healthy controls.
When SOL was at active state (Figure 3.2 A-II):
Hypothesis 1.2.a: SOL latency, normalized latency, and cSP would be the most
reliable in both groups.

Hypothesis 1.2.b: SOL latency would be significantly longer and more variable in
people post-stroke than in healthy controls.
Hypothesis 1.2.c: SOL normalized latency would be significantly longer and more
variable in people post-stroke than in healthy controls.
Hypothesis 1.2.d: SOL cSP would be significantly longer and more variable in
people post-stroke than in healthy controls.
Specific Aim 2: To determine which of the eight TA MCE measures were
reliable both in healthy controls and in people post-stroke yet differed in both variance
and mean between groups (Figure 3.1 B).
When TA was at resting state (Figure 3.1 B-I):
Hypothesis 2.1.a: TA rMT, latency, and normalized latency of SOL would be the
most reliable in both groups.
Hypothesis 2.1.b: TA rMT would be significantly higher and more variable in
people post-stroke than in healthy controls.
Hypothesis 2.1.c: TA latency would be significantly longer and more variable in
people post-stroke than in healthy controls.
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Hypothesis 2.1.d: TA normalized latency would be significantly longer and more
variable in people post-stroke than in healthy controls.
When TA was at active state (Figure 3.2 B-II):
Hypothesis 2.2.a: TA latency, normalized latency, and cSP would be the most
reliable in both groups.
Hypothesis 2.2.b: TA latency would be significantly longer and more variable in
people post-stroke than in healthy controls.
Hypothesis 2.2.c: TA normalized latency would be significantly longer and more
variable in people post-stroke than in healthy controls.
Hypothesis 2.2.d: TA cSP would be significantly longer and more variable in
people post-stroke than in healthy controls.
Aims 3 and 4:
The overall goal of Aims 3 and 4 was to investigate the associations between the

descending drive, quantified by MCE measures determined in the two previous aims, and
the specific ankle neuromechanics of the paretic SOL and TA during walking and MVIC
in people post-stroke. Instead of using clinical measures that can be influenced by
multiple factors, we chose to use specific neuromechanical measures that quantify
indirectly the function of each muscle during specific phases of walking and during
MVIC. These neuromechanical measures included both the muscle activity and the ankle
mechanics (i.e., kinematics and kinetics) of the paretic SOL and TA.
In healthy adults, Capaday et al. (1999) demonstrated that the contributions of the
descending drive to SOL and TA depended on the nature of the task. Specifically, SOL
MCE was less during the stance phase of walking than in plantarflexion MVIC, whereas

65

the TA MCE was the same during the swing phase of walking as in dorsiflexion MVIC.
Since stroke detrimentally affects the integrity of the neuromotor axis in people post-

stroke, the contributions of the descending drive to each muscle should be weaker than in
healthy controls. However, the pattern of contributions to the paretic SOL and TA should
be similar in both tasks as described in Capaday et al. (1999). Additionally, because
stroke increases the MCE measures (as we hypothesized to pass all three criteria in Aims
1 and 2), and stroke decreases the neuromechanical measures used to quantify paretic
SOL and TA during walking and MVIC, we expected to find negative associations
between the MCE measures and the neuromechanics of the paretic SOL and TA.
Specific Aim 3: To investigate the associations between the MCE measures
determined in Aim 1 and the neuromechanics of the paretic SOL during walking and
MVIC in people post-stroke (Figure 3.1 C).
For the functional task (i.e., walking):
Hypothesis 3.1.a: SOL MCE would not be significantly associated with SOL
EMG in stance phase (Figure 3.2 C-I).
Hypothesis 3.1.b: SOL MCE would not be significantly associated with PI
(Figure 3.2 C-II).
For the isolated voluntary task (i.e., MVIC):
Hypothesis 3.2.a: SOL MCE would be significantly and negatively associated
with SOL EMG (Figure 3.2 C-III).
Hypothesis 3.2.b: SOL MCE would be significantly and negatively associated
with SOL isometric torque (Figure 3.2 C-IV).
Specific Aim 4: To investigate the associations between the MCE measure(s), as
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determined in Aim 2, and the neuromechanics of TA during walking and MVIC in people
post-stroke (Figure 3.1 D).
For the functional task (i.e., walking):
Hypothesis 4.1.a: TA MCE would be significantly and negatively associated
with TA EMG in the first half of swing phase (Figure 3.2 D-I).
Hypothesis 4.1.b: TA MCE would be significantly and negatively associated
with AAV (Figure 3.2 D-II).
For the isolated voluntary task (i.e., MVIC):
Hypothesis 4.2.a: TA MCE would be significantly and negatively associated with
TA EMG (Figure 3.2 D-III).
Hypothesis 4.2.b: TA MCE would be significantly and negatively associated with
TA isometric torque (Figure 3.2 D-IV).

Figure 3.1: Outline of the aims
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Figure 3.2: Outline of the hypotheses

3.2

Study Design
This study was cross-sectional. All experimental procedures took place in the

Functional Neurostimulation Laboratory (FNL; testing MCE), Locomotion Energetics
and Assessment Laboratory (LEA; testing walking neuromechanics), and the Locomotor
Rehabilitation Laboratory (LRL; testing MVIC neuromechanics). All labs are located in
the College of Health Professions research building (CHP-C) at the Medical University of
South Carolina (MUSC), Charleston, SC.

3.3

Participants
Fifteen people with chronic stroke were recruited within a period of 6.5 months

(2/11/2015 - 8/24/15). People post-stroke were included in the study if they met the
following criteria: 1) 18 to 85 years of age; 2) >6 months post-stroke; 3) either a cortical

or subcortical lesion and either an ischemic or hemorrhagic type of stroke; 4) residual

68

paresis in the lower extremity (FM-LE motor score <34) preservation of minimal DF and
PF contraction (at least 2 of 5 on a manual muscle test); 5) able to walk 1 minute on a
treadmill with minimum speed of 0.2 m/s; 6) passive ROM of 5° of plantarflexion; 7)
provision of informed consent; and 8) no cognitive impairments that made it difficult to
follow the instructions about experimental procedures. Individuals were excluded from
the study if they 1) had a history of seizures or used medications that could lower seizure
thresholds; 2) had a history of brain injury or preexisting neurological disorder; 3) had a
pacemaker or intracranial metallic implants (Rossi, Hallett, Rossini, Pascual-Leone, &
Safety of, 2009); or 4) had severe arthritis or orthopedic problems that limit passive
ROM.
Twenty five neurologically intact controls were recruited within a period of 3.5
months (12/1/2014 - 3/15/2015) and were free from any neurophysiological or
musculoskeletal ailments.

3.4

Experimental Procedures
People post-stroke and healthy controls attended two data collection sessions

(Stroke: 8 ± 2 days apart; Healthy: 7 ± 2 days apart). Before the first experimental
session, a MRI session occurred either on a separate day or on the same day. That session
lasted 31 and 26 minutes, respectively, for people post-stroke and for healthy controls.
For the people post-stroke, the experimental procedures lasted approximately 3 and 4
hours for the first and second sessions, respectively. For the healthy controls, the
experimental procedures lasted approximately 3 hours in both sessions. Figures 3.3 and

3.4 present each of the overall experimental procedures carried out in healthy controls
and stroke participants, respectively.

Figure 3.3: Flowchart of the experimental procedures used in healthy controls

Figure 3.4: Flowchart of the experimental procedures used in people post-stroke
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The first time that all participants came to the setting and prior to any testing (i.e.,
MRI), we informed them orally about the experimental procedures and potential risks,
then asked them to read and sign written informed consents approved by the MUSC
Institutional Review Board and adhering to the Declaration of Helsinki. To ensure
participants’ safety and qualification for MRI and TMS testing, we administered MRI
(Shellock & Spinazzi, 2008) and TMS (Rossi, Hallett, Rossini, & Pascual-Leone, 2011)
safety-screening questionnaires (Appendices). Then we collected anthropometric (e.g.,
height, body mass) and demographic (e.g., age, gender) data. For people post-stroke, we
also collected information about their mobility capacity and present comorbidities, and
one of three licensed physical therapists with multiple years of clinical experience
administered a single clinical test (FM-LE).
The FM-LE scale was used to assess the sensorimotor function of the lower
extremity in people post-stroke, and it consisted of 17 items (Fugl-Meyer, Jaasko,
Leyman, Olsson, & Steglind, 1975). Each item was scored on a 0 to 2 scale; a total score
of 34 points was possible (Appendices).
At the two subsequent data collection sessions, the MCE testing occurred in both
groups. At the second data collection session, the walking and MVIC neuromechanics,
which were measured only in people post-stroke, were always tested after MCE to avoid
any interference with MCE testing (e.g., fatigue of descending pathways due to the
neuromechanics testing). The order of the two neuromechanical tests was randomized;
they were administered consecutively, with a short break between tests. There was a 30minute break between the cessation of the MCE testing and beginning of the
neuromechanical testing.

3.4.1 Structural MRI and TMS Frameless Stereotaxy Neuronavigation
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System
To ensure accurate and precise positioning of the coil throughout the MCE testing
and across sessions, we used a BrainsightTM (v2.2) TMS Frameless Stereotaxy
Neuronavigation System (Rogue Research Inc.; Montreal, Quebec, Canada), into which
each participant’s structural MRI was imported. We asked people post-stroke and healthy
controls, who did not have the anatomical images of their brain taken in a previous study,
to attend a MRI session. In addition to structural MRI (both groups: localizer and
MPRAGE), several other MRI protocols (stroke group: flair, DKI, ep2d resting state;
healthy group: flair, DKI) were carried out for secondary analyses which were part of
other studies. During scanning, participants were in a supine position with a cushion
placed under their knees to ensure a comfortable posture; they wore earplugs to attenuate
the loud noise of the scanner and were asked to keep still (Figure 3.3 A & 3.4 A). For the
structural MRI of each participant, high-resolution T-1 weighted anatomical brain images
were acquired (TR=1900 ms, TE= 2.26 ms, voxel dimensions 1.0 x 1.0 x 1.0 mm, 192
slices (1 mm thickness), full brain and cerebellar coverage) using a Siemens 3T TIM trio
scanner (Siemens, Erlangen, Germany) with a thirty-two-channel head coil (Siemens,
Erlangen, Germany). MRI testing occurred in the Center of Biomedical Imaging located
at the Medical University of South Carolina.
Shortly after the end of the MRI session, we uploaded each participant’s images
(i.e., DICOM files) into Brainsight and several steps were undertaken prior to the
experiment (Figure 3.3 B & 3.4 B). The first step was to co-register manually each
participant’s MRI to two well-established brain structures, the anterior and posterior
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commissures, so the individual’s MRI could be mapped using a widely used stereotaxic
coordinate system, the Montreal Neurological Institute (MNI) atlas. The origin of the
MNI atlas was the anterior commissure (0, 0, 0); therefore, any spot in the brain had x
(mediolateral), y (anteroposterior), and z (vertical) coordinates in relation to the origin.
Then we reconstructed the 3D skin and curvilinear brain models. We used the 3D skin

model to identify four anatomical landmarks, which we used to calculate the participant
to image registration. These anatomical landmarks were the tip of the nose, bridge of the
nose (i.e., nasion), and supratragic notch of the right and left ear. We used the 3D
curvilinear brain model to identify manually the leg motor area on which a rectangular 15
mm (4 columns in the mediolateral axis) x 40 mm (9 rows in the anteroposterior) grid
(total of 36-points) was overlaid at each hemisphere (Figure 3.5).

Figure 3.5: Bilateral 36-spot grid superimposed over the leg motor areas of a representative brain

The space between points was 5 mm; using 5 mm was found to determine the hot spot
more accurate than longer distances (e.g., 10, 15, and 20 mm) (Brasil-Neto, McShane,
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Fuhr, Hallett, & Cohen, 1992). Rather than using a scalp based target approach in which

any error in orientation can alter the stimulation site, we used a cortex based approach in
which error in orientation has a negligible effect on the stimulation site (Comeau, 2014).
For this reason, we positioned the centered row of the grid at the center and below the
surface of the leg motor cortical area where CST that innervate leg motor pools originate
(Conti et al., 2014). For consistency across participants, the same person created all
Brainsight files.
3.4.2

SOL and TA MCE

MCE was assessed twice in both groups, and each data collection occurred at the
approximately the same time of the day (e.g., morning). In healthy controls, SOL and TA
MCE were assessed bilaterally at both visits (Figure 3.3 C & D). In people post-stroke,
SOL and TA MCE were assessed bilaterally at the first visit, whereas the MCE of the
paretic SOL and TA were only assessed at the second visit (Figure 3.4 C & D). Other
than this minor difference, all MCE procedures were the same for both groups (Figure
3.6). We strongly suggested to all participants to avoid consuming caffeine or alcohol for
at least 3 hours prior to experimental procedures.|
After EMG placement and testing (Figure 3.6 Step 1; see below for further
explanation), participants sat comfortably in a reclined position (~95° from horizontal)
with both arms and shanks supported by armrests and limb-support pads, respectively
(Figure 3.6 Step 2). To ensure consistent feet placement across participants, both feet
were secured in walking boots that allowed the ankle ROM to be adjusted from 30°
dorsiflexion to 45° plantarflexion in 7.5° increments. The angles at the hip, knee, and
ankle were approximately 90° (flexion), 20° (flexion), and 7.5° (plantarflexion),

respectively. Both hip and knee angles were slightly adjusted in case the participant
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reported discomfort with the current posture. When there was a need to keep the head still
during TMS application, we used a forehead rest arm that was attached on the chair and
positioned opposite to the site where the coil was placed. Throughout the experiment, we
instructed participants to keep still.

Figure 3.6: Flowchart of the experimental procedures carried out for MCE testing

After EMG placement and the participant’s setup on the chair, we determined the
MVIC of the SOL and TA bilaterally using EMG (Figure 3.6 Step 3). For each motion,
participants were instructed to maximally contract the target muscle (e.g., SOL) 4 times
(~5 seconds contractions seperated by 60 seconds of break) while they were seated at the
posture described above. After each contraction, the maximum contraction, which was
quantified using EMG, was calculated immediately using Spike v7.15 (Cambridge
Electronic Design; Cambridge, UK) by taking the average within a 100 ms window
centered around the maximum rectified and low-pass filtered (i.e., RMS amplitude of
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0.165 sec) EMG. We used the same method to calculate simultaneously the joint torque
and EMG during the voluntary isolated task (MVIC); see section 3.6.3 for further
explanation. The highest value of the four was used to calculate the 15% MVIC, which

was used during the active TMS conditions. We chose that level of MVIC because it has
been commonly used in previous studies which examined TA MCE in people post-stroke
(Beaulieu et al., 2014; Beaulieu, Masse-Alarie, Brouwer, & Schneider, 2015). During
pilot testing, futhermore, we found that level to be achievable by people post-stroke and
adequate to yield cSP during pilot testing.
Following the MVIC protocol, we prepared the neuronavigation system. First, a
headband with reflective markers was placed on the participant’s head. After creating a
new TMS session on the participant’s Brainsight file, the target grid for stimulation was
selected. Our next step was to verify the proper position of the motion capture camera,
Polaris Vicra System (Northen Digital Inc.; Waterloo, Ontario, Canada) by placing the
headband tracker, the pointer, and the coil tracker on its capture volume space. Then we
performed the participant-image registration by placing the tip of the pointer on 4
anatomical landmaks: nasion (Figure 3.6 Step 4-A), the tip of the nose (Figure 3.6 Step 4B), and the supratragic notch of the right and left ear (Figure 3.6 Step 4-C). Once all
anatomical landmarks were sampled, we verified whether registration occurred accurately
by placing the tip of the pointer on random spots over the participant’s skull. If the
distance from the tip of the pointer to the reconstructed skin was less than 5 mm, we
procceeded to TMS experiment; otherwise, participant-image registration was repeated
until the desired values were obtained.
All experimental procedures involving TMS were the same among muscles and

across hemispheres. For all experiments, the same TMS user applied a single pulse
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stimuli on the optimal site (i.e., hot spot; see next paragraph for further details) of the
target muscle using a BiStim module magnetic stimulator (The Magstim Company
Limited; Whitland, UK). The stimulator was set at the standard mode; the power of the
second unit was set at 0%, while ISI was greater than 0 sec (i.e., 10 sec). We used a
double cone coil (part number: 9902AP; 120 mm outer and 90 mm inner diamater of each
winding with an 100° angle between windings; maximal output of 1.4T; weight ~ 2 kg;
average inductance 17.85 µH) that induced a posteroanterior intracranial current. The
stimulated pulse was monophasic current waveform with rise and duration time of 100μs
and 1ms, respectively. The TMS user controlled the coil manually, and its position in
relation to the desired stimulated spot was corrected when it was necessary prior to each
stimulus using the neuronavigation system. Throughout MCE testing, the ISI was
controlled manually by the TMS user and ranged randomly from 5-10 s to avoid stimulus
anticipation and to minimize the carry-over effects of the previous pulse to the
subsequent one (Awiszus, 2003). In both conditions, we instructed participants to keep
their legs still and fully relaxed between stimuli.
To ensure that the hot spot of the SOL and TA was systematically stimulated in
both hemispheres and across participants, we placed and used the neuronavigated 36-spot
grid over each hemisphere (Figure 3.6 Step 5-I). Prior to the hot spot grid protocol, a
suprathreshold intensity was determined by applying a single stimulus over the centered
spot next to the medial fissure (Figure 3.6 Step 5-A). We chose to use that single spot in
that step to achieve consistency between days and across participants, and because that
spot is located at the locus of the leg motor area; our decision was based on evidence

from neurophysiological studies (Alkadhi et al., 2002; Conti et al., 2014). We started
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always at 30% MSO and gradually increased the TMS intensity by 5% increments, until
the intensity that elicited MEP with peak-to-peak amplitudes was greater than 50 µV in
all contralateral target muscles in 3 consecutive stimuli. Both raw waveforms with total
duration 500 ms (100 and 400 ms pre- and post-TMS, respectively) and peak-to-peak
amplitudes (25-125 ms post TMS) of all muscles were displayed and determined
immediately after each stimulus using Signal v5.11 (Cambridge Electronic Design;
Cambridge, UK). We used the intensity determined in the previous step for the hot spot
hunting for two reasons. First, that intensity was most likely above SOL and TA rMT
since MEPs were elicited at least in both muscles in 3 consecutive stimuli. Second, it has
been suggested a slighty supratheshold intensity should be used for mapping procedures
when target muscle is in the resting state (Krings et al., 1997; Saisanen et al., 2010),
although in the present study a single stimulus was applied over each point of the 36-spot
grid (Figure 3.6 Step 5-B) compared to 3-5 stimuli per spot used typically in mapping
studies (Malcolm et al., 2006; Wassermann, McShane, Hallett, & Cohen, 1992). During
hot spot hunting, which was done in both days, the stimulation order was always the
same (i.e., start at the top spot in the most rightward column and move downwards)
(Figure 3.5). After we completed the hot spot protocol, the amplitude values of each spot
for all muscles were tranferred and sorted from high to low in a Excel spreadsheet. The
hot spot of contralateral SOL and TA was defined as the spot in the grid that a single
stimulus applied over that spot elicited the largest response (Rossini et al., 2015) as
quantified by the peak-to-peak amplitude (µV) on the contralateral SOL and TA,
respectively. Contrary to the general notion that a single spot is used to elicit MEPs in

both SOL and TA (e.g., 0-2 cm posterior and 1-2 cm lateral to the vertex when either
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figure-of-eight or double cone coil was used), we found that SOL and TA hot spots
differed within each hemipshere in the majority of cases. Thus, each hot spot, which was
the scalp position over the virtual spot at the neuronavigated grid (Figure 3.6 Step 5-C),
was used to determine the rMT of each muscle and to apply 10 stimuli at 120% rMT of
each muscle in two muscle state conditions. The first condition was the resting state, in
which the target muscle was fully relaxed; whereas during the second condition, the
active state, the target muscle was slightly contracted at 15% MVIC. For the remaining
procedures the MCE testing was fixed; we always started the MCE testing on the right
TA and SOL (Stroke: Day 1; Healthy: Days 1 & 2). At the second visit, when only the
MCE of the paretic muscles was assessed in people post-stroke, TA was tested before
SOL.
rMT is a fundamental parameter for TMS protocols, both assessment and
treatment, and it can be used either as a measured outcome or to test MCE using a
suprathreshold intensity to apply a specific number of stimuli (e.g., 10) in order to elicit
MEPs. To determine rMT, there are few established methods (Farzan, 2014). The most
widely used and recommended by the International Federation for Clinical
Neurophysiology is the relative frequency method (Groppa et al., 2012), which is based
on the following Rossini-Rothwell criterion (Rossini et al., 1994; Rothwell et al., 1999):
the MEP response to half of N stimuli, usually 10, must be greater than 50 µV. In the
present study, nevertheless, we used an adaptive threshold-hunting method over the
relative frequency method because the former is more efficient (i.e., fewer stimuli are
required to determine rMT) than the latter; both methods share similar precision (Silbert,

Patterson, Pevcic, Windnagel, & Thickbroom, 2013). There are two types of adaptive

79

threshold-hunting: the simple adaptive parameter estimation by sequential testing (SAPEST) and the maximum likelihood PEST (ML-PEST) (Awiszus & Borckardt, 2011).
Between the two, we selected the SA-PEST because it determines more accurately rMT
than the ML-PEST, even though the latter can determine rMT quicker (Borckardt, Nahas,
Koola, & George, 2006). The first intensity used in rMT hunting was always set at 45%
MSO, while the initial step size was set at 6% MSO. For example, if the first stimulus at
45% MSO induced a MEP with amplitude greater than 50 µV on the contralateral target
muscle, the next intensity was set at 39% MSO. Conversely, if amplitude was less than
50 µV on the contralateral target muscle, the next intensity was set at 51% MSO. We ran
twice the rMT protocol for each target muscle and then calculated the average of the two
(Figure 3.6 Step 5-II). For both resting and active conditions, we used a suprathreshold
intensity, 120 % of the averaged rMT. We chose that intensity because it is the most
commonly used and is high enough to elicit MEP at the target muscle. We did not
calculate the aMT of the target muscles because there is not well established
methodology for that measure. Besides, aMT was found to be correlated with and lower
than rMT (~ 82%) (Ngomo, Leonard, Moffet, & Mercier, 2012). Therefore, even when
using a suprathreshold intensity of rMT, the intensity is high enough that MEP can be
elicited. The resting condition was always administered prior to active condition.
During the resting condition, we asked participants to stay still and relax the target
muscles bilaterally, especially the contralateral muscles, while a single pulse TMS at
120% rMT and over the hot spot of the target muscle was applied 10 times (Figure 3.6
Step 6-I). Prior to each stimulus, the muscle activity of all muscles was monitored by a

real time visual feedback displaying on a computer screen. In case any contralateral
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target muscles were active before or after TMS. we applied a single pulse again. The
goal was to get 10 waveforms of each contralateral target muscle at rest.
During the active condition, we asked participants to contract the target muscle at
15% MVIC while a single pulse TMS at 120% rMT was applied over the hot spot of the
target muscle 10 times (Figure 3.6 Step 6-II). When SOL was the target muscle, we
instructed participants to push slightly down against the boot on their contralateral leg,
match the moving line with the horizontal cursor, and sustain that contraction at that level
for few seconds. When TA was the target muscle, we instructed participants to pull
slightly up against the bootstraps on their contralateral leg, match the moving line with
the horizontal cursor, and sustain that contraction at that level for few seconds. The
moving line was the rectified and low-pass filtered (RMS amplitude of 0.165 sec) EMG
of the target muscle, whereas the cursor was set at 15 % MVIC of the target muscle prior
to the onset of the active condition. Participants were instructed to maintain contraction at
least 1 sec after TMS and to relax between stimuli. As in resting condition, the muscle
activity of all muscles was monitored by a real time visual feedback displaying on a
computer screen.
3.4.3

SOL and TA Neuromechanics during Walking

In addition to EMG electrodes that were already attached on the participants, we
positioned bilaterally 36 active LED markers on the pelvis, knee joint, shank, ankle joint,
and foot using a lower extremity specific configuration. Then participants wore a safety
harness (Robertson Mountaineering; Henderson, NY, USA), which was worn across the
shoulders and chest and was mounted to the laboratory ceiling for protection in the event

of loss of balance. The harness off-loaded no body weight.
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After setup, participants stood on the center of the treadmill for 5 sec to capture a
static trial, from which a static model of each participant was reconstructed and used for
the inverse dynamic analysis. During walking assessment, people post-stroke walked on a
dual-belt treadmill instrumented with 2 independent 6-degree of freedom force platforms
(Bertec Corporation; Columbus, OH, USA; treadmill dimensions: 206 x 139 x 39 cm;
size of each belt: 175 x 30 cm; walking surface: 175 x 62 cm) under one walking speed
condition, self-selected walking speed (SSWS), and grade, 0 degrees (Figure 3.4 E).
During SSWS, we instructed participants to “Walk at your normal usual walking pace.”
During walking assessment, a licensed physical therapist was always present to guard
closely the participants as they walked on a treadmill; however, no form of manual
support was provided during the actual data collection. Since participants had to walk
without an assistive or orthotic device before we begun testing, they were allowed to
practice treadmill walking until they felt comfortable walking without assistive and
orthotic devices. During this practice time, the physical therapist offered any physical
support the subject may have needed. After each participant reported comfort walking on
the treadmill without any assistance, SSWS was determined by setting the treadmill
speed initially at 0.2 m/s. Treadmill speed was gradually increased by 0.05 m/s
increments until the participant reported that the current speed was his/her SSWS. Once
SSWS was determined, participants walked for three 1-minute trials. Between trials,
participants rested for at least 1 minute or until they were ready to resume. In addition,
participants were allowed to sit any time they felt there was a need.
3.4.4

SOL and TA Neuromechanics during MVIC
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During MVIC, people post-stroke sat comfortably with similar posture as during
MCE testing on a Biodex Multi-Joint System Pro dynamometer (Biodex Medical
Systems, Shirley, NY, USA) with their test leg fixed to a limb-support pad and a
footplate (Figure 3.4 F). The shank was parallel to the floor, and the foot was firmly
secured by placing the calcaneus in the metal heel cup mounted on the footplate, with
plastic straps fastened across the toes and the dorsum of the foot. The back of the chair

was set at 85° from horizontal, while the dynamometer axis of rotation was aligned with
the lateral malleolus of the ankle (i.e., ankle joint axis of rotation). To ensure proximal
stabilization of the participants during contractions, a waist strap, thigh strap, and two
crossover shoulder straps were used.
After performing a single practice trial for each motion to ensure that participants
understood the procedures, all participants performed three successive MVIC of PF and
DF with the non-paretic leg. We repeated the same procedures with the paretic leg.
During each contraction, we instructed participants to sit with their arms folded across
their chest and to “gradually push down on” (SOL) or “gradually pull up on” (TA) the
footplate “as hard” as they could and “hold it for few seconds.” Additionally, during each
contraction, participants received a verbal encouragement from the experimenter to
ensure maximal effort and visual feedback displayed on a screen for their torque output.
Each contraction lasted approximately 5 seconds (i.e., rapid contraction and maintenance
of 100% MVIC); there was a 60 seconds rest between contractions.

3.5

Data Collection
3.5.1

Muscle Activity

Activity of four muscles was collected bilaterally in all three labs using the same

sEMG electrodes and hardware, yet the software used to acquire EMG data at each lab
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differed. We used pre-amplified (x20) single double differential MA-411 (Motion Lab
Systems; Baton Rouge, LN, USA) sEMG electrodes (body size of 38 mm x 19 mm x 8
mm, two 12 mm discs of medical grade stainless steel, a 13 x 3 mm bar of medical grade
stainless steel separating the two discs, and inter-electrode distance of 17 mm). The antialias filter and gain were preset at 1000 Hertz (Hz) and 2000, respectively, on MA-300
Back-Pack Unit (Motion Lab Systems; Baton Rouge, LN, USA). During MCE testing,
the muscle activity signal was sampled at 5000 Hz using CED Micro 1401-3 data
acquisition unit (Cambridge Electronic Design; Cambridge, UK). Online data acquisition
was achieved using both Spike2 v7.12 (EMG electrode placement and signal quality
testing, MVIC protocol, active condition) and Signal v5.11 (rMT protocol and resting
condition) software. During walking and MVIC, muscle activity signal was sampled at
2000 Hz. However, it was acquired using LabVIEW (National Instruments; Austin, TX,
USA) and WinDaq v3.30 (DATAQ Instruments, Inc.; Akron, OH, USA) during walking
and MVIC, respectively. We saved EMG data automatically after each trial as coded data
files on a password-protected computer at each lab for offline analysis.
The preparation and placement of sEMG always occurred prior to MCE testing at
FNL using published guidelines (Cram & Criswell, 2011; Hermens & Klug, 1999) with
the participants in the standing position. First, to improve the electrode-skin contact, the
areas over which the electrodes would be placed were shaved and lightly exfoliated with
alcohol swaps to remove any dead skin cells and oils from the skin surface. Then, eight
sEMG electrodes were attached over TA, SOL, LG, and MG bilaterally. For the TA
EMG placement, participants were in upright position and instructed to lift toes upwards.

Then we placed the TA sEMG electrode at 1/3 of the line between the tip of the fibula
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and the tip of the medial malleolus (Cram & Criswell, 2011). For the SOL, LG, and MG
placement, participants were also in upright position while raising their heels. We placed
the SOL sEMG electrode at 2/3 of the line between the lateral femoral condyle to the
lateral malleolus (Cram & Criswell, 2011). We placed the LG and MG sEMG electrodes
at the most prominent aspect of the muscle belly 2 cm laterally and medially from the
midline, respectively (Cram & Criswell, 2011). A reusable stainless steel ground
reference passive electrode with a diameter of 30 mm (Natus Medical Incorporated; San
Carlos, CA, USA) was placed on the patella. We applied electrolyte gel (SIGNALGEL®,
Natus Medical Incorporated; San Carlos, CA, USA) on the metal surface of the ground
electrode to optimize the conductive path between that surface and skin (Kamen &
Gabriel, 2010). We attached all sEMG electrodes and the reference electrode on the skin
using surgical tape.
After electrodes fixation and prior to experimental procedures, we first tested the
electrodes placement (e.g., for clear visually detectable EMG burst) and then the quality
of the signal (e.g., for baseline noise). To test the placement of the electrodes, we asked
participants to either plantarflex or dorsiflex their ankle in an upright posture while the
raw EMG signal of all muscles tested was displayed on a computer screen. All
participants from both groups were capable of performing those tasks, yet a few people
post-stroke required some assistance with standing balance while performing those ankle
motions. If an electrode was misplaced, we removed and replaced it until there was a
clear visually detectable EMG burst. To test the signal quality, we discharged the
capacitor a few times while the TMS coil was held away from the participant seated on

the chair in resting state. The expectation was that the baseline signal at each EMG
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channel should be close to zero since TMS pulse was applied on air and not at the
participant’s head. If there was no baseline noise (e.g., 60 Hz power line hum), the peakto-peak amplitude was less than 50 µV. If baseline noise occurred at a channel, we
removed the corresponding electrode and repeated the skin preparation procedures. If the
noise was still present (i.e., peak-to-peak amplitude > 50 µV), we adjusted the reference
electrode’s position and replaced the electrolyte gel. After we determined that the
electrodes’ position and signal quality were satisfactory, we secured the electrodes using
underwrap. Periodically throughout the experimental procedures, we checked electrodes’
position and signal quality.
3.5.2

Ankle Joint Kinematics and Kinetics during Walking

Twelve motion capture system cameras (PhaseSpace Inc.; San Leandro, CA,
USA) tracked the 36 active LEDs during a static trial and walking trials, in which pelvis,
shank and foot segments were defined bilaterally using a lower extremity specific
configuration. Before any testing, the capture volume space surrounding the treadmill
was calibrated using a calibration wand; calibration lasted less than 5 minutes. GRF was
measured bilaterally by force plates, which were built-in underneath each treadmill belt.
To optimize capture of steady state data on the treadmill, participants walked for 10-30
seconds prior to the 30 seconds of data collection (~ 1 min per trial). The coordinates of
active LED markers, GRF, and EMG of four muscles were collected bilaterally during
each trial. Coordinates data were sampled at 120 Hz, while the GRF data were sampled at
2000 Hz. Both sets of data were acquired using LabVIEW (National Instruments; Austin,
TX, USA). All types of signals were saved automatically after each trial as coded data

files on a password-protected computer for offline analysis.
3.5.2
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Ankle Joint Kinetics during MVIC

Peak torques and EMG of the SOL and TA were simultaneously collected during
each trial. Like EMG, torque data were sampled at 2000 Hz, acquired using DI-720-USB
(DATAQ Instruments, Inc.; Akron, OH, USA), and collected using WinDaq/Pro v3.30
(DATAQ Instruments, Inc.; Akron, OH, USA). Both types of signal were saved
automatically after each trial as coded data files on a password-protected computer for
offline analysis.

3.6

Data Analyses
All offline data analyses were carried out using a customized script written in

Matlab v8.1 (Mathworks, Inc.; Natick, MA, USA).
3.6.1

SOL and TA MCE

For all measures but rMT, we calculated the value of each measure from each
MEP sweep (total duration of 500 ms: 100 ms pre-TMS and 400 ms) for all muscles and
then averaged these 10 values to get a single value (i.e., mean). A recent study
demonstrated this approach to be more reliable than using the value calculated from the
average MEP sweep in people post-stroke (Lewis et al., 2014). The EMG signal of each
muscle collected during MCE testing was corrected for the gain amplification, and the
units were converted from Volts to mV.
Resting Condition: rMT, amplitude, latency, and normalized latency were
calculated to quantify SOL and TA MCE while the target muscle was relaxed. rMT was
expressed as a percentage of the MSO (%) of the machine; that value was recorded
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directly from the output display on the master unit of the stimulator pair. Amplitude (mV)
was calculated from the raw EMG and defined as the largest difference between positive
and negative peaks (i.e., peak-to-peak) of the MEP (Figure 3.7 A). Latency was
calculated from the rectified EMG (Figure 3.7 B). Latency (ms) was defined as the time
between TMS onset and MEP onset, which was defined as the time when a rectified
EMG trace first crossed a predetermined threshold, pre-stimulus mean EMG (over a 100
ms period) plus 3 standard deviation (SD) (Cacchio et al., 2011). In addition to raw

latency, we normalized latency relative to each participant’s height ([latency (ms) / height
(cm)] ∗ 100) because latency was found to be correlated with participant’s height
(Livingston, Friedlander, Gibson, & Melvin, 2013).

Active Condition: Amplitude, latency, normalized latency, and cSP were
calculated to quantify SOL and TA MCE while the target muscle was slightly contracted
at 15% MVIC. As in resting condition, amplitude (mV) was calculated from the raw
EMG and defined as the largest difference between positive and negative peaks (i.e.,
peak-to-peak) of the MEP (Figure 3.7 C), and latency (ms) was calculated from the
rectified EMG and defined as the time between TMS onset and MEP onset (Figure 3.7
D). Yet MEP onset in active state was calculated differently than in resting. For the
calculation of the MEP onset and offset, and for EMG resumption, which was used for
cSP calculation (see below), we adopted an automated approach published previously
(Damron, Dearth, Hoffman, & Clark, 2008; Daskalakis et al., 2003). Additionally, we
slightly modified this automated method to ensure that the MEP onset and offset were
accurately calculated across muscles and participants. First, we found the time points that
the rectified EMG trace crossed and predetermined threshold set to the level of pre-
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stimulus mean EMG (over a 100 ms period). Then we found the peaks that were at least
greater than the mean of the pre-stimulus EMG plus three SD and between those two
time points. Then we searched from the first peak to 50 data points before that peak for

the time that the rectified EMG trace first crossed the threshold of the mean pre-stimulus
EMG; we defined that time as the MEP onset. Similarly, we searched from the last peak
to 200 data points after that peak for the time that the rectified EMG trace last crossed the
threshold of the mean pre-stimulus EMG; we defined that time as the MEP offset. As in
resting, the normalized latency relative to each participant’s height ([latency (ms) / height
(cm)] ∗ 100) was calculated. Lastly, cSP (ms) was also calculated from the rectified EMG

(Figure 3.7 D). In the present study, we calculated the absolute cSP (i.e., exclusion of
MEP): the time between MEP offset and the resumption of baseline EMG (Saisanen,
Pirinen, et al., 2008). EMG resumption was the time that the rectified EMG trace last
crossed the 25% of the mean pre-stimulus EMG (Damron et al., 2008).

Figure 3.7: Schematic of the analysis of the MCE measures

3.6.2

SOL and TA Neuromechanics during Walking
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All measures collected during gait were divided into strides (i.e., starting at foot
contact of one leg and ending with the next foot contact of the same leg). Additionally, all
those gait measures except GRFAP were linearly interpolated to 100 points (i.e., GC was
normalized to stride period and presented in %). In order to do this, specific gait events,
bilateral heel strikes and toe offs, were determined using an automated method, which
used GRFV (Zeni, Richards, & Higginson, 2008). GRFV was filtered with a low-pass 20
Hz cut-off frequency using a fourth order, zero phase lag Butterworth filter (Gottschall &
Kram, 2003) and was resampled at 120 Hz. After digital filtering, any potential offsets
were corrected, and body weight (N) was calculated using bilateral GRFV, which were
then normalized by the body weight and multiplied by 100. A threshold of 20 N divided
by the body weight (N) multiplied by 100 was used to determine the threshold crossings
in GRFV trace. Each crossing at this preset threshold denoted bilateral heel strike and toe
off (Figure 3.8).

Figure 3.8: Outline of the analysis used to detect gait events
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The first step for EMG analysis was to divide the EMG of each muscle by the
gain (i.e., 2000) and then multiply by 1000 to convert the units from Volts to mV. Then
EMG data were band-pass filtered (20-500 Hz) and band-stop filtered (156-158 Hz – to
remove a 157 Hz power line hum which was detected using a spectrum analysis) using a
third order zero phase lag Butterworth filter, rectified, smoothed (50 Hz filter), divided
into strides, and averaged across strides. Then the average EMG of each muscle was
calculated in specific gait phases based on when each muscle was typically active: single
leg stance and second double limb support for SOL (Figure 3.9 A) and first half of swing
for TA (Figure 3.9 B). Lastly, these EMG values (mV) were averaged across trials.
GRFAP was filtered with low-pass 20 Hz cut-off frequency using a fourth order,
zero phase lag Butterworth filter (Gottschall & Kram, 2003), normalized by the body
weight (N), multiplied by 100, and divided into strides. In order to calculate accurately
the positive area under the curve during the SLS and DLS2, we searched first for the
maximum positive peak between 30 data points after the initial heel strike and next heel
strike. We selected 30 data points as a mark for two reasons. First, the period of the
GRFAP that we were interested in occurred approximately 0.25 sec after the initial heel
strike, and secondly to avoid miscalculating the fast spike of propulsion happening
immediately after heel strike. After finding the positive peak, we found the times that last
crossed the zero line left and right from the positive peak. Next, the area under the
positive curve between those two time points was calculated (i.e., PI; % BW.sec) for each
stride and averaged across strides and trials (Figure 3.9 C).
The first step for AAV analysis was to resample the coordinates of active LED
markers data from 120 Hz to 100 Hz. Then AAV was calculated using the numerical

differentiation of the time-based ankle joint sagittal angle (i.e., Euler angle that was
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calculated using rotational matrices). All aforementioned steps were carried out using a
custom written script in LabVIEW, the only data analysis steps that used a software other
than Matlab. After transferring AAV data to a Matlab workspace, we divided AAV into
strides. The peak AAV (rad/sec) during the first half of swing was calculated for each
stride and averaged across strides and trials (Figure 3.9 D).

Figure 3.9: Outline of the analysis of the SOL and TA walking neuromechanics

3.6.3

SOL and TA Neuromechanics during MVIC

For both SOL and TA, the isometric torque was first low-pass filtered (10 Hz)
using a third order zero lag Butterworth filter and then calculated by averaging the torque
within a 100 ms window centered around the max torque of each trial (Figure 3.10 A). A
500 ms window (i.e., ± 250 ms from max) has been reported to be used for simultaneous
torque and EMG analysis in healthy adults (Soylu & Arpinar-Avsar, 2010). However, in
this study we used a 200 ms window (i.e., ± 100 ms from max) to avoid occasions where

the peak occurred immediately after the contraction onset, a case that was observed in
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pilot testing. Therefore, the 200 ms window was selected after getting consistent results
in the analysis of pilot data. Then torque (N·m) was subsequently averaged across the
three trials.
Similar to walking EMG analysis, the EMG of each muscle was first divided by
the gain (i.e., 2000) and then multiplied by 1000 to convert the units from Volts to mV.
The EMG data was band-pass (20-500 Hz) and band-stop filtered (59-61 Hz – to remove
a 60 Hz power line hum which was detected using a spectrum analysis) using a third
order zero phase lag Butterworth filter, rectified, smoothed (50 Hz filter), and averaged
over the same time window as torque (Figure 3.10 B). Then it (mV) was subsequently
averaged across the three trials.

Figure 3.10: Outline of the analysis of the SOL and TA MVIC neuromechanics

3.7

Statistical Analyses
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For this project, we focused our statistical analyses on the paretic SOL and TA in
people post-stroke and on the right (i.e., dominant) SOL and TA in healthy controls,
although we collected SOL and TA data from both legs and from LG and MG bilaterally.
We will run secondary analyses for extra data collected. In addition to the mean and SD,
we reported the coefficient of variation (CV), which is independent of units and is a
measure of relative variation (Portney & Watkins, 2009). Therefore, three descriptive
statistics (mean ± SD, CV) were reported for all data used in those analyses. The intergroup differences in age, height, weight, and test-retest period were tested. Normality of
all data was tested using the Shapiro-Wilk test because it has more power to find
differences than the Kolmogorov-Smirnov test (Field, 2009). We conducted statistical
analyses using IBM SPSS Statistics for Windows v23 (IBM Corp, Armonk, NY, USA).
Figure 3.11 presents the overall statistical analyses carried out in each aim.

Figure 3.11: Outline of the statistical analyses.

3.7.1

Aims 1 and 2
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These aims were exploratory and had two goals. The first goal was to characterize
the MCE measure (s) of SOL and TA that had low methodological error (i.e., reliable)
both in people post-stroke and in healthy controls. The second goal was to identify
stroke-related impairments to the CNS (i.e., detect true differences between people poststroke and healthy controls) testing the variances and means between the two groups. To
achieve these goals, we ran three statistical procedures/steps that were the same for both
aims. The level of significance was set at p < 0.05, and the test of significance was onetailed.
First, we examined the test-retest reliability of all SOL and TA MCE measures
using the coefficient of variation of method error (CVME) instead of using ICC, which is
the most widely used reliability metric. ICC is the ratio of the between-subject variance
to the total variance (sum of the between-subject and between-day variance), is a relative
measure of reliability, has no units, and ranges from 0 to 1, with a value closer to 1
reflecting greater reliability (Weir, 2005). However, it has one main pitfall. When
samples are homogeneous, ICC of the target measure is low, but low ICC does not
necessarily mean the measure is unreliable. Therefore, pure reliance on ICC may lead to
incorrect conclusions. For this reason, we did not use ICC as the reliability metric.
Nevertheless, we calculated and reported ICC with lower and upper 95% confidence
interval (CI) so we could conduct post-hoc comparisons with the present limited
evidence. Briefly, we calculated ICC using the 2-way random model with absolute
agreement type and average measures form. ICC values above 0.75 indicated good
reliability (Portney & Watkins, 2009). We used CVME for two reasons: (1) CVME is

insensitive to the lack of variation in the samples and (2) CVME is independent of ICC
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(Portney & Watkins, 2009). To calculate CVME, we first calculated the method error,
which is the ratio of the SD of the test-retest score differences to √2 (Portney & Watkins,
2009). Then CVME was calculated using the following equation: (2ME / (Mean of Day 1
+ Mean of Day 2))*100 (Portney & Watkins, 2009). The advantage of using CVME
instead of ME is that CVME is expressed as a percentage and has no units as ICC. A
measure with CVME equal or less than 15 was considered a reliable measure (Stokes,
1985). For steps 2 and 3, we used measures whose CVME was lower than 15. If no
measure met that requirement, we chose the measure with the lowest CVME. Based on the
previous literature, we expected that at least one measure for each muscle would have
low CVME (≤ 15).
The second step was to examine whether the between-subject variability differed
for each group. Because the MCE measures used in these procedures would have good
reliability determined in the previous step, we expected that the within-subject variability
would be low in both groups. Low between-subject variability in healthy controls would
result from random factors (i.e., unsystematic variation). Conversely, between-subject
variability in stroke would be high because the differences in stroke characteristics had
different (and larger) effects on the MCE in each stroke patient. Thus, the difference in
variability between the two groups would most likely be due to the CNS lesion.
Therefore, the second procedure tested whether the variance (i.e., SD2) of a MCE
measure collected in day 2 differed between people post-stroke and healthy controls
using Levene’s test. If the results of Levene’s test were significant (p ≤ 0.05), this finding
would imply that the variance of the MCE measure differed between the two groups, and

the third procedure was carried out for that MCE measure.
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The third step examined whether the means (day 2) of the two groups differed. A
recent study reported that the MEP amplitude and latency of the paretic TA decreased
and increased, respectively, compared to the dominant side of the healthy controls
(Beaulieu et al., 2014). These changes in MCE after a stroke also reflected the lesioned
CNS. We tested the normality of each distribution to ensure that we had selected the right
test, either parametric or non-parametric, to examine the differences in mean between the
groups. We used an independent t-test when the data were normally distributed;
otherwise, we used the Mann–Whitney U test. If the group means were significantly
different (p ≤ 0.05), the MCE measure of either the paretic SOL or paretic TA was used
in Aim 3 and 4, respectively.
In summary, the MCE measure(s) used in Aims 3 and 4 had to demonstrate the
following: 1) good reliability, CVME ≤ 15, in both groups, 2) significantly higher variance
in people post-stroke versus in healthy controls (Levene’s test), and 3) a significant
difference in means between people post-stroke and healthy controls (independent t-test
or Mann–Whitney U test) (Figure 3.11 A & B).
3.7.2

Aims 3 and 4

The MCE measure(s) determined by Aims 1 and 2 were used in the statistical
analyses for Aims 3 and 4, respectively. Because we assessed eight MCE measures each
for Aims 1 and 2, there was a possibility for more than one MCE measure to qualify for
use in the correlational analyses of Aims 3 and 4. However, due to the small sample size,
a maximum of two MCE measures that passed all three statistical steps in Aims 1 and 2
was used for each muscle. Therefore, the maximum total number of associations

performed for each muscle was eight; otherwise, a minimum of four associations per
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muscle would need to occur. Since we performed multiple associations for each aim
(minimum four and maximum eight), we corrected the level of significance using a
Bonferroni adjustment. In case of four associations, the level of significance was adjusted
to 0.012, whereas in case of eight associations, the level of significance was adjusted to
0.006. The test of significance was two-tailed.
To test the relationships between MCE (day 2) and neuromechanics for each
muscle group, we performed correlations between the MCE and walking neuromechanics
and between MCE and MVIC neuromechanics (Figure 3.11 C & D). The strength and
direction of each correlation was determined using correlation coefficients. The selection
of the correlation coefficient, either parametric or non-parametric, was determined by
testing the normality of each distribution. If both distributions were normally distributed,
we used Pearson’s correlation coefficient (r); otherwise, we used Spearman’s correlation
coefficient (rs). Correlation coefficients less than 0.5, greater than 0.5 and less than 0.75,
and greater than 0.75 indicated a poor, good, or excellent relationship, respectively
(Portney & Watkins, 2009).
Aim 3: For this aim, we examined the relationships between paretic SOL MCE
and paretic SOL neuromechanics during walking and MVIC. At least four associations
were tested (Figure 3.11 C). During walking, we tested the relationships between SOL
MCE measure(s) and SOL EMG, and SOL MCE measure(s) and PI. During MVIC, we
tested the relationships between SOL MCE measure(s) and SOL EMG, and SOL MCE
measure(s) and SOL torque.
Aim 4: For this aim, we examined the relationships between paretic TA MCE and

paretic TA neuromechanics during walking and MVIC. At least four associations were
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tested (Figure 3.11 D). During walking, we tested the relationships between TA MCE
measure(s) and TA EMG, and TA MCE measure(s) and AAV. During MVIC, we tested
the relationships between TA MCE measure(s) and TA EMG, and TA MCE measure(s)
and TA torque.

CHAPTER FOUR
RESULTS

4.1

Group Characteristics
Healthy: Of the 25 participants, one female, and one male withdrew from the

study due to TMS discomfort, one male’s data could not be used due to insufficient MRI
quality, and one male could not attend the second session. Therefore, all data presented
here are from 21 healthy controls (8F/13M, 42 ± 11 years, 174 ± 12 cm, 75 ± 17 kg).
Stroke: Of the 15 participants, one female withdrew from the study due to TMS
discomfort. Therefore, all data presented here are from 14 stroke participants (6F/8M, 62
± 13 years, 173 ± 12 cm, 83 ± 22 kg). Lesion related characteristics (type, subtype, and
location) were characterized by a stroke neurologist using each participant’s MRI. Table
4.1 presents the individual and group demographical, clinical, and experimental
characteristics of 14 stroke participants.
People post-stroke (N = 14) were significantly older than the healthy adults (N =
21) were (p = 0.000; Figure 4.1 A), whereas there were no significant differences
between groups for height (p = 0.855; Figure 4.1 B), weight (p = 0.561; Figure 4.1 C),
and test-retest period (p = 0.907; Figure 4.1 D). All participants in both groups were
right-leg dominant. We determined leg dominance by simply asking participants the
question: “Which leg would you use the most if you had to kick a soccer ball three
times?”

Table 4.1: Demographical, clinical, and experimental characteristics of stroke participants

Figure 4.1: Inter-group differences in age, height, weight and test-retest period

4.2
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Aim 1: Quantification of the Soleus MCE Measures in Stroke and Healthy
Table 4.2 includes the test-retest normative data of eight SOL MCE measures

collected in both groups on day 1 and 2.
4.2.1

Resting Motor Threshold: Responses and Number of Stimulations

Healthy: On day 1, we could not measure the SOL rMT in two participants. In
both participants, MEPs on the right SOL were inconsistently elicited using intensities
greater than 85% MSO, so we stopped rMT hunting. On day 2, we could measure the
SOL rMT in one of the two participants whose SOL rMT could not be determined on day
1; however, we were unable to measure the SOL rMT in the second participant. In
summary, we measured the rMT of the right SOL from 19 participants on day 1 and 20
participants on day 2, and fewer than 15 stimulations were required on average to
calculate rMT of the right SOL on both days (Day 1: 13 ± 5, 41; Day 2: 15 ± 6, 41).
Stroke: On day 1, we were unable to measure the SOL rMT in five participants. In
four participants, we were unable to elicit a MEP on the paretic SOL even with intensities
greater than 90% MSO. The fifth participant could not tolerate intensities greater than
70% MSO. On day 2, we again could not measure SOL rMT in those same four
participants, but we could measure the SOL rMT of the fifth participant who could not
tolerate intensities greater that 70% MSO on day 1. In summary, we measured the rMT of
the paretic SOL from 9 participants on day 1 and 10 participants on day 2, and on both
days fewer than 25 stimulations on average were required to calculate rMT of the paretic
SOL (Day 1: 15 ± 5, 30; Day 2: 22 ± 10, 46).
4.2.2

Testing Reliability

Table 4.3 includes the test-retest reliability metrics, CVME and ICC, for eight SOL

MCE measures in both groups. For these analyses, we used data collected from 19
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healthy adults and 9 stroke participants on both days.
Healthy: All measures but amplitude had CVME less than 15 during resting
condition (Figure 4.2 A) while only raw and normalized latency had CVME less than 15
during the active condition (Figure 4.2 B). During the resting condition, all measures but
normalized latency had ICC greater than 0.75 (Figure 4.2 C), while only amplitude and
raw latency had ICC greater than 0.75 in the active condition (Figure 4.2 D).
Stroke: As in the healthy group, for all measures but amplitude, CVME was less
than 15 during the resting condition (Figure 4.2 A), and only for raw and normalized
latency CVME was less than 15 during the active condition (Figure 4.2 B). Of the eight
measures, only rMT, amplitude, raw latency during resting (Figure 4.2 C) and cSP during
active (Figure 4.2 D) had ICC greater than 0.75.
Only the following measures with CVME less than 15 in both groups were used in
the next step: rMT, raw and normalized latency during resting, and raw and normalized
latency during active.
4.2.3

Testing Group Variances

For the variance analyses, we used data collected with the five aforementioned
measures from 20 healthy adults and 10 stroke participants on day 2.
The variances of all measures except raw latency in resting were equal between
stroke participants and healthy adults (rMT: F(1,28) = 0.657, p = 0.425; resting normalized
latency: F(1,28) = 0.194, p = 0.663; active raw latency: F(1,28) =1.846, p = 0.185; active
normalized latency: F(1,28) = 1.164, p = 0.290) (Figure 4.3 A, C - E). Conversely, the
variance of the resting raw latency was significantly higher (F(1,28) = 6.816, p = 0.014) in
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stroke participants (35.9) than in healthy adults (16.6) (Figure 4.3 B). Therefore, we used
only the resting raw latency to test whether the group means differed.
4.2.4

Testing Group Means

The resting raw latency in both groups was normally distributed (Stroke: W(10) =
0.854, p = 0.064; Healthy: W(20) = 0.983, p = 0.967); therefore, an independent t-test was
used. The resting latency was significantly longer (t(1,28) = 2.135, p = 0.026) longer in
stroke participants (42.0 ± 6.0 ms) than in healthy controls (37.6 ± 4.1 ms) (Figure 4.4).
In Aim 3, therefore, only the resting raw latency was used in the correlational
analyses for walking and MVIC neuromechanics of the paretic SOL.
Soleus - Resting
Measures
Groups

Healthy
(Right)

Stroke
(Paretic)

Motor Threshold
(% MSO)

MEP Amplitude
(mV)

MEP Latency
(ms)

MEP Normalized
Latency ((ms/cm)*100)

Statistics

Day 1

Day 2

Day 1

Day 2

Day 1

Day 2

Day 1

Day 2

N

19

20

19

20

19

20

19

20

Mean ± SD
(CV)

52 ± 11
(11)

52 ± 12
(23)

22 ± 2
(9)

22 ± 2
(9)

N

9

10

9

10

Mean ± SD
(CV)

51 ± 9
(18)

53 ± 9
(17)

24 ± 1
(4)

24 ± 3
(12)

0.118 ±
0.119 ± 37.5 ± 4.4 37.6 ± 4.1
0.063 (53) 0.058 (49)
(12)
(11)
9

10

9

10

0.138 ±
0.140 ± 42.6 ± 3.8 42.0 ± 6.0
0.068 (49) 0.095 (68)
(9)
(14)

Soleus - Active (15% MVIC)
Measures
Groups

Healthy
(Right)

Stroke
(Paretic)

MEP Amplitude
(mV)

MEP Latency
(ms)

MEP Normalized
Latency ((ms/cm)*100)

Silent Period
(ms)

Statistics

Day 1

Day 2

Day 1

Day 2

Day 1

Day 2

Day 1

Day 2

N

19

20

19

20

19

20

19

20

20 ± 2
(10)

19 ± 2
(11)

124.9 ±
44.1 (35)

157.5 ±
40.9 (26)

9

10

9

10

22 ± 2
(9)

21 ± 2
(10)

141.8 ±
49.0 (35)

151.1 ±
50.6 (33)

Mean ± SD
(CV)
N
Mean ± SD
(CV)

0.739 ±
0.832 ± 35.0 ± 4.7 33.8 ± 3.3
0.637 (86) 0.555 (68)
(13)
(10)
9

10

9

10

0.476 ±
0.481 ± 37.1 ± 4.2 36.6 ± 4.5
0.158 (33) 0.202 (42)
(12)
(11)

Table 4.2: Test-retest normative data, mean ± SD (CV), of eight SOL MCE measures in Healthy
(right SOL) and Stroke (paretic SOL)
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Soleus - Resting
Group

Measures
Days

Healthy Mean ± SD (CV)
(N=19)
CVME
ICC (95% CI)
Day
Stroke Mean ± SD (CV)
(N=9)
CVME

Motor Threshold
(% MSO)
1

2

52 ± 11
(22)

52 ± 13
(25)

MEP Amplitude
(mV)

MEP Latency
(ms)

1

1

2

1

2

37.5 ± 4.4
(12)

37.3 ± 4.1
(11)

22 ± 2
(9)

21 ± 2
(10)

2

0.118 ±
0.122 ±
0.063 (53) 0.059 (48)

MEP Normalized Latency
((ms/cm)*100)

9

26

7

7

0.93 (0.81 - 0.97)

0.86 (0.64 - 0.95)

0.79 (0.44 - 0.92)

0.71 (0.22 - 0.89)

1

2

1

1

1

2

51 ± 9
(18)

52 ± 9
(17)

24 ± 1
(4)

24 ± 3
(12)

2

2

0.138 ±
0.142 ± 42.6 ± 3.8 42.5 ± 6.1
0.068 (49) 0.101 (71)
(9)
(14)

4

31

7

7

ICC (95% CI)

0.97 (0.87 - 0.99)

0.87 (0.39 - 0.97)

0.8 (0.01 - 0.96)

0.45 (-2.2 - 0.88)

Measures

MEP Amplitude
(mV)

MEP Latency
(ms)

MEP Normalized Latency
((ms/cm)*100)

Silent Period
(ms)

1

1

2

1

2

1

2

35.0 ± 4.7
(13)

33.5 ± 3.1
(9)

20 ± 2
(10)

19 ± 1
(5)

124.9 ±
44.1 (35)

155.2 ±
40.7 (26)

Soleus - Active (15% MVIC)
Group

Days

2

0.739 ±
0.849 ±
Healthy Mean ± SD (CV)
0.637 (86) 0.565 (67)
(N=19)
CVME
26
ICC (95% CI)
Day

7

7

17

0.93 (0.82 - 0.97 )

0.78 (0.42 - 0.92)

0.51 (-0.19 - 0.81)

0.72 (0.03 - 0.90)

1

1

1

2

1

2

22 ± 2
(9)

21 ± 3
(14)

141.8 ±
49.0 (35)

153.7 ±
52.0 (34)

2

0.476 ±
0.489 ±
Stroke Mean ± SD (CV)
0.158 (33) 0.213 (44)
(N=9)
CVME
31
ICC (95% CI)

0.55 (-1.46 - 0.90)

2

37.1 ± 4.2 36.6 ± 4.8
(11)
(13)
9

9

19

0.63 (-0.89 - 92)

0.6 (-0.95 - 0.91)

0.83 (0.31 - 0.96)

Table 4.3: Test-retest reliability, CVME and ICC (95% CI), of eight SOL MCE measures in Healthy
(right SOL) and Stroke (paretic SOL)
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Figure 4. 2: Test-retest reliability, CVME and ICC, of eight SOL MCE measures in Healthy (right
SOL) and Stroke (paretic SOL)

Figure 4.3: Inter-group differences in variances for five SOL MCE measures
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Figure 4.4: Inter-group differences in mean for the resting raw latency of SOL

4.3

Aim 2: Quantification of the Tibialis Anterior MCE Measures in Stroke and

Healthy
Table 4.4 includes the test-retest normative data of eight TA MCE measures
collected in both groups on day 1 and 2.
4.3.1

Resting Motor Threshold: Responses and Number of Stimulations

Healthy: On both days, we measured the rMT of the right TA in all participants
(N = 21), and on average fewer than 15 stimulations were required to calculate the right
TA rMT (Day 1: 14 ± 6, 40; Day 2: 13 ± 4, 33).
Stroke: On day 1, we measured the paretic TA rMT in all participants. In two
participants, the paretic TA rMT was higher than 83% MSO (86 & 90% MSO), making
120% intensity greater than 100% MSO. As a result, data collected from those two
participants were not included in the reliability analyses. On day 2, TA rMT was
measured in all but one participant. In this one participant, MEPs on the paretic TA were

not elicited even using 100% MSO. In summary, TA rMT was measured from 14
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participants on day 1 and 13 participants on day 2, while fewer than 20 stimulations were
required on average to calculate paretic TA rMT on both days (Day 1: 16 ± 7, 44; Day 2:
14 ± 3, 24).
4.3.2

Testing Reliability

Table 4.5 includes the test-retest reliability metrics, CVME and ICC, for eight TA
MCE measures collected in both groups. For those analyses, we used data that were
collected from 21 healthy adults and 12 stroke participants on both days.
Healthy: All measures except amplitude had CVME less than 15 during the resting
condition (Figure 4.5 A) while only raw and normalized latency had CVME less than 15
during the active condition (Figure 4.5 B). All measures in both conditions except active
normalized latency had ICC greater than 0.75 (Figure 4.5 C & D).
Stroke: In both resting and active conditions, all measures except resting and
active amplitude had CVME less than 15 (Figure 4.5 A & B), while all measures had ICC
greater than 0.75 (Figure 4.5 C & D).
Only the following measures with CVME less than 15 in both groups were used in
the next step: rMT, raw and normalized latency during resting, and raw and normalized
latency during active.
4.3.3

Testing Group Variances

For those analyses, we used data from the five aforementioned measures collected
from 21 healthy adults and 13 stroke participants on day 2.
Of five TA MCE measures, the variances of three measures differed significantly
between groups. The variances between stroke participants and healthy adults were equal
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for rMT (F(1,32) = 0.479, p = 0.494; Figure 4.6 A) and active raw latency (F(1,32) = 1.393, p
= 0.247; Figure 4.6 D). The variance of resting raw latency was significantly higher
(F(1,32) = 8.999, p = 0.005; Figure 4.6 B) in the stroke group (55.9) than in the healthy
group (13.6). Additionally, the variance of resting normalized latency was significantly
higher (F(1,32) = 18.6, p = 0.000; Figure 4.6 C) in the stroke group (13.2) than in the

healthy group (1.7). Similarly, the variance of active normalized latency was significantly
higher (F(1,32) =5.6, p = 0.024; Figure 4.6 E) in the stroke group (4.2) than in the healthy
group (1.4). Therefore, resting raw latency and resting and active normalized latency
were used to test whether the group means differed.
4.3.4

Testing Group Means

In both groups, the distributions of the resting raw latency (Stroke: W(13) = 0.921,
p = 0.259; Healthy: W(21) = 0.983, p = 0.960) and resting normalized latency (Stroke:
W(13) = 0.887, p = 0.089; Healthy: W(21) = 0.953, p = 0.396) were normally distributed.
The distribution of the active normalized latency was normally distributed in stroke (W(13)
= 0.892, p = 0.103) but not in healthy adults (W(21) = 0.883, p = 0.017). Consequently, we
used an independent t-test for the resting raw and normalized latency and Mann–
Whitney U test for the active normalized latency.
The means of all three measures were different between groups. The resting raw
latency was significantly (t(1,32) =3.013, p = 0.004) longer in stroke participants (41.2 ±
7.5 ms) than in healthy controls (34.5 ± 3.7 ms) (Figure 4.7 A). Furthermore, the resting
normalized latency was significantly (t(1,32) =3.976, p = 0.000) longer in stroke (24 ± 4
ms) than in healthy controls (20 ± 1 ms) (Figure 4.7 B). Similarly, the active normalized
latency was significantly (p = 0.000) longer in stroke (21 ± 2 ms) than in healthy controls
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(19 ± 1 ms) (Figure 4.7 C).

Although three measures passed all three criteria, we could use only two measures
in the correlational analyses. In Aim 4, therefore, the resting raw latency and the active
normalized latency were used in the correlational analyses for walking and MVIC
neuromechanics of the paretic TA.

Tibialis Anterior - Resting
Measures
Groups

Healthy
(Right)

Stroke
(Paretic)

Motor Threshold
(% MSO)

MEP Amplitude
(mV)

MEP Latency
(ms)

MEP Normalized
Latency ((ms/cm)*100)

Statistics

Day 1

Day 2

Day 1

Day 2

Day 1

Day 2

Day 1

Day 2

N

21

21

21

21

21

21

21

21

Mean ± SD
(CV)

47 ± 11
(23)

48 ± 12
(25)

19 ± 1
(5)

20 ± 1
(5)

N

14

13

12

13

Mean ± SD
(CV)

57 ± 16
(28)

56 ± 14
(25)

23 ± 3
(13)

24 ± 4
(17)

0.458 ±
0.379 ± 33.9 ± 3.1 34.5 ± 3.7
0.354 (77) 0.291 (77)
(9)
(11)
12

13

12

13

0.402 ±
0.343 ± 39.6 ± 6.4 41.2 ± 7.5
0.262 (65) 0.217 (63)
(16)
(18)

Tibialis Anterior - Active (15% MVIC)
Measures
Groups

Healthy
(Right)

Stroke
(Paretic)

MEP Amplitude
(mV)

MEP Latency
(ms)

MEP Normalized
Latency ((ms/cm)*100)

Silent Period
(ms)

Statistics

Day 1

Day 2

Day 1

Day 2

Day 1

Day 2

Day 1

Day 2

N

21

21

21

21

21

21

21

21

19 ± 1
(5)

19 ± 1
(5)

143.0 ±
49.1 (34)

140.1 ±
50.7 (36)

12

13

12

13

21 ± 2
(10)

21 ± 2
(10)

148.9 ±
44.3 (30)

148.6 ±
46.2 (31)

Mean ± SD
(CV)
N
Mean ± SD
(CV)

1.790 ±
1.640 ± 32.1 ± 3.0 32.6 ± 3.2
(9)
(10)
0.675 (38) 0.694 (42)
12

13

12

13

1.260 ±
1.263 ± 36.6 ± 5.3 36.8 ± 4.6
0.555 (44) 0.530 (42)
(14)
(12)

Table 4.4: Test-retest normative data, mean ± SD (CV), of eight TA MCE measures in Healthy (right
TA) and Stroke (paretic TA)
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Tibialis Anterior - Resting
Group

Measures
Days

Healthy Mean ± SD (CV)
(N=21)
CVME
ICC (95% CI)
Day
Stroke Mean ± SD (CV)
(N=12)
CVME

Motor Threshold
(% MSO)
1

2

47 ± 11
(23)

48 ± 12
(26)

MEP Amplitude
(mV)

MEP Latency
(ms)

1

1

2

0.458 ±
0.379 ±
0.354 (77) 0.291 (77)

2

33.9 ± 3.1 34.5 ± 3.7
(9)
(11)

MEP Normalized Latency
((ms/cm)*100)
1

2

19 ± 1
(5)

20 ± 1
(5)

11

40

3

4

0.89 (0.73 - 0.96)

0.84 (0.61 - 0.93)

0.93 (0.84 - 0.97)

0.76 (0.42 - 0.90)

1

2

1

1

1

2

52 ± 11
(21)

54 ± 12
(22)

22.9 ± 2.7
(12)

23 ± 3
(13)

2

0.402 ±
0.338 ±
0.262 (65) 0.226 (67)

2

39.6 ± 6.4 40.4 ± 7.1
(16)
(18)

6

31

6

6

ICC (95% CI)

0.95 (0.83 - 0.99)

0.87 (0.56 - 0.96)

0.93 (0.75 - 0.98)

0.86 (0.52 - 0.96)

Measures

MEP Amplitude
(mV)

MEP Latency
(ms)

MEP Normalized Latency
((ms/cm)*100)

Silent Period
(ms)

1

1

2

1

2

1

2

32.1 ± 3.0
(9)

32.6 ± 3.2
(10)

19 ± 1
(5)

19 ± 1
(5)

143.0 ±
49.1 (34)

140.1 ±
50.7 (36)

Tibialis Anterior - Active (15% MVIC)
Group

Days

2

1.790 ±
1.640 ±
Healthy Mean ± SD (CV)
0.675 (38) 0.694 (42)
(N=21)
CVME
21
ICC (95% CI)
Day

3

4

20

0.83 (0.58 - 0.93)

0.93 (0.84 - 0.97)

0.70 (0.24 - 0.88)

0.81 (0.53 - 0.92)

1

1

1

2

1

2

21 ± 2
(10)

21 ± 2
(10)

148.9 ±
44.3 (30)

152.9 ±
45.5 (30)

2

1.260 ±
1.284 ±
Stroke Mean ± SD (CV)
0.555 (44) 0.548 (43)
(N=12)
CVME
22
ICC (95% CI)

0.86 (0.49 - 0.96)

2

36.6 ± 5.3 36.3 ± 4.5
(15)
(12)
3

3

14

0.97 (0.90 - 0.99)

0.93 (0.74 - 0.98)

0.88 (0.58 - 0.97)

Table 4.5: Test-retest reliability, CVME and ICC (95% CI), of eight TA MCE measures in Healthy (right
TA) and Stroke (paretic TA)
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Figure 4. 5: Test-retest reliability, CVME and ICC, of eight TA MCE measures in Healthy (right TA)
and Stroke (paretic TA)

Figure 4.6: Inter-group differences in variances for five TA MCE measures
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Figure 4.7: Inter-group differences in mean for three TA MCE measures

4.4

Aim 3: Associations Between MCE Measures and Neuromechanics of the

Paretic Soleus
For this aim, we used data from the 10 stroke participants who had detectable
MEP in the paretic SOL on day 2. Since four correlations were carried out, we considered
a correlation significant only if its p was less than 0.012.
Prior to correlational analyses, we tested the normality of distributions for the
paretic SOL neuromechanical measures collected during walking and MVIC. The
distributions of the walking EMG (W(10) = 0.928, p = 0.430), PI (W(10) = 0.954, p = 0.711)
and MVIC torque (W(10) = 0.955, p = 0.726) were normally distributed, whereas the
MVIC EMG (W(10) = 0.802, p = 0.015) was not. During walking, the descriptive data of
the paretic SOL EMG and PI were 0.028 ± 0.017 mV (60) and 1.36 ± 0.64 % BW.sec
(47), respectively. During MVIC, the descriptive data of the paretic SOL EMG and

torque were 0.053 ± 0.058 mV (109) and 18.5 ± 9.1 N.m (49), respectively.
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Walking: Resting raw latency was not significantly associated with either
neuromechanical measure. Specifically, the resting raw latency of the paretic SOL had
good positive and non-significant association with the paretic SOL EMG (r = 0.713, p =
0.021; Figure 4.8 A), and it had poor negative and non-significant association with the
paretic SOL PI (r = -0.127, p = 0.728; Figure 4.8 B).
MVIC: Resting raw latency was not significantly associated with either
neuromechanical measure. Specifically, the resting raw latency of the paretic SOL had
good positive and non-significant association with the paretic SOL EMG (rs = 0.576, p =
0.082; Figure 4.8 C), while it had poor positive and non-significant association with the
paretic SOL torque (r = 0.341, p = 0.335; Figure 4.8 D).

Figure 4.8: Associations between resting raw latency and neuromechanics during walking and MVIC
of the paretic SOL

In summary, resting raw latency of the paretic SOL was not significantly
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associated with any neuromechanical measure of the paretic SOL during walking and
MVIC. Despite the absence of significance in any of the four associations, the association
between resting raw latency and walking EMG was positive and strong (r = 0.713),
therefore as latency increased the EMG increased (Figure 4.8 A). For that specific
association, the p was less than 0.05, yet higher than the corrected value of 0.012.

4.5

Aim 4: Associations Between MCE Measures and Neuromechanics of the

Paretic Tibialis Anterior
For this aim, we used the data from the 13 stroke participants who had detectable
MEP in the paretic TA on day 2. Because eight correlations were carried out, we
considered a correlation significant only if its p was less than 0.006.
Prior to correlational analyses, we tested the normality of distributions for paretic
TA neuromechanical measures collected during walking and MVIC. The distributions of
the walking EMG (W(13) = 0.929, p = 0.335) and MVIC torque (W(13) = 0.935, p = 0.394)
were normally distributed, but the AAV (W(13) = 0.853, p = 0.031) and MVIC EMG (W(13)
= 0.836, p = 0.019) were not. During walking, the descriptive data of the paretic TA
EMG and AAV were 0.071 ± 0.041 mV (58) and 0.90 ± 0.67 rad/sec (74), respectively.
During MVIC, the descriptive data of the paretic TA EMG and torque were 0.137 ±
0.080 mV (58) and 11.1 ± 5.5 N.m (50), respectively.
Walking: Resting raw latency and active normalized latency were associated only
with the angular velocity of the paretic ankle. The resting raw latency of the paretic TA
had poor positive and non-significant association with the paretic TA EMG (r = 0.393, p
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= 0.184; Figure 4.9 A) and excellent negative and significant association with the paretic
TA AAV (rs = -0.929, p = 0.000; Figure 4.9 B). Similarly, the active normalized latency
of the paretic TA had poor positive and non-significant association with the paretic TA

EMG (r = 0.393, p = 0.184; Figure 4.10 A) but good negative and significant association
with the paretic TA AAV (rs = -0.728, p = 0.005; Figure 4.10 B).
MVIC: Resting raw latency and active normalized latency were not associated
with either neuromechanical measure. The resting raw latency of the paretic TA had poor
negative and non-significant association with both paretic TA EMG (rs = -0.308, p =
0.306; Figure 4.9 C) and with paretic ankle dorsiflexion torque (r = -0.128, p = 0.678;
Figure 4.9 D). Similarly, the active normalized latency of the paretic TA had poor
negative and non-significant association with paretic TA EMG (rs = -0.206, p = 0.499;
Figure 4.10 C) and good negative and non-significant association with paretic ankle
dorsiflexion torque (r = -0.504, p = 0.079; Figure 4.10 D).
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Figure 4.9: Associations between resting raw latency and neuromechanics during walking and MVIC
of the paretic TA

Figure 4.10: Associations between active normalized latency and neuromechanics during walking
and MVIC of the paretic TA

In summary, both latencies of the paretic TA were significantly associated only
with the angular velocity of the paretic ankle during walking. Notably, both associations
(Figure 4.9 B & Figure 4.10 B) were strongly negative, therefore as the latency of the
paretic TA increased the angular velocity of the paretic ankle during walking decreased.

CHAPTER FIVE
DISCUSSION
5.1

Overall Findings
Despite the common use of nearly all available measures to quantify SOL and TA

MCE in healthy and clinical populations, evidence has been sparse regarding which MCE
measure of the two muscles is reliable and, thus, preferable for detecting true differences
between neurologically intact and impaired CNS. Additionally, the relationships between
the descending drive and the neuromechanical measures of SOL and TA can elucidate the
cortical contributions to these muscles during a motor task, yet there is limited evidence
about this kind of relationship, especially in stroke. Therefore, in the present project, we
first quantified the MCE of SOL and TA in healthy and stroke participants, and second,
we investigated the associations between MCE and neuromechanical measures during
walking and MVIC for the paretic SOL and the paretic TA in people post-stroke. For the
quantification of SOL and TA MCE, we employed a relatively different methodological
approach compared to previous studies with similar research goals. In addition to testing
reliability, which was determined using CVME with ICC also reported, we subsequently
investigated which measures differed between groups in both variance and means. We
included variance in this analysis because we reasoned that a variance of a reliable MCE
measure would be low in a healthy control and high in a stroke participant.

For the brain-behavior relationships, we used the MCE measures that met all three predefined requirements for reliability, variance, and mean, and as well as certain
neuromechanical measures that quantified indirectly the biomechanical functions of the
paretic SOL and TA during walking and MVIC in stroke participants.
Several findings occurred. First, not all MCE measures of SOL and TA were
reliable in both groups, whereas only latencies had good reliability and differed in
variance and mean between the two groups. Specifically, resting raw latency of the
paretic SOL, resting raw latency of the paretic TA, and both resting and active
normalized latencies of the paretic TA met all three pre-defined requirements. In the
associations, therefore, one SOL and two TA MCE measures were used; thus, a total of
four and eight correlations were run for the paretic SOL and TA, respectively. Second,
the resting raw latency of the paretic SOL was not significantly associated with any
neuromechanical measure in both walking and MVIC; however, there was a strong
positive association between the resting raw latency of the paretic SOL and the EMG of
the paretic SOL during the stance phase of walking. Third, both the resting raw latency
and active normalized latency of the paretic TA were significantly and negatively
associated only with the AAV during the swing phase of walking; the remaining
associations were relatively weak and non-significant. In the following sections, we
discuss in depth the meaning and importance of the findings, the clinical implications, the
methodological considerations, and the future directions for each aim.

5.2

Aim 1: Quantification of the Soleus Motor Cortical Excitability in Stroke and

Healthy
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For this aim, we characterized eight MCE measures of the paretic SOL in stroke
participants and right SOL in healthy controls. The evidence on the reliability of SOL
MCE in both healthy and stroke participants is limited to a single study (Lewis et al.,
2014). Therefore, our hypotheses were exploratory and based on the few prior studies
that had examined TA MCE reliability in various populations (Cacchio et al., 2009;

Cacchio et al., 2011; Meaney et al., 2015; Tallent et al., 2012; van Hedel et al., 2007). All
those studies determined reliability using ICC; in contrast, we quantified reliability using
CVME. We hypothesized that only certain measures would be reliable in both groups and
their variances and means would differ between groups. Results partially supported our
hypotheses. As we hypothesized, rMT, raw and normalized latency were reliable during
resting in both groups whereas only raw and normalized latency were reliable during
active condition in both groups. Among those five measures, only the variance and mean
of the resting raw latency differed between groups. Therefore, only resting raw latency of
the paretic SOL had a low measurement error and, thus, detected the differences between
a neurologically intact versus a neurologically impaired CNS.
As anticipated, of the six measures that were hypothesized to be reliable, all
measures were except cSP; however, the resting and active amplitude of SOL were not
reliable. To the best of our knowledge, this is the first attempt to examine systematically
and thoroughly the reliability of SOL MCE in healthy adults and people post-stroke while
the SOL was in either resting or active state. While SOL was at complete rest, all
measures but amplitude could be quantified reliably in both groups; thus, they had low
measurement error. Similarly, during active, only the raw and normalized latency had
good reliability in both groups. Because no prior study had investigated those SOL MCE
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measures, we cannot directly compare our findings with results from previous research.
To the best of our knowledge, the work by Lewis et al. (2014) is the only study that
allows a relative comparison of results. In that prior study, the authors investigated the
test-retest reliability of three MCE measures of SOL (aMT, MEP amplitude, and MEP

area) in both healthy adults (randomly assigned side) and stroke participants (paretic side)
while SOL was slightly contracted with a target force level at 10% MVIC. Although the
prior research measured SOL aMT and not rMT as our study did, SOL aMT was reliable
in both groups using both ICC (Healthy: 0.92; Stoke 0.82) and typical percentage error
(TPE; Healthy: 5; Stroke: 8). They calculated TPE in a similar way we calculated CVME.
Interestingly, our results showed that CVME was lower and ICC was higher in people
post-stroke than in healthy adults while Lewis et al. (2014) found the opposite. This
discrepancy might be due to certain differences in methodology (rMT versus aMT; use of
neuronavigation versus no use of neuronavigation). Despite this difference, in general the
previous finding about SOL aMT was in agreement with our results on SOL rMT.
Findings from both studies indicate that SOL MT can be reliably measured in both
healthy adults and stroke participants regardless of the state of contraction of the SOL.
In addition to rMT, our results indicated that both raw and normalized latencies
were reliable in both groups while SOL was either relaxed or contracted. No other study
has examined the reliability of these SOL MCE measures in either group; therefore,
comparisons with previous literature are limited. Interestingly, only the ICC of the resting
raw latency in both groups and the active raw latency in healthy adults indicated good
reliability. However, as we discussed in section 3.7.1, the ICC may misinterpret the
reliability of measure, if the group variability of that measure is low. That was the case
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for the SOL latency measures whose ICC was less than 0.75. For example, the ICC of the
active raw latency of the paretic SOL was 0.63, yet the group CV in both days was less
than 15 (Day 1: 11; Day 2: 13), indicating low between-subject variability. That was the
reason we chose using CVME, which is insensitive to variability in the samples and is
independent of ICC, as the main reliability metric. Including SOL rMT, SOL latencies
had a CVME much lower than 15%. Therefore, in addition to SOL rMT, the raw and
normalized latencies in both conditions can be reliably measured in both healthy adults
and stroke participants.

Despite the wide use of MEP amplitude to quantify SOL MCE, neither resting nor
active amplitude was a reliable measure. Both measures had CVME higher than 15; hence,
they had low reliability. On the other hand, only active amplitude in stroke had ICC less
than 0.75. Again, if ICC was used as a reliability metric, resting amplitude in stroke and
healthy and active amplitude in healthy would be considered reliable measures. However,
that was the case due to high variability within each sample. Lewis et al. (2014) reported
low ICC and high TPE for active amplitude of the paretic SOL but high ICC and TPE for
active amplitude of SOL in healthy. Similar to our results, they found that SOL amplitude
in both groups had high TPE, hence high measurement error. Combining the findings
from both studies, one would postulate that SOL amplitude is not a good reliable measure
to quantify SOL MCE despite the fact that the majority of studies use and report MEP
amplitude as a major metric to investigate SOL MCE.
Though our hypothesis about SOL cSP was exploratory, we postulated that SOL
cSP would be a reliable measure in both groups. That postulation was based on the
limited evidence derived from studies which examined TA cSP in healthy (Cacchio et al.,
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2009; Tallent et al., 2012; van Hedel et al., 2007). Based on CVME, SOL cSP did not have
good reliability in either group whereas the ICC of SOL cSP was higher than 0.75 in
stroke and lower than 0.75 in healthy. As this is the first study to investigate this measure
for SOL in both healthy and stroke, we cannot make sound comparisons with previous
studies. One reason that SOL cSP was not reliable in either group might be the fact that
we calculated the maximum isometric SOL EMG instead of using force. Tallent et al.
(2012) reported recently that TA cSP is an excellent reliable measure in healthy controls
when TA was contracted at a certain level of maximum target force, either during
concentric (ICC: 0.94) or eccentric (ICC: 0.96) contraction. Due to the lack of evidence
on SOL cSP, we cannot ensure that this can be applied to the SOL cSP. Future studies
should use similar approaches as Tallent et al. (2012) to determine whether SOL cSP can
be reliably measured when it is contracted, either concentrically or eccentrically. To the
best of our knowledge, our study was the first to measure SOL cSP, either in healthy or
stroke.
Among the five measures with good reliability, only raw resting latency of SOL
detected differences between groups. Specifically, raw resting latency of SOL had higher
variance and mean in stroke than in healthy. In order to define a reliable measure, we
asked whether a reliable measure could detect true differences between a neurologically
intact and an impaired population. Rather than focusing only on group differences in
mean, we also looked at the between group difference in variance. No group differences
in variances implied that the variability of each group was due to factors other than the

integrity level of CNS. As the methodology was the same across participants and between
days, these factors might be due to biologically related factors (e.g., initial cortical

activation state) (Rubens & Zanto, 2012). Surprisingly, the variance of the resting
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normalized latency was not different between groups though the variance of the resting
raw latency was. As normalized latency was the raw latency divided by the height, the
fact that there was no significant difference in variance might be due to the height
difference between groups. However, there was no significant difference in height
between the groups. These findings indicate that although multiple SOL MCE measures
were reliable in both groups, the detection of true differences between the two groups
was limited only to resting raw latency. Therefore, studies that examine the SOL MCE in
just healthy adults may use any of the five measures that our results demonstrated to be
reliable using CVME. On the other hand, if the goal of a study is to quantify the MCE of
the paretic SOL after stroke, we suggest that resting raw latency might be the only
measure that should be used to ensure reliability and distinction with an intact CNS.

5.3

Aim 2: Quantification of the Tibialis Anterior MCE Measures in Stroke and

Healthy
Similar to Aim 1, we characterized eight MCE measures of the paretic TA in
stroke and right TA in healthy. In contrast to the limited evidence of SOL MCE reliability
studies, some evidence on the reliability of certain TA MCE measures exists in healthy
(Cacchio et al., 2009; Forster et al., 2014; Tallent et al., 2012; van Hedel et al., 2007),
stroke (Cacchio et al., 2011), SCI (van Hedel et al., 2007), and Multiple Sclerosis
(Meaney et al., 2015). Therefore, this aim’s hypotheses were based on the cumulative
evidence reported in those studies. As for SOL, we hypothesized that only certain TA
MCE measures would be reliable in both groups and their variances and means would
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differ between groups. Results partially supported the hypotheses. During resting, rMT,
raw and normalized latency had good reliability in both groups whereas during active
only raw and normalized latency had good reliability in both groups. Of the five
measures, the variance and mean of resting raw and normalized latency and active
normalized latency differed between groups. Therefore, three of these five TA MCE

measures had low measurement error and detected differences between a neurologically
intact and impaired CNS.
While TA was relaxed, all measures but amplitude had good reliability in both
groups. Interestingly, both CVME and ICC indicated good reliability for rMT, resting raw
and normalized latency. Other studies have also demonstrated good reliability for TA
rMT in healthy participants (Cacchio et al., 2009; Forster et al., 2014; Tallent et al.,
2012), stroke participants (Cacchio et al., 2011) and people with Multiple Sclerosis
(Meaney et al., 2015). Although all of those studies relied solely on ICC to determine
reliability, their results are in agreement with ours. Therefore, rMT is a reliable measure
to quantify TA MCE, either in people with or without neurological impairment. No study
has investigated whether resting latency of TA is reliable in either healthy or stroke
populations. As for SOL latencies during resting condition, resting raw and normalized
latency of TA also had good reliability, indicating that these measures, which reflect the
conductivity of the signal from MC to the muscle, can also be measured consistently
across days.
Although TA was slightly contracted, only raw and resting latency had good
reliability in both groups. The CVME of active raw and normalized latency was very low
in both groups, indicating low measurement error. On the other hand, the ICCs of the

same measures were very high except for the ICC of normalized latency in healthy,
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whose ICC was 0.70. This is another example that sole reliance on ICC may misinterpret
the consistency of measuring a metric. No other study has reported the ICC of the active
normalized latency of TA in any population; therefore, we cannot make comparisons
about the reliability values of this measure. However, one study that examined the
reliability of the active raw latency of TA among other measures in 16 stroke participants
and 16 age-matched healthy controls did report high ICC bilaterally in both groups
(Cacchio et al., 2011). Another study also reported good ICC of active raw latency in
both healthy and people with SCI, especially when TA was contracted in high
percentages of maximum torque effort (van Hedel et al., 2007). Although neither study
calculated any reliability metric similar to CVME, their results, in conjunction with our
findings, indicate that both active raw and normalized latency of TA can be reliably
measured with consistent low measurement error in both healthy and stroke.
Regardless of the contraction state of TA and the integrity level of CNS, MEP
amplitude had low reliability using CVME but good reliability using ICC. The CVME
ranged between 31-40 in both groups for the resting amplitude whereas it was 21 in
healthy and 22 in stroke for the active amplitude. Because we chose a cutoff value of 15
to distinguish a reliable measure from a non-reliable measure, amplitude might not be a
consistent measure of TA MCE for either group. Conversely, the ICC for resting and
active amplitude ranged from 0.82 to 0.87 in both groups. Similar to our results, other
studies reported high ICC for TA amplitude. van Hedel et al. (2007) reported good
reliability of TA amplitude in both healthy adults (ICC = 0.77) and people with SCI (ICC
= 0.77) while TA was contracted at 40% maximum voluntary contraction quantified by
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torque. Additionally, a more recent study demonstrated that the amplitude of the resting
TA could be also reliably (ICC = 0.92) measured in people with Multiple Sclerosis
(Meaney et al., 2015). Cacchio et al. (2011) reported similar ICCs for TA active
amplitudes measured bilaterally in healthy and on the non-paretic side in stroke.
However, the ICC of the TA active amplitude measured on the paretic side was 0.38,
indicating poor reliability (Cacchio et al., 2011). The differences that our study and the
latter study had in methodology, such as type of coil, use of neuronavigation, time
between sessions, and MVIC level, may explain the disagreement between the studies
about the reliability of the paretic TA active amplitude. Furthermore, the fact that
cumulative evidence indicates that TA amplitude can be consistently measured due to
high ICC may lead to wrong assumptions about TA MCE. As the variabilities of TA

amplitudes reported here and elsewhere were high, one would expect that ICC would be
high as well. As we discussed previously, this is the main drawback of using ICC to
quantify reliability. As we chose CVME as the metric to determine reliability, measuring
and reporting amplitude, either resting or active, to quantify TA MCE should be done
with caution in both healthy and stroke participants.
The TA cSP could be reliably measured in stroke but not in healthy. For the
paretic TA, CVME and ICC were 14 and 0.88, respectively. If only ICC was used to
determine reliability, one could argue that the high ICC of paretic TA cSP could be due
to high variability. However, because of low CVME, that might not be the case. Therefore,
these findings indicate that TA cSP can be consistently measured in stroke participants.
Thus far, no other study has examined the reliability of paretic TA cSP in this patient
population. Conversely, two studies investigated TA cSP in healthy. The first study (van
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Hedel et al., 2007) reported poor reliability for TA cSP while the second study (Cacchio
et al., 2009) reported good reliability with ICC higher than 0.75. The former study
calculated the absolute cSP (i.e., period between MEP offset and EMG resumption), as

we did in this study while the latter calculated the relative cSP (i.e., period between MEP
onset and EMG resumption). In our study, CVME and ICC of the right TA cSP was 20 and
0.79, respectively; therefore, this measure in healthy did not have good reliability based
on the criterion (CVME <15) that we used in the present study. The inconsistencies of
results across the three studies might be due to methodological differences. First, neither
of the previous studies used a neuronavigation system, which can improve accuracy and
precision of the stimulation site within and between sessions (Krings et al., 2001;
Ruohonen & Karhu, 2010; Sparing et al., 2010). Second, neither of the previous studies
used a double cone coil, which is considered to have an adequate stimulation depth
appropriate to stimulate cortical representations of leg muscles (Deng et al., 2013, 2014;
Lontis et al., 2006; Terao et al., 1994). Third, it was not clear in the methods section of
the previous studies whether the TA cSP was calculated manually or automatically. In
our study, we used published automated algorithms, which could assist in the consistent
calculation of cSP across participants. Regardless of those differences across studies,
caution should be taken when using cSP to quantify the inhibitory mechanisms of TA’s
neuromotor axis, especially in healthy controls.
Despite the fact that some TA MCE measures were reliable, only few of those
detected differences between groups. As for SOL MCE, the variance and the mean of the
resting raw latency were higher in stroke than in healthy. Additionally, the variance and
the mean of the resting and active normalized latencies were also higher in stroke than in
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healthy. These results indicate that TA latencies, especially after taking into account each
participant’s height, might be a good MCE measure that can quantify accurately the TA
MCE in people post-stroke. Of course, all five measures that were found to be reliable
might be used to quantify TA MCE in healthy controls. Therefore, our findings can
provide some guidance concerning which measure should be used to quantify TA MCE
in either healthy or stroke participants; a final decision should be thoroughly made based
on the research question asked and the kind of population investigated. Researchers
should bear in mind that our results are limited only to healthy and stroke participants.

5.4

Aims 1 and 2: Clinical Applications, Methodological Considerations, and

Future Work
The findings of the present study may provide novel information on the
measurement characteristics of certain SOL and TA MCE measures that clinical studies
may utilize in the future. In recent years, non-invasive brain stimulation techniques have
been employed in neurorehabilitation science, as either an assessment or intervention tool
(Liew, Santarnecchi, Buch, & Cohen, 2014). However, the number of studies that have
investigated the MCE of upper extremity muscles (in the thousands) is much larger than
the number of studies that have investigated the MCE of the lower extremity (less than
500). Additionally, the characteristics of the upper extremity muscles MCE measures
have been quantified more extensively than lower extremity MCE. Thus, despite the fact
that there is no sound evidence on the measurement characteristics of the SOL and TA,
studies continue to use nearly all available MCE measures to quantify SOL and TA MCE
either in healthy or clinical populations. However, our findings demonstrated that of eight

measures, only the rMT and the resting and active latencies of SOL and TA can be
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reliably measured in both stroke and healthy participants. As those five MCE measures
were reliable for both muscles and groups, one could argue that the measurement
consistency of the ankle musculature MCE is independent of muscle and damage in CNS,
and, as a result, the inter-muscle and inter-group differences can be investigated.
Furthermore, studies that investigate the cortical plastic changes either in SOL or TA due
to an intervention (e.g., behavioral, neurophysiological) should carefully choose the MCE
measures to quantify these changes. According to our findings, rMT or latencies might be
the most appropriate measures to use to assess these changes in neuromotor axis without
the caution of high measurement error. Hence, the observed changes in SOL or TA MCE
would be most likely due to the true effect of the intervention. Additionally, if a goal of a
study is to assess globally the MCE of either SOL or TA, any MCE measure of the five,
either rMT or latency, can be used. For example, a potential study may choose to use
only the rMT to quantify SOL and TA MCE; as a result, the total number of stimuli
applied over participants’ brains will be small and the total assessment period will be
short. Furthermore, our results provide normative data of eight MCE measures of SOL
and TA in both healthy adults and stroke participants; similar studies in the future can use
the present findings either for comparisons or as a guide in intervention studies. In
summary, findings from the present study can be used in both scientific and clinical
studies to either assess cross-sectional or longitudinal SOL and TA MCE in either healthy
adults or people post-stroke.
We acknowledge a few methodological considerations that were present in these
aims. One methodological consideration was the small sample size of the stroke group (N

= 14) which was similar to the sample size of the stroke groups used in Lewis et al.
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(2014) study (N = 13) and Cacchio et al. (2011) (N = 16). As we could not get responses
on the paretic SOL and TA from all participants in both days, the sample size used to
determine reliability of SOL (N = 9) and TA (N = 12) MCE measures decreased. Also,
for the between group comparisons for measures collected in day 2, the sample size of the
paretic SOL (N = 10) and TA (N = 13) were smaller than the sample size of the right
SOL (N = 20) and TA (N = 21). Interestingly, the number of people that we could not get
responses from was greater for SOL than in TA; this pattern was more apparent in the
stroke group. This finding may add to the existing notion that higher stimulus is required
to elicit a response to SOL than in TA (Bawa et al., 2002). Importantly, no detectable
MEP does not necessarily imply absent MCE for that target muscle. If a coil with higher
maximum output (e.g., figure-of-eight coil with maximum magnetic field of 2T) was
used than the one we used in the present study (i.e., double cone coil with a maximum
magnetic field of 1.4T), we could potentially get responses from all stroke participants.
Another methodological consideration was the significant difference in age
between our groups while both Lewis et al. (2014) and Cacchio et al. (2011) recruited
age-matched healthy controls. We did try to recruit age-matched healthy controls, yet it
was not feasible. We do acknowledge that age has generally a significant effect on the
MCE of the lower extremity muscles; in general, compared to young adults, older people
have higher rMT, smaller amplitudes, and longer latencies. These changes might be due
to multiple factors, such as reduction of the overall brain volume, nerve fiber
degeneration, muscle atrophy, and increase of subcutaneous fat tissue (Budui, Rossi, &
Zamboni, 2015; Fotenos, Snyder, Girton, Morris, & Buckner, 2005). Each factor can
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affect a different component of the neuromotor axis. Reduction of brain volume results in
increase of the skull to cortex distance; therefore, the coil to cortex distance increases as
well. Because of these increases, higher intensities are required since as the coil to cortex
distance increases, the TMS intensity increases (Danner et al., 2012; McConnell et al.,
2001). Degeneration of nerve fiber may contribute to increases in latency, which reflects
the conductivity of the descending pathways. Muscle atrophy and increase of the
subcutaneous fat tissue may contribute to the reduced detection of the muscle activity
measured by sEMG; thus, amplitudes are smaller in the elderly. Nevertheless, the
summative evidence from these studies is that age does not have a significant effect in all

MCE measures of leg muscles (Baudry, Collignon, & Duchateau, 2015; Rossini, Desiato,
& Caramia, 1992; Saisanen, Julkunen, et al., 2008; Stevens-Lapsley, Thomas,
Hedgecock, & Kluger, 2013; Tobimatsu, Sun, Fukui, & Kato, 1998). However, the MCE
measure that was found to be significantly higher always in the elderly was the latency;
this finding was for multiple ankle muscles: SOL (Baudry et al., 2015), TA (Eisen &
Shtybel, 1990; Saisanen, Julkunen, et al., 2008), and AH (Tobimatsu et al., 1998). In the
present study, we found that latencies collected in both muscle state conditions and for
both muscles were significantly higher in stroke participants than in healthy.
Consequently, both damage in CNS and aging might affect those inter-group differences
in latencies; there was no height or weight difference between groups. However, the
significant inter-group differences in variances might decouple the effect of damage in
CNS and aging on latencies; therefore, latency may still distinguish a damage in CNS
regardless of the factor of age. Nevertheless, as age has an effect on certain MCE
measures of the lower extremities, especially latency, future studies with similar

objectives as ours should definitely recruit controls whose age is matched with the
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experimental or clinical group.
In addition to age, numerous factors can influence the effect of TMS over the
neuromotor axis. These factors are either physiological or methodological and are present
in both healthy and stroke participants (Cortes, Black-Schaffer, & Edwards, 2012;
Ridding & Ziemann, 2010; Rubens & Zanto, 2012; Wassermann, 2002). The level of
control is less for the physiological factors than the methodological ones. In the present
study, we tried to control those physiological factors over which we had some control,
such as no consumption of alcohol and caffeine at least three hours prior to experiment,
level of arousal, height, weight, and gender. Similarly, we employed a methodology that
was tight and consistent across participants and days. The same sEMG electrodes were
used for the same muscles between days and across participants; the same person placed
sEMG in all experiments using standardized protocol for the sEMG placement and
testing. Furthermore, we used the simple adaptive PEST, an automated method, to
determine rMT, which was tested twice for each muscle. Then we used the average of
two to calculate the 120% intensity used during the resting and active conditions.
Furthermore, use of the neuronavigation with each participant’s structural MRI increased
both the accuracy and precision of stimulating the hot spot, which was determined for
each target muscle. In contrast to other studies, we detected the hot spot of each muscle in
a 36-points grid (see Figure 3.5) using a suprathreshold intensity. From repeated
measures of pilot experiments in our lab, we found that the hot spot of each muscle is not
exactly the same, even with a 30 minute break between each hot spot hunting process.
For this reason, we ran the hot spot hunting protocol on both days; most of the time, the
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inter-session hot spot differed for each muscle in both hemispheres and groups. Certainly,
future studies should investigate similar approaches to detect hot spot using mathematical
models. Establishment of a precise method for searching for the hot spot of the target
muscle may reduce a portion of the methodological error that is inherent in TMS.
One further methodological consideration was that we did not examine the
reliability of RC derived measures, measures that quantify intracortical mechanisms, or
measures that characterize the motor representations of SOL and TA in either group.
Therefore, the application of our results is limited only to the measures tested in the
present study. Furthermore, our results are limited to only the two muscles and groups
that we investigated here.
Two subjects remain to elucidate the cortical control of SOL and TA: the
intracortical networks and the motor representations of SOL and TA. A few studies have
reported intracortical measures (i.e., SICI and SICF) of SOL and TA in both healthy and
clinical populations (Beaulieu et al., 2014; Liepert, Hassa, Tuscher, & Schmidt, 2011;
Liepert & Neveling, 2009; Oliveri et al., 2012; Roy, Norton, & Gorassini, 2007).
However, no study examined whether these measures are reliable in either group and
detect true differences between the target groups. Future studies may use similar
approaches used in aims 1 and 2 to determine SOL and TA intracortical measures that
have good reliability and detect truly existing differences between healthy and clinical
populations. Elucidation of this subject may hold clinical significance, especially in
stroke participants. It has been suggested that MCE measures, similar to the ones used in
this study, might be more appropriate to quantify corticospinal integrity within the first
three months after stroke whereas intracortical measures should be used after that period

133

(Di Pino et al., 2014). The underlying hypothesis is that the motor recovery of a certain

muscle may rely on the remaining CST in the early phase after stroke while that reliance
might be shifted to cortical networks in later stages of stroke (Di Pino et al., 2014).
Therefore, since the majority of stroke studies recruit stroke participants in the chronic
phase, it would be worth quantifying the measurement characteristics of intracortical
measures of SOL and TA in both healthy and stroke participants.
Motor mapping of SOL and TA is the second subject that future work should
focus on. Compared to the number of studies that examined the motor cortical area of TA
(Forster et al., 2014; Niskanen et al., 2010; Thordstein et al., 2013; Vaalto et al., 2013),
only one study reported the motor cortical area of SOL from a single patient with focal
cortical dysplasia (Saisanen et al., 2010). A common characteristic that all these studies
share is the use of the same nTMS system (Eximia, Nexstim Ltd.; Helsinki, Finland).
However, this system is extremely expensive, and it is usually found in hospitals. Future
work should systematically investigate and establish normative data of cortical mapping
measures for SOL and TA in healthy controls using user-friendly neuronavigation
systems that are more available to researchers. This will establish which motor mapping
measures should be used to specifically quantify the motor representations of SOL and
TA. Then, clinical studies can use these metrics to characterize plastic changes at the
cortical areas of each muscle after an intervention.

5.5

Aim 3: Associations Between MCE Measures and Neuromechanics of the

Paretic Soleus
For this aim, we examined the associations between one paretic SOL MCE
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measure, resting raw latency, and the neuromechanics of the paretic SOL during walking

and MVIC. We hypothesized that paretic SOL MCE (in this case, it was quantified using
resting raw latency) would not be associated with either walking neuromechanical
measure of paretic SOL whereas it would be negatively associated with both MVIC
neuromechanical measures. Results partially supported our hypotheses. As we
anticipated, there was no significant association between the resting raw latency and
neuromechanics of the paretic SOL during walking, but, in contrast to our hypotheses, the
resting raw latency of the paretic SOL was not significantly associated with either
neuromechanical measure of the paretic SOL during MVIC.
During walking, resting raw latency of the paretic SOL increases were strongly
associated with increases in EMG of the paretic SOL, yet the association was not
statistically significant. Evidence from studies that applied TMS during walking in
healthy controls supports the notion that the activity of SOL is also generated by motor
cortical signals, particularly during the stance in which SOL is active ((Knikou, Hajela, &
Mummidisetty, 2013; N. Petersen et al., 1998; N. T. Petersen et al., 2001). The cortical
contribution to SOL in those studies was quantified calculating MEP amplitude of SOL.
In contrast to those studies, Capaday et al. (1999) reported a weak linkage between the
descending drive from MC to SOL and SOL EMG during stance in healthy controls; they
quantified descending drive using RC derived measures. Although there were differences
in methodology and results between those studies, descending drive from MC does
contribute to SOL activity during the stance phase of walking; this evidence comes
mainly from healthy controls. In the case of SOL, those cortical contributions might not
be as strong as the contributions from spinal centers and sensory feedback, yet such
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distinction is difficult to be made (J.B. Nielsen, 2002). Additionally, SOL has weak CM
connections (Bawa et al., 2002) while other pathways (e.g., corticorubrospinal,
corticoreticulospinal) might contribute to its activation (J. Nielsen & Petersen, 1995).
Due to those particular characteristics of the SOL MCE and the fact that stroke affects

multiple descending pathways, including CST, we postulated that the contributions of the
descending drive to the SOL EMG during stance would be weak (i.e., non-significant
association); hence other parts of the CNS might be responsible for the activation of
SOL. As we hypothesized, the association was not statistical significant after correcting
for multiple comparisons, but the association was strong and positive. In other words, the
more impaired the descending drive to paretic SOL was, the higher the activation of the
paretic SOL was during stance. A potential explanation for this unanticipated finding
could be that stroke participants with a greater level of impairment in SOL MCE activate
their paretic SOL at high levels just to accomplish the task during the stance phase. As
stroke alters SOL MCE (i.e., resting raw latency), increase in the activation of paretic
SOL might be due to the increased contributions from either sensory receptors (e.g., force
receptors) or spinal networks. Whether this is true cannot be addressed by the current
study. Moreover, the results from this specific association cannot be definitive because of
the small sample size (N = 10) and the low p (0.021). If the size of the sample had been
larger, there might have been statistically significant association. Future studies should
test this assumption.
As we anticipated, resting raw latency of the paretic SOL was not significantly
associated with PI. We chose PI as one of the walking neuromechanical measures of SOL
because it can characterize indirectly the biomechanical function of SOL during walking,

along with LG and MG. Our results suggest that the capacity to accelerate the COM
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forward after stroke is not associated with the integrity of SOL MCE. After stroke, a
positive association exists between paretic SOL EMG and PI in stroke participants
(Turns, Neptune, & Kautz, 2007). However, PI is not exclusively dependent on the
activation of SOL, along with LG and MG. Other factors, including ankle moment and
power and the trailing limb, contribute to PI in both healthy adults and stroke participants
(Hsiao, Knarr, Higginson, & Binder-Macleod, 2015a, 2015b; Peterson et al., 2010).
Therefore, stroke participants can still generate adequate PI to accelerate forward the
COM using several biomechanical patterns regardless of the level of integrity of the
descending drive to the paretic SOL.
As in walking, the resting raw latency of the paretic SOL increased when the
activation of the paretic SOL during MVIC increased; yet association was nonsignificant. Capaday et al. (1999) reported a strong linkage between the descending drive
to SOL and activation of SOL during MVIC in healthy adults; therefore, we postulated
that as the MEP latency of the paretic SOL would be increased due to stroke, the
activation level of SOL during MVIC would be decreased. Contrary to our hypotheses,
the association was non-significant and positive, but it was still strong. Results suggest
that the activation of paretic SOL during MVIC may increase due to the impaired
conductivity of the descending drive to the paretic SOL. A potential explanation for this
unanticipated finding might be that the increase in activation of the paretic SOL during
MVIC might be due to increased neuromotor output from the SOL motor pools. Paretic
SOL motor pools may be activated by other descending pathways (e.g.,
corticorubrospinal and corticoreticulospinal) (J. Nielsen & Petersen, 1995) due to the
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delayed signal from the MC to the paretic SOL via CST. Although this postulation may

be true, because this association was strong but non-significant, no definitive inferences
can be made.
In contrast to our hypothesis, we found no associations between resting raw
latency and paretic plantarflexion torque production during MVIC. In contrast to walking
in which the leg is in contact with the ground during the stance phase and factors other
than SOL EMG may affect PI, during MVIC the leg is fixated to a footplate. This results
in the torque production being mainly affected by the activation of the responsible muscle
whose contraction is most likely generated by a descending and spinal drive and, to a
lesser extent, by the feedback from sensory receptors. Nevertheless, results indicate that
impaired conductivity of the descending drive to the resting paretic SOL was not
associated with the paretic plantarflexion torque production during MVIC.

5.6

Aim 4: Associations Between MCE Measures and Neuromechanics of the

Paretic Tibialis Anterior
For this aim, we examined the associations between two MCE measures of the
paretic TA, resting raw latency and active normalized latency, and the neuromechanics of
the paretic TA during walking and MVIC. We hypothesized that paretic TA MCE would
be negatively and significantly associated with both walking and MVIC neuromechanical
measures. Results partially supported our hypotheses. Both the resting raw latency and
active normalized latency of the paretic TA were significantly, strongly, and negatively
associated with only the peak AVV during the swing phase of walking. Conversely, the
remaining associations were non-significant and mainly weak.
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During walking, activation of paretic TA was not significantly associated with

either resting raw latency or active normalized latency, both associations were weak and
positive. It is generally accepted that activation of TA during walking, especially in
swing phase, relies heavily on descending drives from the MC (T. H. Petersen et al.,
2012). Therefore, when the descending drive to TA increases, the activation of TA also
increases. Conversely, if the descending drive to TA is impaired due to a lesion at the
brain level of the neuromotor axis, TA activation should be decreased as well. In the past,
studies that attempted to elucidate the descending drive to TA during walking employed
associations with either kinematic measures or clinical measures (Barthelemy et al.,
2013; Barthelemy et al., 2015; Barthelemy et al., 2010); therefore, there is no evidence
about the relationship between the descending drive to TA and the activation of TA in
stroke participants. In disagreement with our hypotheses, results indicated that neither TA
latencies were significantly associated with the activation of the paretic TA while the
associations were positive rather negative.
During walking, the AAV decreased as both resting raw latency and active
normalized latency of paretic TA increased. The significant, negative, and strong
associations between latency and AAV were one of the most robust results in our study.
As previously discussed, one of the TA’s primary functions during walking is to clear the
foot sufficiently during early and mid-swing. For this reason, previous studies examined
the relationship between the descending drive to TA and toe clearance during mid-swing,
in both healthy individuals and people with SCI. Similar to our results, they demonstrated
a significant and negative association between the latency of the most impaired TA and
toe clearance (Barthelemy et al., 2013; Barthelemy et al., 2010). Their results suggested
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that delayed TA latency might indicate impaired toe clearance, which may either cause

the emergence of compensatory walking patterns or increase the risk of potential falling
due to foot scuffing. For reasons that have been explained in section 2.6.4, here we chose
AAV to quantify kinematically the function of TA during early to mid-swing. As in the
two aforementioned studies, findings from the present study suggest that delayed TA
latency, either resting or active, can also indicate an impaired biomechanical pattern of
the ankle during early to mid-swing.
During MVIC, activation of the paretic TA was not significantly associated with
either MCE measure of the paretic TA. We expected that the more impaired the
descending drive to TA was, the less the activation of the paretic TA would be during
paretic dorsiflexion isometric torque. The non-significant associations for either latency
might imply that impaired conductivity may not be a good indicator of TA activation
during MVIC. Our findings are in agreement with Beaulieu et al. (2014). In that study, no
significant associations between six MCE measures of the paretic TA, including
normalized latency, and MVIC EMG were found. Findings from both studies suggest that
TA MCE cannot indicate the activation of the paretic TA during MVIC.
Paretic dorsiflexion torque was not significantly associated with either latency of
the paretic TA, yet both associations were negative as we predicted. As in walking,
delayed latency of the paretic TA indicated less production of the paretic ankle
dorsiflexion torque. However, only active normalized latency was strongly associated
with the reduction of torque. This might have occurred because during active conditions
motoneurons are excitable similar to MVIC whereas during resting motoneurons are
silent. Contrary to our results, Beaulieu et al. (2014) found a significant association

between MCE and isometric strength of the paretic TA. Yet, that MCE measure was
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MEP amplitude. In their study, amplitude of the paretic TA increased as the strength of
the paretic TA increased. Therefore, the cumulative evidence from both studies suggests
that the MEP amplitude of the paretic TA may indicate the production of the paretic
dorsiflexion torque, yet not latency.

5.7

Aims 3 and 4: Clinical Applications, Methodological Considerations, and

Future Work
Findings from this study may provide insight into the understanding of the
descending drive to the paretic SOL and TA, two muscles that have an important role
during various motor tasks and are impaired after stroke. Furthermore, the findings may
have important clinical applications. Up until now, the studies that attempted to elucidate
this matter in clinical populations were limited only to associations with clinical measures
and the TA (Arac et al., 1994; Barthelemy et al., 2013; Barthelemy et al., 2015;
Barthelemy et al., 2010; Beaulieu et al., 2014; Hendricks et al., 2003; Piron et al., 2005;
Steube, Wietholter, & Correll, 2001). First, numerous factors other than just
neuromechanics may affect the outcome of the clinical measures; therefore, an existing
association between the descending drive and a clinical measure may not elucidate the
exact relationships between the MC and the target muscle during a motor task. Second,
although TA has a crucial role during the GC, especially during the swing phase,
exclusive focus on the descending drive to the TA does not clarify fully what the the
cortical contributions are during the whole GC, both stance and swing phase. This issue is
one of the reasons that we examined the SOL, which is mainly active during the stance
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phase of gait. Therefore, investigating the relationships between the descending drive and

the neuromechanics of both muscles during two motor tasks that may require neural drive
in different patterns may shed light on to what extent MC in a lesioned brain contributes
to the activation of the SOL and TA during a functional and isolated motor task. Limited
evidence exists only in healthy individuals (Capaday et al., 1999). Here, we demonstrated
statistically that only TA MCE could indicate neuromechanical patterns during walking.
Our study is the first that has investigated the descending drive to the ankle antagonist
muscles and the associations with specific neuromechanical measures during walking and
MVIC in individuals post-stroke. Two MCE measures of the paretic TA were strongly
associated with the same neuromechanical measure (AAV) only during walking. This
finding implies that motor cortical contributions from a lesioned brain can strongly
indicate an impaired mechanical pattern of the paretic ankle, during a specific phase of
walking. Thus, these findings may have clinical implications; however, the clinical
relevance of the SOL results may not be as clear. As the latency of the descending drive
to the paretic SOL increased, the activation of the paretic SOL during the stance phase of
walking also increased. However, it is not clear whether a reduction in latency would
mitigate or exacerbate the motor function of that muscle during walking. Conversely, a
delayed descending drive to the paretic TA does detrimentally influence the mechanics of
the paretic ankle during the swing phase. Therefore, an intervention that can strengthen
the conductivity of the descending drive to the paretic TA may improve mechanical
patterns during specific motor tasks in people post-stroke.
An potential neurophysiological approach is the use of non-invasive brain
stimulation techniques, such as repetitive TMS (Lefaucheur et al., 2014) and transcranial

direct current stimulation (Feng, Bowden, & Kautz, 2013); both technologies can
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modulate the excitability of intracortical networks. Within the last few years, a few
studies investigated whether these two techniques can improve walking ability in people
post-stroke. The results demonstrated that brain modulation enhanced both
neuromechanical and clinical measures of walking (Chang, Kim, & Park, 2015; Chieffo
et al., 2014; Kakuda et al., 2013; van Asseldonk & Boonstra, 2015; Wang et al., 2012).
Although the results from these studies are promising and interesting, further
investigation is required on this topic.
A few methodological considerations were present in Aims 3 and 4. The first is
the relatively small sample size used for the correlational analyses of each muscle. Power
analysis using results from the few studies that examined the relationships between the
descending drive to TA and a mechanical measure in either stroke or SCI (Barthelemy et
al., 2013; Barthelemy et al., 2015; Barthelemy et al., 2010; Beaulieu et al., 2014),
demonstrated a minimum of 12 participants should be recruited to detect a statistical
significance. Of the 15 recruited stroke participants, data from 14 participants were
collected. Yet, the final sample size for SOL and TA was 10 and 13, respectively, due to
no MEP responses detected for some stroke participants on day 2. Thus, the correlational
analyses were limited to stroke participants with detectable MEPs in the paretic SOL and
TA. Interestingly, the four participants with no detectable MEPs in either muscle
successfully completed both walking and MVIC tasks; they activated both muscles and
produced force similar to a healthy adult, especially during walking. There is some
evidence that stroke participants with a discontinued CST are able to produce walking
patterns (Ahn, Ahn, Kim, Hong, & Jang, 2006; Seo et al., 2014). However, as previously
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stated, no detecting a MEP does not necessarily imply absent MCE for that target muscle.
Multiple methodological (e.g., not strong enough coil) and physiological (e.g. low level
of arousal) factors could explain the undetectable MEP responses in these four stroke
participants.
A second methodological consideration is that the SOL and TA MCE were not
assessed during the task that the SOL and TA neuromechanics were calculated. We do
acknowledge that this discrepancy may affect the results, yet we chose this methodology
for several reasons. First, we did not have access to the equipment used for TMS
application during walking. To the best of our knowledge, only one group has this
technology in the United States (Hajela, Mummidisetty, Smith, & Knikou, 2013; HannaBoutros et al., 2015; Knikou et al., 2013). Along with the application of TMS during off
task, the application of TMS during a motor task may not necessarily elucidate fully the
cortical contributions to that muscle during that task. Nevertheless, findings from this

study, in which methodology was tightly controlled, may assist in the improvement of the
methodology of studies that use TMS during walking.
Another methodological consideration specific to the walking task was the large
range of SSWS (0.20 – 0.95 m/s) of the stroke participants. In general, walking speed has
an effect on walking neuromechanics (Kirtley, Whittle, & Jefferson, 1985; Panizzolo et
al., 2013; Peterson, Kautz, & Neptune, 2011). Although we did not run any betweensubject comparisons, having participants walk at the same speed could potentially reduce
the between-subject variance of neuromechanical measures. A similar methodological
consideration is the potential between-subject variance within the EMG data, due to
different thicknesses of subcutaneous fat tissue over the target muscles. Specifically,
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subcutaneous fat thickness is negatively associated with sEMG amplitude; the greater the
subcutaneous fat tissue, the smaller the sEMG amplitude (Hemingway, Biedermann, &
Inglis, 1995; Nordander et al., 2003). In our study, we did not measure the subcutaneous
fat tissue thickness; therefore, stroke participants with thick subcutaneous fat tissue over
the target muscles might have smaller sEMG amplitudes. However, small sEMG
amplitudes might not be a true indication of low muscle activation. A solution to this
issue is to measure subcutaneous fat tissue thickness using a skinfold caliper, which is
easy to use, inexpensive, and better tool than ultrasound for calculating fat tissue

(Nordander et al., 2003). Future studies should measure the thickness of subcutaneous fat
tissue and use it as a covariant within their statistical analyses. A last methodological
consideration is that we did not normalize walking EMG to MVIC EMG, which is the
most commonly used normalization method. Though we do acknowledge the pros and
cons of EMG normalization (Cronin, Kumpulainen, Joutjarvi, Finni, & Piitulainen, 2015;
Sousa & Tavares, 2012), we decided to use the raw EMG values in the correlational
analyses.
Future work should extend the understanding of these relationships between the
descending drive and neuromechanical measures of SOL and TA. Correlational analyses
are limited to the description of the relative strength and direction between two measures.
An alternative is regression analyses, which could be used for a deeper understanding of
that relationship using the basis of prediction, yet to run regression analysis a larger
sample size is required than for a correlational analysis. Since we found a significant and
strong association between the MEP latency of the paretic TA and the angular velocity of
the paretic ankle, a first step for future studies is to investigate the regression between

these two measures. Of course, a larger sample size than the one used here should be
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utilized. For example, if a normalized latency of the paretic TA is shown to be a strong
predictor of the angular velocity of the paretic ankle, this finding implies that stroke
participants who have delayed descending drive to the paretic TA will demonstrate
impaired ability to move the paretic ankle during swing. If this is the case,
neurorehabilitation scientists can use these findings to develop either a behavioral or a
neurophysiological intervention to reverse this relationship. Furthermore, future work
should further investigate whether these relationships are present in other clinical
populations, such as SCI and Parkinson’s.
5.8

Conclusions
The present study was a first attempt to thoroughly quantify certain MCE

measures of SOL and TA in both healthy controls and stoke participants, and to elucidate
the relationships between reliable MCE measures and the neuromechanics of the paretic
SOL and TA during walking and MVIC. Despite the fact that nearly all MCE measures
are currently used in studies to quantify the MCE of these two muscles, findings from this
study showed that only a few measures can be reliably measured, and can detect
differences between a neurologically intact and impaired nervous system. Furthermore,
using correlational analyses, we found that certain relationships exist between the
descending drive and neuromechanical measures of the paretic SOL and TA in stroke
participants. Future studies may use our findings to accurately quantify the SOL and TA
MCE in either healthy or stroke participants and to expand knowledge about the role of
the descending drive to SOL and TA during motor tasks in neurologically impaired
adults.
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Medical University of South Carolina
Center for Rehabilitation Research for Neurological Conditions
MRI Screening Questionnaire
Study:___________________________

Investigator:_______________

Subject ID:________________________

Date:_____________________

Subject Weight: ____________________

Subject Age: _______________

MRI Screening Questionnaire: Directions- Ask participant the following questions and record
the answers accordingly. Any additional notes may be written at the lower ‘Notes’ section.
Yes

No

1. Have you had prior surgery? (If yes, state type and date of surgery in
‘Notes’)
2. Have you ever had ear surgery (cochlear implant or staples)?
3. Do you have metal clips in your head or brain from previous surgery?
4. Do you have a pacemaker or replacement valve?
5. Have you ever been exposed to metal being welded, drilled, or cut?
6. Is there any possibility of metal/metal pieces in your eyes?
7. Have you ever been treated for metal in your eyes?
8. Have you ever been shot?
9. Do you have any metal in your body (like shrapnel, bullets, or
implants)?
10. Do you have a permanent tattooed eyeliner, wig, or hairpiece?
11. Do you have an infusion pump implant for taking insulin or
medication?
12. Do you have a nerve stimulator implant (TENS unit)?
13. Do you have a false eye, especially one that is magnetic?
14. Do you have dentures or removable dental bridges?
15. Do you think you are claustrophobic?
16. Do you have any trans-dermal patches (i.e. nicotine patch)?
17. Female: Are you pregnant?
18. Female: Do you have an IUD?
Is there any possibility of metal, metal pieces, or metal implants in your body? Yes

No

Notes:

____________________________________
Signature of Person Obtaining Screening

_________________________
Date

Medical University of South Carolina
Center for Rehabilitation Research for Neurological Conditions
TMS Screening Questionnaire
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Study Name: __________________________________________________________________
Pro#: _____________

Subject ID: ____________________

Your head will be exposed to a strong magnetic pulse. To maximize safety, please answer the
questions below. Please do not hesitate to ask any questions you may have regarding any of the
questions.

Contraindications:
Do you have, or have you ever had, any of the following? If Yes, please explain.
Y

N

1. Metallic or plastic hardware, plates, or prosthetics on your scalp?

Y

N

2. Cardiac Pacemaker

Y

N

3. Implanted medication pumps, intracardiac line, or central venous catheter

Y

N

4. Prior diagnosis of seizure or epilepsy

Y

N

5. Any electrical, mechanical, or magnetic implants

Y

N

6. Any body or clothing metal above your shoulders.

Y

N

6a. If yes to #6, are you willing and able to remove the item(s) for testing?

Y
N
7. Any metal on your body (i.e. watch or jewelry, hair holders or pins, eye
glasses, body piercings, wallet, keys)?
Y

N

7a. If yes to #7, are you willing and able to remove the item(s) for testing?

Precautions:
Do you have, or have you ever had, any of the following? If Yes, please explain.
Y

N

1. Previous brain neurosurgery

Y

N

2. Is there any possibility you are currently pregnant?

Y

N

2a. If yes to #2, what is the date of the last menstrual period?_______________

Y

N

3. Migraine Headaches

Y

N

3a. If yes to #3, are the migraine headaches controlled?

Please list current medications: We are looking for the presence of any medicines that affect
seizure threshold such as tricyclic antidepressants and neuroleptics).
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_______________________________

_______________________________

_______________________________

_______________________________

_______________________________

_______________________________

_______________________________

_______________________________

_______________________________

_______________________________

Signature of Study Personnel: _______________________________ Date: ______________

Medical University of South Carolina
Center for Rehabilitation Research for Neurological Conditions
Fugl-Meyer Lower Extremity Assessment Form
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MOTOR FUNCTION - Lower Extremity
TEST
I. Reflex Activity

ITEM
Achilles
Patellar

II. A. Flexor Synergy (in supine)

Hip flexion
Knee flexion

SCORE

SCORING CRITERIA
0-No reflex activity can be elicited
2-Reflex activity can be elicited
0-Cannot be performed at all
1-Partial motion
2-Full motion

Ankle dorsiflexion
II. B. Extensor Synergy
(in sidelying)

Hip extension
Adduction

0-No motion
1-Weak motion
2-Almost full strength compared to normal

Knee extension
Ankle plantar flexion
III. Movement combining synergies
(in sitting: knees free of chair)

A. Knee flexion
beyond 90°

B. Ankle dorsiflexion

IV. Movement out of synergy (in
standing, hip at 0°)

A. Knee flexion

B. Ankle dorsiflexion

0-No active motion
1-From slightly extended position, knee can be
flexed, but not beyond 90°
2- Knee flexion beyond 90°
0-No active flexion
1-Incomplete active flexion
2-Normal dorsiflexion
0-Knee cannot flex without hip flexion
1-Knee begins flexion without hip flexion, but does
not reach to 90°, or hip flexes during motion
2-Full motion as described
0-No active motion
1-Partial motion
2-Full motion

V. Normal Reflexes (sitting)

Knee flexors
Patellar
Achilles

0-At least 2 of the 3 phasic reflexes are markedly
hyperactive
1-One reflex is markedly hyperactive, or at least 2
reflexes are lively
2-No more than one reflex is lively and none are
hyperactive

VI. Coordination/speed - Supine:
Heel to opposite knee (5 repetitions
in rapid succession)

A. Tremor

0-Marked tremor
1-Slight tremor
2-No tremor
0-Pronounced or unsystematic dysmetria
1-Slight or systematic dysmetria
2- No dysmetria
0-Activity is more than 6 seconds longer than
unaffected side
1-(2-5) seconds longer than unaffected side
2-Less than 2 seconds difference

B. Dysmetria

C. Speed

Total Maximum Score of the Lower Extremity =
0-34

TOTAL SCORE OF THE LOWER EXTREMITY:

Tally 1_____________(Max = 34)

(Check addition – Tally 2 MUST EQUAL Tally 1)

Tally 2_____________(Max = 34)

